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ABSTRACT
Hospices and support teams offering palliative care have
increased by over four fold in the U.K. during the last decade.
However, evaluations have been limited, often because of a lack
of suitable outcome measures. This study aimed to develop and
test the validity and reliability of a measure of palliative care
provided by support teams.
Through detailed discussion of work objectives with care staff,
assisted by review of the literature, the Support Team Assessment
Schedule (STAS) was developed. 	 STAS has 17 items, each scaled 0
(best) to 4 (worst), with definitions for each scale point.
Median time to complete a STAS rating was 2 minutes (range <1
15). Face validity was demonstrated by use in five settings.
Criterion validity was assessed by comparing team ratings with
ratings from patients and family members (or other carers)
collected through interview. Patient and team ratings showed
moderate correlations (rho ranging 0.45 - 0.66 for 5 out of 7
items): team ratings were usually closer to those of patients
than those of family members. As a test of construct validity,
quality of life (HCRA-QL) index items were shown to correlate
with similar STAS items in patients more than four weeks before
death (a STAS sub-scale of six items was correlated with the
total HRCA-QL, Spearman rho -0.45).
Reliability of STAS was assessed by comparing the ratings of
different staff. Out of a total of 45 patient assessments, 16
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items showed agreement or ratings within one score in 88% or more
cases, Cohen's Kappas were greater than 0.48 (up to 0.87) and
were highly significant (p ( 0.0005). There were high
correlation coefficients (Spearman's rho ranged 0.65 - 0.94).
Split-half reliability and internal consistency was assessed
using Spearman Brown coefficients and Cronbach's alpha for
ratings at referral, at death or discharge, and on all weeks
(combined). The coefficients ranged 0.68 - 0.89: slightly higher
than the coefficients found for the HRCA-QL index.
Serial scores of patients that improved (the majority) and
deteriorated (a minority) under care, and results from first and
last assessments of patients under the care of five support
teams, indicate that the STAS was discriminating in practice.
Although STAS was used to audit support team care the items are
relevant to the assessment and evaluation of palliative care in
other settings.
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1. INTRODUCTION
This thesis describes the development, validity, reliability
and practicality of a new measure of palliative care, the Support
Team Assessment Schedule (STAS).
Palliative services have expanded rapidly during the last 20
years, to assist in the provision of holistic care and relief of
symptoms for dying patients and their families. This expansion
has brought new challenges for accountability, evaluation and
research (Dush and Cassileth 1985). In a climate of increased
cost effectiveness within the health services, hospice growth
will not be supported by health authorities unless the care is
evaluated. Hillier (1988) pointed out that for the new
speciality to speak with authority those working in palliative
care "must continue to plan services, strive for long term
funding and be willing to submit themselves to audit and peer
review".
Although a wide variety of measures have been developed to assess
health status and quality of life or to aid clinical practice,
none adequately assesses the outcomes of palliative care. These
measures tend to concentrate on functioning or daily living, or
on single aspects such as pain. They have not included the wider
aims of palliative care and have rarely included any assessment
of the family's experience. When measures were adapted for
palliative care they were usually insensitive to changes close to
death.
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Evaluations have been hampered by the lack of measures and
failings in research design. These have assessed various
outcomes believed to be associated with good palliative care,
including pain and symptom control, daily living or quality of
life (using established scales), patient and family anxiety,
depression and satisfaction, place of care and cost to the health
service (e.g. Parkes 1979a and 1980, Cartwright and Seale 1990,
Kane et al 1985, Mor el al 1988c, McCusker and Stoddard 1987).
No study has found palliative care to be worse than conventional
care in these respects. In some cases little difference has been
found (Parkes 1985, Morris et al 1988), but more commonly
palliative care has been associated with increased satisfaction
and better symptom control, and home care with greater periods in
the terminal period spent at home (Parkes 1979b and 1980, Hinton
1979, Hannan and O'Donnell 1984). However, only two randomised
controlled trials have been carried out on hospice services, both
in the USA. One showed little difference between in-patient
hospice and conventional care (Kane et al 1984 and 1985,) the
other demonstrated benefits for home care (Zimmer et al 1984). In
both conventional and hospice settings the care of dying
patients is suggested to have improved over the years. This has
been attributed largely to the educational effect of the hospice
movement (Parkes 1985).
The cost of care has been studied in many units. In-patient
hospice care varies from unit to unit , but is usually cheaper to
the health service than conventional care (Hill and Oliver 1984
and 1988, Kidder 1988b). Home care is considerably cheaper, at
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between one quarter and one third the cost to the health service
(see Parkes 1980, Kidder 1988a and 1988b).
The evaluations to date show that palliative care is a viable
alternative to conventional care. Future evaluations will need
to demonstrate the effectiveness of care, and in particular to
identify where care is most effective. Clinical audit is one
method of achieving this, although before this can proceed better
measures are needed.
This project aimed to develop valid, reliable and practical
outcome measures of palliative care. The measures are aimed
primarily for use in support team and community settings, and for
use in the audit of care, although their adaptation for other
settings is discussed. The work required a number of stages.
First, the items and ratings for the Support Team Assessment
Schedule (STAS) were developed and then tested for face, content
and consensus validity and initial practicality. Then criterion
and construct validity, reliability and internal consistency of
STAS were tested. Finally, STAS was tested for practicality in
the audit of five support teams in the south east of England, and
the results analysed to determine the effectiveness of care.
The discussion considers the methodological difficulties
encountered during the work, possible ways these may have been
overcome, the properties of STAS compared with other measures,
and the potential future developments and uses of STAS. A
summary of conclusions is given.
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2. AIMS
2.1 Aim
To develop outcome measures of palliative care which were valid,
reliable, practical and useful to audit palliative care in
support team and community setting.
2.2 Objectives
The aim included the following objectives:
1. To develop items suitable as outcome measures for palliative
care which reflected the work and goals of palliative teams.
2. To develop methods of scaling the items in the measure.
3. To test the face, content and consensus validity of the measure.
4. To test the practicality of the measure for an audit of care.
5. To test the criterion and construct validity of the measure.
6. To test the internal consistency and inter-rater reliability
of the measure.
7. To determine if the measure could be used to assess the
effectiveness of palliative care in different support teams, and
provide useful information on when and where care was not
effective.
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3. LITERATURE
3.1 Palliative care
3.1.1 Development of palliative services
Over the last 20 years there has been an increasing interest in
the care of dying patients, especially cancer patients. In the
U.K. and Ireland the number of in-patient specialist units or
hospices grew rapidly from 17 in 1969 to 145 (with 2,600 beds) in
1990 (Lunt and Hillier 1981, Hospice Information Service 1990).
The number of support teams, offering palliative care at home or
through advice in hospitals, in the U.K. has grown exponentially
in the last 21 years, from the first team in 1969 (Parkes 1980)
to 317 teams in 1990 (Hospice Information Service 1990). In 1988
palliative medicine became a medical speciality (Hillier 1988).
A similar growth has occurred in the United States of America
(USA) which has over 1,500 hospice programmes and in Canada which
has over 200 (Mor and Masterson-Allen 1987, National Hospice
Organisation 1985). In Australia there has been a rapidly
expanding growth in interest and services over the last six years
(Cavenagh and Gunz 1988). 	 In November 1988, the Hospice
Information Service (1988) knew of 30 hospice programmes in
Australia. Lichter (1990) describes 23 in New Zealand. In other
European countries services are expanding more slowly: Germany is
% known to have five in-patient hospices and three support teams,
and France one in-patient hospice and 12 services offering
support at home (Hospice Information Service 1988). However,
many new services are planned (see, for example, Albrecht 1990).
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3.1.2 Why was palliative care developed?
There were several reasons for this growth. A variety of studies
showed that dying patients suffered severe, unrelieved symptoms,
particularly pain, had unmet practical, social and emotional
needs, and suffered as a result of poor communication, both
between health professionals and from them (Wilkes 1965 and 1984,
Cartwright et al 1973). Their families also had suffered poor
communication from health professionals, and needed emotional,
practical and bereavement support (Parkes 1978, Bowling and
Cartwright 1982, Cartwright et al 1973). Cancer patients were
found to have high psychiatric morbidity, while their families
often developed social and psychiatric problems (Maguire 1980).
Attention shifted to home care when further work emphasised the
increased severity of many problems while the patient was at
home, where the main burden of care fell (Ward 1974). Also, care
at home could be provided more cheaply and may be preferred by
many patients (Working Group on Terminal Care 1980, Creek 1982).
The voluntary sector was largely responsible for initiating many
of these studies and outlining standards of good practice (Lunt
and Hillier 1981, Saunders 1978). Taylor (1983) argues that the
voluntary nature of early hospices gave them the opportunity to
develop their own models of care and to establish standards of
excellence.
3.1.3 The palliative model of care
Palliative care is concerned with the study and management of
patients, and relief of their suffering, when cure is impossible.
The focus of care is the quality of remaining life (Doyle 1987).
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Many clinicians describe these patients as terminally ill.
Hospices and support teams specialise in providing palliative
care, although many patients on general wards in hospitals also
require palliative care.
Although in Britain the term hospice usually refers to a unit
with in-patient beds, in the USA the terminology differs. There,
hospice refers to the philosophy of care, and hospices programmes
include in-patient units and home care support teams. This
thesis will use the British definition, and will attempt to
clarify whether the American units provide in-patient or home
care.
Hospices
Hospices offer symptomatic, spiritual, social and emotional
support and treatment to people suffering from a terminal
illness, usually a cancer. Support following bereavement is also
offered. The unit of care is the patient and his/her family and
friends. The hospice model is of holistic care in a homely
atmosphere (Saunders 1978, Parkes 1979a, Taylor 1983). Most
patients admitted to hospices are no longer responding to
curative treatment, but there are exceptions (McCusker 1983).
Patients may be admitted for care until death, for respite care,
or for control of symptoms (Saunders 1978, Parkes 1979a, McCusker
1983). The average length of stay is short (St Joseph's Hospice
1988, reported a mean stay of 21 days).
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Hospices are often independent buildings, sometimes on a hospital
site but more usually in a separate unit, such as a converted
house or home. Occasionally, a ward or dedicated beds within an
NHS hospital block are deemed a 'hospice' (Hospice Information
Service 1990). Most hospices (112 out of 145, 77%) are funded
wholly or mainly by voluntary contributions, including
contributions from cancer charities, e.g. the Cancer Relief
Macmillan Fund, Marie Curie Cancer Care, (calculated from
listings in Hospice Information Service 1990). In 1989, the
Department of Health gave eight million pounds to voluntary
hospices and support teams in England and Wales: this money was
distributed by Regional Health Authorities (Department of Health
1989a). In 1991 the figure rose to seventeen million pounds
(Department of Health 1991). The Scottish Home and Health Office
already provided funding to voluntary hospices.
Support Teams
Support teams are based either in hospices (32%), hospitals (13%)
or in community units (55%) and usually work within the National
Health Service (calculated from listings in Hospice Information
Service 1990). They visit and advise on any patients admitted to
hospital, although the teams rarely have admission beds for their
own use. They accept referrals from hospital specialists and
general practitioners but will visit patients at home only if the
general practitioners agree. In the community, the general
practitioner and community nurses are expected to remain involved
in the patient's care and offer 24 hour on-call care; however,
teams provide extra support for these community services, both
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with advice and shared care, some teams also providing a 24 hour
on-call service (Parkes 1980, Ward 1985, Lunt and Yardley 1986).
3.2 Measures of health care and palliative care
3.2.1 Structure, process and outcome: the underlying model for the
measurement of health care
The model of structure, process and outcome has been used over
the last 40 years to measure health care. It is adapted from
manufacturing industry: raw materials (structure or input) are
handled in a certain manner (process) to produce a finished
article (outcome) (Shaw 1980).
Sheps outlined the earliest model (Donabedian 1980). He
classified hospital quality assessment into four categories, the
pre-requisites, elements of performance, clinical evaluations,
and effects of care (Sheps 1955). Donabedian (1966) built on
this theme, and outlined three approaches to assess quality -
structure, process and outcome. His categories were similar to
Sheps, but combined the two middle components of the Sheps model
into process (Table 3.1). Recently, variations on this triad
have been suggested, although these incorporate Donabedian's
basic framework (Table 3.1).
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Table 3.1 Alternative formulations of approaches to quality assessment
and their interrelationships. Source, Donabedian 1980.
Investigator	 Elements of the Formulation
1. Sheps	 Prerequisites,	 Elements	 Clinical	 Effects
1955	 desiderata	 of performance evaluations 	 of care
1	 \ /	 1
2. Donabedian	 Structure	 Process	 Outcome
1966
1	
1	 I	 Eind	 1
Conte .	Configuration	 result Impact
\/
4. Donabedian	 Structure	 Process
	 Outcome
\ / \ I
(modified)
1970
5. Dror	 Input	 Structure	 Process	 Nominal output	 Real output
1968
1	 /\ / \
3. De Geyndt	 Structure	 Content	 Process	 Outcome Impact
1970
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3.2.2 Structure, process and outcome: in health care
In health care, structure represents the relatively stable
characteristics of the providers of care, of the tools and
resources they have at their disposal, and the physical and
organisational settings in which they work (Donabedian 1980).
Structure includes the human, physical, and financial resources
needed to provide health care.
Process represents the activities that go on with and between the
practitioners and patients. In simpler terms, Shaw (1980)
described it as the use of resources. It includes measures of
throughput and whether patients were assessed and treated
according to agreed quality guidelines (Donabedian 1980), such as
treatment protocols. Guidelines are based on the values or
ethics of the health profession or society (Donabedian 1980).
Outcome represents the change in a patient's current and future
health status that can be attributed to antecedent health care.
If a broad definition of health is used, such as the World Health
Organisation (WHO) (1947) definition of total physical, mental
and social well-being, then improvements in social and
psychological functioning are included. Donabedian (1980)
included patient attitudes (including satisfaction), heath-
related knowledge and health related behaviour within the
definition of outcome.
The structural characteristics of care influence the process of
care so that its quality can be either diminished or enhanced.
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Similarly, changes in the process of care, including variations
in its quality, will influence the effect of care on health
status and outcomes.	 Thus, there is a functional relationship
as follows:
structure	 -->	 process	 -->	 outcome.
3.2.3 Measures of structure, process and outcome: their use and
meaning
Structure is easiest to measure because its elements are the most
stable and identifiable. However, it is an indirect measure of
the quality of care and its value depends on the nature of its
influence on care (Donabedian 1980). Structure is relevant to
quality in that it increases or decreases the probability of a
good performance. Although structure is important in designing
health services, to measure the quality of care it can only
indicate general tendencies.
Process is one step closer to changes in the health status of
individuals. The advantage of process is that it measures the
most immediately discernible attributes of care activities.
However, it is only valuable as a measure once the elements of
process are known to have a clear relationship with the desired
changes in health status (Donabedian 1980).
Outcome reflects the true change in health status, and thus is
the most relevant for patients and society. 	 However, Donabedian
(1980) argued that changes in health status are useful as a
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measure of quality of care only if other causes for change have
been eliminated. For example, prior care or other factors may be
equally important. A useful approach is to focus on the
difference between the desired outcome and the actual outcome
(Shaw 1980). Services can then identify whether or not their
goals are being achieved and investigate any failings.
3.2.4 Choosing measures relevant to the goals of care
It is important to ensure that measures are relevant to the goals
of care, as this influences validity (De Geyndt 1970). For
example, it is not appropriate to use mortality rates to assess
care which aims to reduce pain, discomfort and anxiety
(Donabedian and Arbor 1982). Also, when monitoring the effects
of an intervention, instruments should be able to measure those
aspects of health and disability that are susceptible to change
within the time span of the study (Bowling 1988). MacKenzie et
al (1986) demonstrated that, although the Sickness Impact Profile
described the functional status of different groups, it was
unable to detect improvements in patients.
Relevant outcome measures are much more difficult to develop than
process measures, especially if these are to include the total
definition of health. Over the last 40 years it has becomes
increasingly important to develop relevant outcomes for health
care. Mortality rates have reduced during this century and, as a
consequence, health care has aimed increasingly to improve health
status and quality of life (Katz 1987). The development of
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palliative care is a move even further in this direction - to
improve quality of life while a person is dying, and to improve
the quality of death.
The following sections will review measures of health status and
quality of life and their value in palliative care.
3.2.5 Health status and clinical measures
Florence Nightingale was one of the first to use outcome measures
other than mortality: she used three categories, 'relieved,
unrelieved or dead' (Rosser 1985). Since then, a wide range of
clinical and health status measures have been developed. These
include quick scoring systems to aid clinical practice or
decision making (e.g. the Apgar score, Apgar et al 1958, or the
Trauma Score, Boyd et al 1987); measures designed for
epidemiological research (e.g. the Nottingham Health Profile,
Hunt et al 1984); and measures for clinical research (e.g.
measures of quality of life for use in cancer trials, Ganz et al
1990, Hollandsworth 1988).
3.2.6 Positive versus negative health
Measures of health status usually take health as a baseline and
then measure deviations away from this (Bowling 1991). 	 In
effect they measure ill health. It is easier to measure
variations from health than to measure health itself (Bowling
1991). Early measures concentrated on the absence of disease,
and then later on symptoms, mobility, the ability to carry out
everyday tasks. Later still, the concept of social health was
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developed. Donald et al (1978) described this as follows:
'Measurement of social health focuses on the individual and
is defined in terms of interpersonal interactions (e.g.
visits with friends) social participation (e.g. membership
in clubs). Both objective and subjective constructs (e.g.
number of friends and a rating of how well one is getting
along respectively) are included in this definition'.
Broad measures of health status include the Sickness Impact
Profile (Bergner et al 1976) and the Nottingham Health Profile
(Hunt et al 1984). Although neither measures positive
functioning both include components which measure the impact of
illness on the person's life and well-being. Separate measures
have been developed to measure psychological status, for example
the Hospital Anxiety and Depression Scale (Zigmond and Snaith
1983) and the General Health Questionnaire (Goldberg and Hillier
1979). The measures of health status, quality of life and
psychological status have been reviewed in detail by Bowling
(1991), Maguire and Selby (1989), Selby and Robertson (1987),
Teeling Smith (1988), and Fowlie and Berkeley (1987).
3.2.7 Assessment of people with different levels of functioning:
health status versus quality of life
There is disagreement in the literature as to the correct use of
the terms health status and quality of life measures. Some
authors, for example Ware (1987), argue that the term 'quality of
life' has been introduced to distinguish measures from those
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which only considered the 'old narrow definitions of health'
(i.e. death and disease). This can cause confusion, for in
addition to health Ware (1987) proposed that quality of life
measures should encompass 'standard of living, quality of
housing, the neighbourhood in which one lives and job
satisfaction'.
However, Spitzer (1987) suggested that health status and quality
of life measures should be used for people with different levels
of health. He described a spectrum of health states from perfect
health to terminal illness. These are shown in Fig. 3.1.
Near
death
PerfectlyDefinitely Transitional / Ostensibly
-7 ill -7 zone -7 healthy healthy
Fig. 3.1 Spectrum of health status states. Source: Spitzer
(1987).
The choice of measure depends on the position of those studied
along this spectrum. Others support this view. Bowling (1991)
notes that when studying severely ill populations, the best
strategy may be to employ measures of negative health status.
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Spitzer (1987) proposed that health status measures should be
'reserved primarily for assessments of ostensibly healthy people,
usually in the context of aggregates of unselected
geographically-defined populations or catchment area ..of a
service programme'. Measurements of quality of life should be
restricted to the assessment of a series of attributes among
those definitely sick.
In the transitional zone both types of measures meet and may
overlap, alternatively a third type of measures may be needed for
this zone (Spitzer 1987).
In practice, Spitzer's (1987) theory has weaknesses. Health
status measures are of limited use in healthy populations because
they rely on a negative definition of health, as already
described. In the general population, health status measures
provide little information on 80-90% of general populations
(Bowling 1991). To provide information on this large group, the
'perfectly healthy' end of Spitzer's spectrum would need to be
expanded, to compare, for example, an athlete and an office
worker.
Similarly, problems occur when populations of near death patients
are considered. Spitzer (1987) argued that this could be
overcome, and that quality of life scales 'can be modified in a
minor way to increase discrimination at the end of the morbidity
spectrum where people are very sick and in fact are terminally
29
ill'. The later sections of this review will examine the use of
scales in patients near death and consider whether the scales
were sufficiently sensitive and where problems occurred.
3.2.8 Measures specifically for cancer patients
Aggressive chemotherapy or other treatments have been used
increasingly to treat cancers which are not curable or are rarely
curable. Measurement of quality of life in these patients is
highly relevant, although reviews of studies have found that
frequently quality of life was not recorded or was poorly
documented (Clark and Fallowfield 1986).
Cancer is not one disease. There are many different types of
cancer, with different presentations, symptoms and prognoses.
Nevertheless, scales have been developed to measure health status
and quality of life in patients who either have 'cancer' (any
type) or who have certain types of cancer (e.g. lung cancer, see
Aaronson et al 1987).
In a review of 6 measures, Clark and Fallowfield (1986) described
their validity, administration and scoring. Karnofsky's (1948)
performance status measure is perhaps the oldest, and although
this is limited to functional activity (rated 100 = normal, 10 =
moribund) it is widely used by clinicians. However,
psychological and mental difficulties often accompany illness,
and patients with depression and anxiety are likely to show a
decline in their enjoyment of life. It is important that
measures include the psychological aspects of illness, and the
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Karnof sky index is limited because it does not. Measures of
general mental health items, such as anxiety, nervousness,
positive and negative affect, may not be appropriate for
diagnosing specific mental disorders such as depression. This
requires separate measures such as interview schedules designed
to standardise the diagnosis of selected mental disorders
(Donovan et al 1989).
Details of some commonly used measures are shown in table 3.2.
Many reviews consider the available measures of quality of life
and health status, and provide guidance on their appropriate use
and analysis. Examples are given in the references, see Maguire
and Selby (1989), Donovan et al (1989), Aaronson (1991), and
Fayers and Jones (1983).
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Measure Description
Table 3.2 Selection of some common quality of life, health status and mental
health measures used in cancer clinical trials.
Karnofsky Performance
Status scale (KPS)
(Karnofsky 1948)
Eastern Co-operative
Oncology Group (ECOG)
(Zubrod et al 1960)
Cancer Inventory of
Problem Situations
(CIPS)
(Schag et al 1983)
Hospital Anxiety and
Depression scale (HAD)
(Zignond and Snalth 1983)
1 item, performance and mobility rated 10 - 100
1 item, performance and mobility (developed from
KPS), rated 0 - 4.
131 problem statements in 4 areas: personal care,
medical situation, interpersonal interactions,
miscellaneous.	 Each rated on 5 point scales
14 items in 2 subscales of anxiety and depression.
Each rated on 4 point scales.
Psychological Adjustment
Illness Scale (PAIS)
(Morrow et al 1978)
to 45 questions in 7 areas: health care orientation,
vocational environment, domestic environment,
sexual relationships, extended family
relationships, social environment, psychological
distress.	 Each rated on 4 point scales.
Spitzer's quality of life
index (QL)
(Spitzer et a7 1981)
Rotterdam symptom checklist
(De Haes et a7 1986)
Linear Analogue self
assessment (Ontario Cancer
Institute and Royal Marsden
Hospital)
(Selby et a7 1984)
European Organisation for
Research and Treatment of
Cancer (EORTC)
(Aaronson et al 1987).
McGill Pain Questionnaire
(Melzack 1975).
5 items; activity, daily living, health, support,
and outlook. Each rated on 3 point scales.
30 symptoms and 8 scales of daily activities in 4
areas: physical toxicity, social functioning,
physical activity, psychological adjustment. 	 Each
rated on 5 point scales.
31 items, divided into two groups - general health
(18 items) and items specific for breast cancer
(13 items).
Self assessment. Core questionnaire for all cancers,
extra module for lung cancer. At development and
testing stage.
102 words describing the intensity and quality of
pain. Short version with 15 groups of descriptions.
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3.2.9 Measures for palliative care
Most palliative care units collect data on aspects of their
process of care, such as the number of patients seen, number of
home visits, drugs used, duration of survival, and use this in
annual reports which are geared towards fund raising (for example
see St Joseph's Hospice, 1976). Harper et al (1988) conducted a
Delphi exercise (Linstone and Turoff 1975), aggregating the views
of hospices in the UK, to suggest standards for in-patient and
day care units, but this was concerned with the structure and
process of care, rather than with outcomes.
Palliative care outcomes have been slow to develop, as these
cannot be measured with the usual indicators of mortality or
morbidity. They require a measure which includes the specific
objectives of quality of life whilst dying, and the quality of
dying.
3.2.10 Palliative measures used to date
Studies of palliative care have used a wide range of measures
developed by researchers conducting the study, for example,
patients' ratings of pain categorised as severe, moderate, mild
or absent, the place of care and death, or patient and family
anxiety (e.g. Parkes 1979a and 1979b, Hinton 1979, Kane 1984).
In some instances satisfaction with care has also been recorded
(Kane 1985, Cartwright and Seale 1990). McCusker (1984)
developed and attempted to validated scales to measure
satisfaction of long-term and terminal care. Measures were not
standardised, or pre-tested for validity or reliability (except
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McCusker 1984), and tended to reflect the specific aims of the
study, rather than the wider aims of palliative care. This was
acceptable for research in single settings, but did not allow for
multicentre, comprehensive evaluation.
The National Hospice Study, USA, used various measures. Patients
were assessed by their carers or family member according to an
adaptation of Spitzer's Quality of Life index (the HRCA-QL
index), the original and uniscale version of Spitzer's index, the
Karnof sky index, the McGill pain questionnaire, an emotional
scale, a social scale and an awareness scale, developed by the
authors (Greer et al 1986, Morris et al 1986). Morris et al
(1986) concluded that the HRCA-QL index was most useful. This
index has 5 items: mobility (replacing activity in Spitzer's
original index), health, support, daily living and outlook, each
rated 0,1 or 2. Spitzer (1981) had expected his QL index to be
'particularly useful in trials of the effectiveness of palliative
care or hospice services'. However, Mount and Scott (1983)
criticised it for omitting many aspects of care: 'improved
communication within the family and between family members and
health care workers; lessened uncertainty and fear of the
unknown; greater acceptance of the reality facing them; greater
ability to express fears, doubts, guilts and anger'. However,
they added: 'Until more valid instruments are developed, we must
use Spitzer's QL index and the other outcome measures of their
study'.
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3.2.11 Measuring the 'quality of death'
Scores according to the Karnof sky index and HRCA-QL index
deteriorate markedly in all patients towards death (Morris and
Sherwood 1987) making these insufficient to measure palliative
care. Mount and Scott (1983) noted: " excellence in hospice
evaluation must await the development of new outcome measures".
The wording of the score definitions is such that if a patient is
unconscious he/she will achieve a score of zero in all 5 items
(including support and outlook). The index is also only concerned
with the patients' condition and not service provision, and only
to a limited degree with the support from family or friends.
Existing psychological measures may have similar problems with
dying patients. Most measures, for example the Hospital Anxiety
and Depression Scale (Zigmond and Snaith 1983), or the Beck
Depression Inventory (Beck 1979), include items which may not be
suitable in palliative care. Questions about feeling slowed
down, worrying about the future or irritability could normally
achieve positive responses in a dying person.
Wallson et al (1988) developed a measure of 'quality of death' by
analysing patients' wishes about their death, collected in the
National Hospice Study. This data was unsatisfactory because the
total sample was biased and included only 11% of hospice
patients and an unknown proportion of those receiving
conventional care (see section 3.3.2). They analysed interviews
conducted with patients in their last three days of life (the
number in this category is not given).
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After the patient's death, the authors interviewed family members
(FMs) to determine which of the 15 most common items had been
successfully addressed. Hospice and conventional care were
compared. However, there was no attempt to match individual
patient's wishes with achievement. For example, only 9% of
patients had said they wished 'to be at peace with God', yet over
90% of FMs said that this was achieved. One possible
interpretation of this is that some patients who did not wish to
be at peace with God had it forced upon them. There is clearly a
need to develop measures which can be sensitive to the wishes of
individual patients. Most measures of health status and quality
of life cannot do this. Measurement is made on an empirical
scale which is set for all patients, with the assumption that all
patients wish for the highest possible score (e.g. of mobility).
However, when items reflect aspects which some people desire and
others would not, for example 'peace with God', scales need to
allow for the wishes of individual patients and their families.
3.2.12 Who should make the assessments?
Measurement of quality of life may rely on assessments made by
patients, their family, external researchers, or by
health professionals. All of these approaches have drawbacks.
a) Patients
Taking assessments directly from the person who is dying would
seem to give the most valid information. However, this has been
criticised mainly for two reasons. First, in some instances it is
36
considered an intrusion. No detailed evidence is available, but,
in one study the relatives reported that they believed dying
patients were willing to help in research, often in the hope that
this would help others (Mor et al 1988c). Fallowfield et al
(1987) found that most breast cancer patients reported that
taking part in a psychological study was a helpful extension to
their treatment. Thus, intrusion may not be the problem feared
by professionals.
Second, the reliability and completeness of assessments from
severely ill patients has been questioned. Ward (1985) and Lunt and
Neale (1985) found that, of patients in hospice and home care
settings, only one half to one third of patients in care survived
and were well enough to be interviewed. Maguire (1980) warned
that self-ratings scales may be subject to error: from a wish to
give socially desirable answers, a favouring of extreme or
central positions on the scale (position bias), or because a far
greater proportion of cancer patients than usually realised may
have impaired attention, concentration or memory.	 The National
Hospice Study (USA), the largest comparison of hospice and
conventional care, included a small proportion of patients
receiving care. (This is discussed in more detail in section
3.3.2). If the most ill patients cannot be assessed by interview
this is a potential source of bias.
b) Relatives, friends or family members (FMs)
Assessments taken from FMs are necessarily limited to cases where
a close relative or friend exists, and will be affected by the
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FMs' own process of grief (Parkes 1985). Only a few very recent
studies have considered this. Epstein et al (1989) tested for
correlations between the ratings of 60 subjects and their closest
relatives or proxies on scales measuring social activity,
emotional status, overall health, functional status and
satisfaction. Pearson's r for all 60 pairs ranged 0.43
(satisfaction) to 0.73 (functional status), but if the subjects
had below median health, or there was below median subject-proxy
contact, or the subjects and proxies lived apart correlations
were poor (for example, 0.12, 0.02, and 0.12 respectively for
satisfaction).	 A study comparing the assessments of FMs in the
bereavement period showed that these did not correlate with the
assessments of patients made during their life (Ahmedzai et al
1988). Cartwright and Seale (1990) compared patient and bereaved
FMs' (or close friends') assessments of symptoms and services.
Mean squared congruence ranged 0.00 (bad temper) - 0.67
(constipation). Relatives tended to be more critical of services
and to report more symptoms. The relatives' assessments may be
affected in unknown ways by the place of care. Parkes (1985)
suggested that relatives may over-report symptoms when patients
are at home. It seems clear that, when FMs' assessments are used
these must be considered as measuring the FMs' 'pain', 'anxiety'
etc. as well as the patients'.
C) External assessors
External assessors can provide an independent view of the
patients circumstances, free from many of the biases of
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professionals or FMs. However, these may cause intrusion and may
interfere with the practice of team members. If the interviewers
ask searching questions concerning the patient's insight and
future plans they could be replicating or altering the support
team's work. The assessments cannot be made 'blind' to the
service received, for the patient is likely to refer to their
services during interview. When assessing psychological
circumstances in interview, an external assessor sees only a very
limited sample of a person's behaviour (Miller and Morley 1986).
d) Professionals
Slevin et al (1988), Mercier et al (1987) and Wilkes (1984) have
found that hospital and community staff gave different
assessments of quality of life compared with dying patients
themselves.	 Results may be biased by the professionals' own
expectations and hopes of a positive outcome. Professionals may
be disposed to recall the successful treatments rather than
failings (Miller and Morley 1986).
	 However, professionals have
the advantage of being able to provide data on all of the
patients in their care.
There is clearly no ideal choice. Each study must choose the
most appropriate assessor(s) depending upon its aims. The
assessments must be validated and the likely biases considered.
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3.3 The evaluation of palliative care
A number of evaluations have been undertaken and the following
review concentrates on those from the U.K., USA and Canada, where
most research is available. The evaluation of bereavement
services is not included.
3.3.1 British experience
Single site evaluations 
Hospices
Early studies of hospice care focused on individual services and
reported their structure and process (e.g. Bates et al 1981 or
Evans and McCarthy 1984). Such information was often presented
in annual reports geared to fundraising (e.g. St Joseph's Hospice
1976). The first formal evaluative studies appeared in the the
1970's. Three research groups - Parkes (1979a and 1979b), Hinton
(1979) and Lunt and Neale (1985) - independently showed in-
patient hospice care to be more effective than hospital care.
Parkes (1979a and 1979b) showed that bereaved spouses
retrospectively reported better pain control, lower patient and
family anxiety and distress, and increased satisfaction than
matched hospital care controls. Hospice care also costs less.
However, Parkes and Parkes (1984) in a follow-up study ten years
later failed to show better pain control in the hospice: pain
control in hospital appeared to have become as effective.
Using his own interviews with patients and spouses and the
reports of a senior nurse, Hinton (1979) found 20 hospice in-
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patients to be less depressed and anxious than 20 in an acute
hospital ward or 20 in a Foundation Home.
Lunt and Neale (1985), in a comparative study of in-patient
hospital and hospice care in Southampton, observed that hospice
doctors set more goals for dying patients than did hospital
doctors. They believed goal setting was an integral part of good
practice, and so, as process evaluation, indicated hospice care
to be more effective. However, there were no differences between
the two settings in the goals set by nurses, and no outcome
measures were used.
Support Teams, home care and out-patients
The results of evaluations of hospice services for out-patients
or home care were less positive. Hinton's (1979) comparative study
included 20 hospice out-patients who showed less anger than
patients in hospital or the Foundation Home but no less
depression or anxiety.	 Although Parkes (1980) initially showed
a domiciliary service increased the amount of time patients spent
at home and cost less than hospital or hospice care, in 1985 he
found that bereaved spouses reported that patients had more pain
and anxiety when at home than in hospice or hospital (Parkes
1985).
multicentre evaluations 
The single site evaluations cannot indicated the effectiveness of
hospice care more widely, because of variations in hospice
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services. The studies of Parkes and Hinton were based on
patients at St. Christopher's Hospice, Sydenham, London. This is
the pioneer centre for the hospice movement and 'a centre of
excellence'. It demonstrates the potential of hospice care
rather than the general effect. Multicentre evaluations are much
more likely to give a reliable picture of palliative care in the
U.K.
The last year of life - a survey of the bereaved
Cartwright and Seale's (1990) study, the Last Year of Life in
1988, gives insight into the effect of hospices (and support
teams). This national survey was based on a random sample of 639
adult (aged 15 years or more) deaths registered in England.
Interviewers tried to contact the person who could tell them most
about the last 12 months of life of the deceased. Seven percent
received some form of hospice care (25% of cancer deaths) either
in-patient or support team or both (Seale 1991a). These patients
were reported to have had better pain relief, greater awareness
of their diagnosis and prognosis, and were more satisfied with
the services they received (Seale 1991a and 1991b). However, the
characteristics of patients receiving hospice care may have been
different. There were social class differences, more middle
class people had been in private hospitals and hospices than
working class people (7% versus 1%, Cartwright 1992).
Support Teams
Other evaluations of support teams have measured only the
structure or process of care. Ward (1985) compared nine
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domiciliary services in the regions of Yorkshire and Trent in
1985.	 She showed major differences in their funding (voluntary,
NHS or a combination of both), attachment to in-patient unit or
free standing, staffing levels and types and especially in their
method of working and number of patients per nurse. She
explained that the lack of clearly defined criteria for a
successful programme made evaluation difficult (Ward 1985 and
1987).
In a stratified random sample of 162 home care and hospital
support nurses from 45 different services, Lunt and Yardley
(1986) found similar variations in the structure and funding of
services. Teams served catchment populations which ranged from
43,000 to 500,000, with variations in the nurse caseload from 11
to 57 current patients per nurse. (One Marie Curie service had
21 nurses, but this worked in a completely different way, not as
a support team.) Apart from variations in the number of nurses
in a team (from 1-11 nurses), there were variations in the
numbers of other members of the support teams: doctors, social
workers and in some cases a chaplain, occupational therapist,
physiotherapist, psychologist, dietitian, administrator or
secretary.	 Input from other disciplines (including doctors) was
less common in the NHS funded teams. There were differences
between teams in the aims and patterns of working, and even
disagreement within teams and between nurses and their managers
on some of the aims of care.
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3.3.2 US and Canadian experience
Difficulties in comparison with the U.K 
The differences between US, Canadian and British health services
may mean that the findings of these studies are not directly
transferable (Editorial 1986). The North American provision of
home hospice care was either through home health agencies or
independent home care units. The latter, especially, are
primarily a nursing initiative with variable access to
doctors (Mor and Masterson-Allen 1987 and Mor 1988a). In
Britain, medical services, even if there are no doctors in the
home care team, can be provided by general practitioners.
In contrast to the British findings, the results of North
American studies of in-patient hospice care were contradictory,
but benefits were demonstrated for home care.
Single site evaluations 
Hospices
In New Haven, Buckingham and Foley (1978) found that 35 hospice
in-patients and their spouses or main carers had less anxiety and
depression and higher social adjustment at interview than 35
matched controls.
Kane et al's randomised controlled trial
One difficulty of all the studies discussed so far is the problem
of self selection by patients into either the hospice or control
group. Any apparent effect of palliative care may be due to
existing differences between hospice and control groups. In
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response, Kane et al (1984 and 1985), in Los Angeles, carried out
the only randomised trial of in-patient hospice care. Patients
admitted to the Veteran's Medical Centre were randomly allocated
to either hospice or conventional care. One hundred and thirty-
seven hospice and 110 conventional care cancer patients were
compared. The results were equivocal. Apart from improved
patient and family satisfaction there was no significant
advantage of hospice care over conventional care in the control
of pain or symptoms, activities of daily living, affect, use of
therapeutic procedures, number of in-patient days or cost.
Equally, hospice care showed no disadvantages over conventional
care.
However, during the study 'hospice' patients received both
hospice care and conventional care. When the hospice unit was
full 'hospice' patients were admitted to general medical wards.
Only 60% of the 'hospice' patients died in the hospice, 3% died
at home and the rest died elsewhere in the hospital. 	 During the
trial 'hospice' patients spent an average (mean) of 13.2 days
on general medical wards, not much less than the average (mean)
of 20.7 days of the control group. Further, the hospice and
general wards were close to each other, so we cannot exclude the
possibility that staff treating the 'control' patients changed
their management after observing the therapy and practices used
in the care of 'hospice' patients. This contamination would
reduce the likelihood of finding differences between control and
hospice groups.
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Support teams
A positive benefit for home care was reported in a randomised
trial in 1984. Zimmer et al (1984) in Rochester, New York,
evaluated one model of home care using a randomised controlled
trial. The home care team consisted of a physician, a nurse
practitioner and a social worker, who provided 24 hour on-call
medical care and nursing and home care services. Elderly
patients with either terminal or severe chronic illness were
referred and then allocated to either team care or to the usual
home health agencies services. Team patients spent less time in
hospital, had lower overall costs and more frequently died at
home. Satisfaction with care was higher for team patients and
their carers than for the control group. There were no
significant differences between team and control patients in
health status, functional status or survival. Other positive
results of home care were reported, although randomised designs
were not used (Creek 1982, McCusker and Stoddard 1987).
Multicentre evaluations 
Hospices
Hannan and O'Donnell (1984) measured the costs and satisfaction
for 12 hospice programmes in New York State. All services cost
less than conventional care. Community-based hospices cost less
than other units providing hospice beds (either free standing or
within existing hospitals). The satisfaction of carers and
family was 'high' in all hospices, but was higher for hospices
with beds than community hospices.
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The National Hospice Study. A study of in-patient hospice, home
hospice and conventional care
The National Hospice Study, USA, was devised to demonstrate
whether hospice care was effective, so as to consider whether it
should receive Medicare funding. The three million dollar
project collected prospective data from 40 hospice and 14
conventional care centres; 833 hospice home care (HC), 624
hospice in-patient (HB) and 297 conventional care (CC) patients
and their nearest carers were interviewed (Greer et al 1986).
The hospice patients were less likely to receive therapies such
as chemotherapy, surgery, radiation therapy, transfusions and
intravenous therapy and significantly more likely to receive
social services (Mor et al 1988a). Home care hospice patients
spent more time at home (Mor et al 1988c).
There were few differences in quality of life outcomes measured
between conventional care and hospice care. Some small but
significant differences were found to the benefit of HB but not
HC patients in pain, symptoms and satisfaction of family members.
However, there were no consistently observable differences
between hospice and non-hospice patients in performance status,
quality of life, or satisfaction with care as reported by
patients' families (Greer et al 1986, Morris et al 1988).
The results of cost savings were mixed. Home care hospices saved
money over conventional care by substituting care at home for
hospital care. The savings occurred mainly in the last months of
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life, and for both HB and HC patients the longer the stay in
hospice, the more likely the costs incurred exceeded those of
conventional care patients in the last year of life (Kidder 1988a
and 1988b).
The National Hospice Study: sample bias and other difficulties
Sampling inconsistencies limit the conclusions of this study. In
the sampling procedure there are three problems (see Mor 1988a
and 1988b, Greer et al 1983 for details of the study design).
First, the main sites of the conventional care group were not
representative, since the criteria for inclusion in the
conventional care group and the hospice group differed.
Conventional care units were probably better than average due to
their four extra selection criteria of good records, follow up,
willing doctors and nurses and proximity to regional centres.
Second, the criteria for selection of patients differed in
conventional care and hospice care settings. In conventional
care settings patients with a low mobility were actively selected
(Karnofsky score of 50 or less), there was a much higher
refusal rate (20.6% compared to 3.3% and 3.5% in the hospice
settings) and patients were selected in conjunction with the
oncology nurse clinician. In addition, the physician was asked
for permission to contact the patient. The authors do not state
the number of cases in which the oncology nurse or physician
objected to the contact. Third, we cannot say whether patients
were selected fairly or not, since no details are given of the
full conventional care denominator populations. In the hospice
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group from an initial denominator of 13374 patients, only 1457
(11%) were interviewed. It is not clear what proportion of
patients died before they could be interviewed, were too ill for
interview, or were selected out by the staff or by random
selection.
3.4 Summary of main findings from literature
The literature shows the value of measuring health outcome, rather
than structure or process. A wide variety of health status and
quality of life measures are available, but these do not address
the goals of palliative care for patients and families, and are
not sensitive to changes in dying patients or to individual wishes.
Although there have been many evaluations of palliative care,
these were limited by the lack of measures, by variations in
palliative practice and by their research design. Future
evaluations should concentrate on determining where improvements
are needed, and which components of care are effective in which
patients. But such evaluation needs measures of the specific
goals of palliative care. This thesis attempts to tackle the
task of developing measures, using the available guidelines for
their development.
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4. METHODS: GENERAL
4.1 Role for audit
4.1.1 Summary of difficulties in the evaluation of palliative
care services to date
1. Lack of available measures 
This was discussed in the previous chapter.
	 Palliative
services need ways to monitor their care if they are to improve
patient care and find the best mode of working.	 In most
clinical practice a patient's blood pressure, pulse etc., are
measured, but in palliative care this is rarely appropriate.
The lack of valid sensitive measures for palliative care has
hampered research to date. These types of measures are required
before future evaluations can be carried out.
2. No Standard Practice 
Services, particularly for home care, operate in many different
ways. As described, major differences have been found between
different hospices or support teams in their structure and
process. This limits the conclusions which can be drawn,
negative or positive results can be attributed to the
characteristics of individual services, rather than to the
'palliative' effect. There is an urgent need to clarify the goals
of palliative care, and then to measure whether these goals are
widely achieved.
3. Palliative care embodies a number of different interventions. 
Palliative care is provided by various professionals and
volunteers, in multiple settings, amidst a complicated network of
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patient and family variables, and have closely interrelated goals
that seek integrated "holistic" palliative care (Buckingham and
Lupu 1982). It subsumes a complexity of palliative
interventions, just as surgery has many factors which have never
been tested in one study as one intervention (Dush and Cassileth
1985).
Given the wide variety of services, we need to know for which
patients palliative care is most effective and which models of
care work best. Rather than posing the global question is
'palliative care effective?', an equally important question would
seem to be what kinds of palliative care interventions, by whom,
in what combination, form and amount, for what kinds of patients
and families, and with which types of concerns, work best under a
particular set of circumstances (Dush and Cassileth 1985)?
4. Difficulties in research design
The World Health Organisation defines evaluation as: 'the
systematic, scientific method of determining the extent which an
action or set of actions was successful in the achievement of
predetermined objectives'(Hogarth 1975). Much evaluation in
health care has relied on randomised controlled trails to assess
efficacy (the benefits to individuals of a procedure applied
under controlled and usually ideal conditions). However, these
have been used only occasionally to evaluate palliative care.
Possible reasons for this include:
a) the influence of voluntary groups in generating funding and
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providing services. Voluntary groups are more likely to be
influenced by local concerns and difficulties than by a wish to
meet rigorous evaluation criteria.
b) the ethical issue of informed consent. Can patients be
asked in their final months of life to agree to a random
allocation between a service and no service? In the National
Hospice Study random allocation was considered 'unethical' (Aiken
1986). In London, before this study, local general practitioners
were asked if they would participate in a randomised trial of a
support team. Most refused, they felt they could not confidently
persuade patients to agree to a support team being involved in
their care if the patients then might, or randomly might not,
receive the service.
c) the evidence that conventional care was failing patients.
Political pressure for palliative services led to the decision to
make hospice care reimbursable under US Medicare Legislation,
before the results of the National Hospice Study were available
(Mor et al 1988c).
d) contamination of controls. Mount and Scott (1983) have argued
that it is unlikely the control or customary care group will
truly represent the traditionally neglected terminally ill,
simply by virtue of their study inclusion. Any identified
control group will have been subject to the "educational effect
of hospice care", which was deemed responsible for the lack of
difference between hospice and conventional care by Parkes (1985)
and Kane et al (1984).
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4.1.2 Future needs for study
The evaluations to date show that hospice care is viable and in
some studies, is an improvement on and cheaper than conventional
care. It has been argued that in a pluralistic society such
choice is justified on its own merits (Greer et al 1986).
The research evidence suggests that evaluations in the future
must look at ways of improving palliative care, at its
effectiveness (the benefits of care at a population level) and at
testing the efficacy of specific interventions. Before any of
these can proceed better measures are required.
4.1.3 Role for audit in the evaluation of palliative care
Definition of audit 
The Department of Health (1989b) publication Medical Audit 
defines medical audit as: 'the systematic, critical analysis of
the quality of medical care, including the procedures used for
diagnosis and treatment, the use of resources, and the resulting
outcome and quality of life for the patient'. All doctors in the
National Health Service are now required to undertake medical
audit, as part of the National Health Service review (Department
of Health 1989b), and audits of hospital and general practice are
regularly published.
Shaw (1980) provided a variety of other terms for audit, see
table 4.1.
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Table 4.1 Audit by any other name. Source: Shaw, 1980.
Medical	 Care	 Evaluation
Health	 Standards	 Assessment
Clinical	 Activity	 Assurance
Professional	 Quality	 Audit
Review
Monitoring
Quality assurance and audit are sometimes confused, but most
researchers (for example Shaw 1989 and Black 1990) consider audit
as one component of quality assurance. Quality assurance is
defined by Shaw (1989) as the 'definition of standards, the
measurement of their achievement and the mechanisms to improve
performance'.
Audit is a cycle. At the outset standards are set. The practice
is observed, and compared with the standards, following which
changes are made to reach the standards (Shaw 1989, Royal College
of Physicians 1989). The cycle is then repeated with the same
standards or with new standards developed from the practice.
Variations of the original cycle have been proposed: for
example, including a preliminary stage of observing practice
before standards are set (Coles 1990).
Medical audit has developed in general practice and hospital
settings where doctors usually lead the decision making (Sheldon
1982).	 In community care, doctors often work in teams, sharing
the tasks of assessment and decision making with other
professionals. Clinical audit is more appropriate to review this
type of work. Although defined in similar terms, clinical audit
is the systematic, critical analysis of the quality of clinical
care, rather than of only medical care (Shaw 1980). Clinical
audit by community teams needs performance to be recorded by all
members of the team, using broad measures that capture the full
range of clinical tasks.
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Benefits of clinical audit in the evaluation of palliative care 
Clinical audit gives a service the opportunity to develop ways
of looking at and measuring their work, and the quick feedback of
results is likely to improve their co-operation. If suitable
outcome measures are used by services in clinical audit, areas
where the service is least effective can be identified leading to
changes and improvements in practice. Differences in outcome
between patients with different characteristics (e.g. diagnoses)
can be shown. Therefore, the outcome measures developed in this
work were geared primarily for use in clinical audit. The
discussion considers whether they are suitable for wider use.
4.2 Developing measures and testing validity and reliability
4.2.1 Standards for developing measures
Various methods have been used to develop measures of health
status and quality of life, but more recently guidelines been
suggested (Streiner and Norman 1989, Spitzer 1987, Ware 1987). A
number of stages, each employing different methods are needed.
a) Determine that no other available measure can be used
The increasing number of available measures makes it important to
review the literature to determine whether existing measures can
be used (Streiner and Norman 1989). Various critical reviews of
measures are available (see Bowling 1991, Maguire and Selby 1989,
Morris 1991 and see literature), although only one considers
palliative care (Fallowfield 1990), and this describes
issues rather than palliative measures. Measures should be
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assessed according to their face, content and criterion validity,
their reliability and, if appropriate, their contruct validity
(Streiner and Norman 1989). Practicality (whether the scale is
suitable for use in ordinary practice) and utility (whether the
scale is able to produce useful results) need to be added to this
list of criteria, if the scale is used in audit. If no measures
are suitable, as demonstrated for palliative care, then new ones
need to be developed using the following guidelines.
b) Devise the items and select ones to be included. This can be
carried out using a combination of: clinical observation, theory,
research findings, expert opinion and consultation with patients,
their representatives or a sample of the general population.
Streiner and Norman (1989) describe clinical observation as potentially
the most fruitful, but Hunt et al (1986) and Bowling (1991) have
noted how seldom patients views are considered in constructing
measures.	 This study used clinical observation, consultation
with professionals and a few patients and bereaved relatives, and
literature review.
Items should be selected according to their ease of
interpretation, considering the reading level of the respondents,
and should avoid ambiguity, double questions, jargon and value-
laden words (Streiner and Norman 1989, Boyle and Torrance 1984)
following guidance on wording, such as that by Oppenheim (1966).
C) Determine face, content and consensus validity at this early
stage. The validity of a scale is assessed by determining its
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success in measuring what it sets out to measure. There are
various types of validity (see table 4.2 for definitions).
Definitions sometimes vary. Face validity is defined here (as by
Streiner and Norman 1989) as whether the scale appears to be assessing
the desired qualities. Abramson (1990) argues that some degree of face
and content validity are sine qua non, and without these there is no
point in proceeding to other stages. Face validity should never
be treated as trivial, for if respondents fail to take the
measure seriously the results may be meaningless (Rust and
Golombok 1989). However, Cronbach (1990) proposes that content
validity, exploring the suitability of items in detail, is more
important than face validity.
Items should be pre-tested to ensure they are understandable to
the target population (Spitzer 1987), are unambiguous and ask
only a single question. Items not meeting these criteria should
be eliminated or rewritten. Items should be added or discarded
to satisfy content validity (Streiner and Norman 1989)
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Table 4.2 Definitions of basic terms in validity. (Compiled from
definitions given by Streiner and Norman (1989), Bowling (1988),
Abramson (1990), Moser and Kelton (1971), Cronbach (1990).
Term	 Definition
Validity	 - The success of a scale in measuring what it sets
out to measure
Face validity	 - Whether the scale appears relevant, reasonable and
Is acceptable to those using the test.
Content validity	 - The items should contain the common thread of
what is under study and sample all the relevant or
Important content or domains in a balanced way.
Consensus validity - When a number of experts agree measurement is
valid.
Criterion validity - Whether there is a correlation between the
measure under consideration and another measure
or event which is suitable for use as a
criterion of validity (a gold standard).
The best criterion is one which has higher face
validity than the measure being tested and/or
which has been tested previously and found to be
of high criterion validity (see Abramson 1990).
Criterion validity can be tested concurrently
(concurrent validity) or by the accurate
prediction of future events (predictive
validity).
Construct validity - On the basis of theoretical considerations the
researcher postulates the types and degrees of
associations between the scale and other
variables, and then examines these associations
to determine if they confirm the expectations
(see Moser and Kalton 1971)
Construct validity is needed when gold standard
measures are not available to test for criterion
validity. This is common when attempting to
measure something which is not readily observed,
such as anxiety or some symptoms (see Streiner
and Norman 1989)
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d) Scale responses. Response scales may be nominal, ordinal,
interval or ratio, depending upon the attribute considered.
Clearly ratio and interval scales are difficult to apply to
health status. Ratio scales require a meaningful zero point which
cannot be found in health status. Some methods have been devised
to achieve apparent interval-level measurement with subjective
scales (Streiner and Norman 1989), but these are relatively rare
and complicated. Such techniques would not be needed for
palliative care. It would be sufficient to identify those
patients who fare poorly according to agreed criteria, without
determining exactly how much worse they fare compared to other
patients.
McKelvie (1978) investigated the reliability and validity of a
continuous and various categorised (five, seven, 11) rating
scales. He recommended scales with five or six categories
because these were most reliable, and subjects, even when using
the continuous scale, operated within five or six categories.
e) Determine practicality and utility. Boyle and Torrance (1984)
proposed that, to maximise its usefulness, a scale must be simple
to apply, acceptable to its respondents, brief and inexpensive to
administer. It should not require prior access to or use of
clinical or laboratory services. It should reflect good
measurement practice and efficiency, by using pre-coded response
categories, an explicit time period of assessment (e.g. today,
the last week or month) and clear unambiguous instructions for
respondents.
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f) Ensure and test criterion and construct validity
Criterion validity
Criterion validity tests measures which have already been shown
to have face validity against 'gold standard' or absolute scales
of the underlying construct to be measured (table 4.2). However,
there are no gold standard measures of palliative care. In the
absence of a gold standard, Abramson (1990) advises that a
criterion with a higher face validity is chosen.
Patients are the most valid assessors of their circumstances
and therefore can serve as a criterion. Assessments from family
members (FMs) have been frequently used as a proxy for the
patient's assessment. Although, as shown in the literature
review, the validity of FMs as patients' proxies is not
established, it is still useful to include their assessments as a
potential criterion. Furthermore, a palliative measure should
include items which assess the FM's problems, because FMs are
included in palliative care. For these items FM assessments
have validity.
Therefore, ratings completed by team members, when using the
developed measure to audit their work, were compared
with:
a) Ratings made by patients, collected at research interview and
b) Ratings made by FMs, collected at research interview
Construct validity
Construct validity refers to a wide range of approaches and is
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used when gold standard measures are not readily available and
the variable of interest in not easily observed (table 4.2).
This approach has been used frequently in psychological testing
and is relevant to palliative care where the quality of dying is
not easily observed. Construct validity tests for correlations
between two instruments according to pre-determined hypotheses.
The danger of construct validity is that is tests the hypotheses
as much as the validity of the new scale (Moser and Kalton 1971)
Construct validity can be divided into convergent validity, which
requires the new measure to correlate with related variables, and
discriminant and divergent validity, which requires the new
measure not to correlate with dissimilar variables (Streiner and
Norman 1989, Bowling 1991).	 Spitzer (1987) advocates that both
should be demonstrated.
'Silver standard' index of quality of life - the HRCA QL-Index
The HRCA-QL is a modified version of Spitzer's quality of life
(QL) index. Spitzer et al's (1981) QL-index has five components,
activity, daily living, health, support and outlook, each rated
on 3 point scales (0-2); with a high score indicating the best
condition (appendix H shows details). In the HRCA-QL, the item
'activity' was replaced by 'mobility' (Morris et al 1986 and
1988). The HRCA-QL was not re-validated, but the original QL-
index was validated. This showed convergent discriminant and
content validity among cancer patients (the common cancers, in
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four stages; early, stable, rapidly evolving and advanced) and
patients with chronic diseases (irreversible or disabling disease
such as rheumatoid arthritis, advanced diabetes, spinal injury or
chronic obstructive airways disease). Assessments of internal
consistency demonstrated a 'high' Cronbach's alpha (0.775) for a
five item scale. 'High and significant' interrater Spearman rank
correlations were found when the independent scores of two
physicians were compared (rho = 0.81, p < 0.001), and when
doctors ratings were compared to the self-ratings of patients
(rho = 0.61, p < 0.001) (Spitzer 1981). The HRCA-QL was
therefore the most appropriate 'silver standard' measure for
validation of a new measure of palliative care.
g) Ensure and test reliability
Reliability refers to the stability and consistency of
information provided by the measure, also sometimes referred to
as the precision of the measurement (Nunnally 1970, Streiner and
Norman 1989). It is reflected by the repeatability of measures.
A measure is reliable to the extent that repeated measures under
constant conditions will give the same result. The reliability
coefficient (or coefficient of generalizability) is the
theoretical correlation between the true result from the test and
the result from the test achieved by normal use when measurement
error occurs (Nunnally 1970).
Reliability is also important in setting a limit on the levels of
validity which can be found. If a measure is valid it must also be
reasonably reliable and any correlations found in testing
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validity will be reduced by the degree to which the measure is
unreliable. However, a measure can be reliable without being
valid (Carmines and Zeller 1979).
Three methods of testing reliability are used.
i) Test-retest reliability 
For this the test is applied to the same population on two
occasions and the results are compared, usually by
correlation (Streiner and Norman 1989).
ii) Multiple/alternative form reliability 
In this scores from two measures, which have been developed in
parallel to assess the same attribute, are tested for
correlations. High correlations indicate high reliability
(Streiner and Norman 1989, Bowling 1988). However, this test is
practically difficult and expensive, because it requires that two
measures are developed when only one will be needed.
iii) Internal consistency 
This considers the homogenicity of the measure. This approach
assumes that the complete test reflects some single trait. For
example some IQ tests, where all items of the test are
reflecting the underlying trait - the person's intelligence.
Scores from combinations of the items in the measure, usually one
half versus the other half, are tested for correlations. In
theory, if the measure is homogeneous the halves can be
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considered approximations to alternative forms. Thus, the
analysis gives an estimate of reliability. But internal
consistency is reduced if the scale is not totally homogeneous
and items within the measure record different attributes which do
not increase and fall together (Carmines and Zeller 1979,
Cronbach 1990, Nunnally 1978).
The palliative measure (STAS) would be expected to reflect the
underlying concept of quality of care whilst dying and quality of
death. However, each item may represent a discrete entity and
would not necessarily correlate strongly with the other items.
Very high levels of internal consistency would not be desirable
because STAS aimed to measure several attributes of palliative
care. Nevertheless, the results from two approaches to test
internal consistency, split half reliability and Cronbach's
alpha, reflect the value of the total measure, and its
reliability.
Split-half reliability
In split-half reliability the items are randomly divided into two
sub-scales which are then correlated with each other. The
easiest split is to put all the odd numbered items into one half,
and the even numbered items into the other. If the scale is
internally consistent the two halves should correlate highly.
The resulting correlation is an underestimate of the scale, since
the reliability of the scale is proportional to the number of
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items in it. Since the sub-scales being correlated are only half
the length of the version that will be used in practice, the
resulting correlation is too low. The Spearman-Brown formula is
used to correct this as follows (Cronbach 1990):
r = 2 rii
1 + rii
where: r = reliability coefficient for the whole test
and rii = reliability coefficient for half of the test.
Ctonbach's alpha
There are two difficulties with split half reliability. First
there are many ways to divide a scale other than an odd / even
split. Second, it does not tell us which item(s) may be
contributing to low reliability. Cronbach's alpha gives an
average of all the possibilities of split half reliability of a
measure (Streiner and Norman 1989, Cronbach 1990). Alpha is
considered a unique estimate of the expected correlation of one
measure with an alternative form containing the same number of
items. Nunnally (1978) has demonstrated that alpha can also be
derived as the expected correlation between an actual test and a
hypothetical alternative form of the same length, one that may
never be constructed (Carmines and Zeller 1979).
Cronbach's alpha is calculated based on the formula (Cronbach
1990):
alpha = k	 (1 - aunza
2
items)(k-1)	 s total
where: k
	 = the number of items in the test
s2
 total = variance of the totalled ratings (of all items in
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the test)
,2 items = variance of each item's ratings.° 
Novick and Lewis (1967) have demonstrated that, in general, alpha
is a lower bound to the reliability of an unweighted scale of N
items. It is equal to the reliability if the items are parallel.
Thus, the reliability of a measure can never be lower than alpha,
even if the items depart substantially from being parallel
measurements. In most instances alpha provides a conservative
estimate of reliability.
The formula indicates that the value of alpha depends on the
average inter-item correlations and the number of items in the
measure. Therefore, the addition of more items in the measure,
which do not result in a reduction in average inter-item
correlation, increases the internal consistency of the measure.
Enhancing reliability
Reliability can be enhanced by using the measure in controlled
conditions, by ensuring that assessors are adequately trained, by
using unambiguous items, and by providing unambiguous rating
instructions (Moser and Kalton 1971).
Spitzer (1987), in his minimum criteria for validity and
reliability, proposes that reliability and validity should be
tested with the types of patients and respondents among whom the
measure will be used.
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4.3 Study setting
4.3.1 Five study teams
Recruitment of teams
Five palliative support teams, all based in the south-east of
England, took part in the study. Criteria for inclusion were:
1. Team management and team members were willing to participate.
2. Teams were based within travelling distance of less than 1.5
hours from the research base in London and total travel costs
would be within budget.
3. The five teams would include community and hospital based
teams, if possible with different methods of funding and
different staff, to reflect the variety of structures available.
Characteristics of the teams
Similarities: aims and supportive role 
Palliative teams have been described in the literature (section
3.1.3, and see Bates et al 1981, Ward 1987, Evans and McCarthy
1984).
	 However, some key characteristics of the five teams in
this study are summarised here.
The five teams all followed the philosophy of the hospice
movement and of palliative care. Even when teams were not funded
by the National Health Service (NHS) they worked with NHS
services in the same way as NHS funded teams. Referrals were
accepted from hospital staff and general practitioners in
all teams, and also from district nurses and social workers in two
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teams. Teams provided extra support, advice and shared care with
other services.
Team members visited and advised on in-patients although the
original hospital consultant remained in charge of in-patient
care. No team had in-patient beds for their own use, but all
teams liaised closely with and would arrange for admission into
local hospices or the hospital as the patient wished.
Teams could reduce out-patient attendance by offering closer home
monitoring, but visited patients at home only if their general
practitioner agreed. The general practitioner and community
nurses were expected to remain involved in the patient's care and
offer 24 hour on-call care.
Differences: in structure, process and catchment populations 
Each team had a slightly different structure and there was no
consistent pattern. Tables 4.3 - 4.5 show details of the
staffing, funding, throughput and area served. Teams B and E were
the largest, with 6.5 and 5.5 whole time equivalent (wte)
salaried team members respectively. Teams C and D were the
smallest, and included only nurses supported by other staff. The
referrals per wte team member (medical, nursing and social work)
ranged from 33 (team C) to 50 (team D) patients per year. These
figures are based on team reports.
Teams B, C and D were hospital based, teams A and E were
community based: sited in the grounds of their local district
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hospital and managed by community services or independently. In
four teams, all except B, all staff worked in the community and
in hospital. Team B had found it easier to have two nurses
working solely in the community and two nurses and the social
worker working solely in the hospital. Their doctor saw patients
in both settings. At the time of entry into the study one team
(B) offered day care, but recently team E has also developed day
care facilities.
Teams A, B and E provided a 24 hour on-call service for patients
and families at home, and for community and hospital staff, and
would visit out of hours if necessary. The smaller teams (C and
D) did not offer this service, although the nurses sometimes
gave their home telephone number to patients and families if they
felt this was necessary. All teams had been established for over
one year, date established ranged 1978 - 1986. Three were based
in inner London, one in a New Town (C) and one in outer London (E).
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Table 4.3 Staffing of the five support teams.
Team	 STAFFING(wte equivalent)
Nurses Doctors Social Workers Secretary/Admin Volunteers Other
A	 2	 0.6	 1	 1	 4	 Consultant attached
B	 4	 1	 0.5	 1	 0	 Consultant + chaplain attached
C	 3	 0	 0	 shared	 0	 Medical support from hospital
D	 2	 0	 0	 shared	 0	 Medical support from hospital
E	 3	 1*	 0.5
	
1	 30+	 Volunteer co-ordinator
* A clinical assistant plus a medical director
Table 4.4 Funding, base, area served and referrals of the five support teams.
Team Funding	 Base	 Area served Referrals per year(approx.)
A	 NHS	 Community Unit*	 Inner London 160
B	 NHS	 Teaching Hospital	 Inner London 200
C	 NHS **	 District Hospital 	 New Town	 100
D Macmillan	 Teaching Hospital 	 Inner London 100
E	 Voluntary/WS District Hospital*	 Outer London 200
* Both teams based in grounds of hospitals (team A - teaching, team E - district).
Team A was managed by the community unit, team E was independently managed.
** Initially funded by Macmillan (Cancer Relief Fund).
Table 4.5 Population and mortality of the local health districts of the five support teams.
Team DEMOGRAPHY IN TEAMS' LOCAL HEALTH
	 DISTRICTS
P OPULATION*	 MORTALITY **
percentage	 percentage	 yearly from neoplasms
Females	 Males	 Total	 >= 65 years >= 75 years 	 n rate/1,000 pop.
A 67,216 59,434 126,650 16.8 8.1 433 3.4
B 80,519 78,109 158,628 14.2 6.7 473 3.0
C 111,766 109,094 220,860 12.2 5.1 468 2.1
D 79,918 69,723 149,641 14.8 7.2 455 3.0
E 152,517 145,706 298,223 16.8 7.3 817 2.7
* OPCS 1968 mid year estimates: resident population
OS 1988 mortality statistics: resident population**
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Local Demography and Mortality rate 
Table 4.5 shows the populations and cancer mortality of the
health districts primarily served by the teams, calculated from
statistics provided by the Office of Population, Census and
Surveys (OPCS). In addition to the resident populations, all
teams advised on in-patients irrespective of their address: this
was a large part of the work for the two hospital-based inner
London teams B and D. Team E, with the largest health district
and the highest number of cancer deaths, worked in half of their
district: the remaining area was covered by another team.
Teams A and E (the two community based teams) worked in districts
with high proportions of elderly people. The district of A
(in inner London) also had the highest mortality rate from
cancer. The district of C, a New Town, had the lowest
proportion of elderly people and the lowest mortality from
cancer.
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5. METHODS: SPECIFIC
5.1 Devising items for the measure called the Support Team
Assessment Schedule (STAS): observation and literature review.
Items were initially developed through clinical observations and
discussion with patients and family members (FMs) during a six
month part-time attachment. The work of team A was observed and
later participated in, by attending team meetings and by visits
to patients, their FMs (including in bereavement), and
professionals.
Areas of work were defined first. 	 Objectives of this work
were agreed and tested through open discussion with patients and
families in the care of team A. An initial list of items, which
represented care objectives, formed the "Support Team Assessment
Schedule (STAS)". This was amended following further discussion
with team A, comparison with the palliative care literature, and
discussion with other teams in the U.K. (including teams B and C)
and observation of their team meetings. This process aimed to
ensure that STAS items made practical sense to the team members,
and covered their work in a balanced way.
5.2 Rating scales and definitions.
Further discussions with the team members and review of their
case notes identified, for each STAS item, the severity and range
of problems encountered. Various types of rating scales, both
ordinal and linear analogue, were tested for suitability with the
STAS and ease of use by team members. Gradings were developed by
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retrospective review of scores on past patients, using case
notes, and definitions for score levels for each item were
agreed.
5.3 Face, content and consensus validity
For STAS these areas of validity would be satisfied if:
a) For face validity - STAS items would have to make logical
sense to palliative clinicians and could be used in clinical
practice. STAS should be perceived as yielding information of
real relevance to the investigation of palliative care.
b) For content validity - clinicians agreed that the range
of their work with patients and families was included
C) For consensus validity - there was a consensus of agreement
from clinicians who dealt with dying patients that the items met
the criteria in (a) and (b).
To test these, STAS was presented at a series of meetings of
hospice, hospital, community, and scientific professionals
(listed in appendix A). Also, teams B, C, D and E tested STAS in
practice for short periods.
5.4 Initial practicality for intended use: pilot audit
The collection of audit data using STAS was tested with team A to
determine what data could be collected, at what intervals and on
which patients. The routine team notes were of a high standard
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and it was possible to adapt these notes to include the audit.
Study population
All patients consecutively referred to the team over a one year
period were included in the audit and were assessed, weekly,
according to the STAS and followed until discharge or death.
Data collection
The data collected included:
1. The patients' demographic, social, referral and diagnostic
details. (Note, occupation was not recorded, as in
testing responses were unreliable: the item was frequently
missed, recorded as 'retired' or referred only to the
patient's last job.)
2. Discharge and death details.
3. Ratings according to the STAS, recorded at referral and then
regularly until death/discharge. A weekly record of patient
location (home, hospital or hospice) was also made.
Analysis
The audit data was reviewed and analysed to determine if changes
in scores occurred during care and if these could be linked to
patient events. Patient trajectories were considered to determine
if STAS ratings allowed individual cases to be reviewed over
time. The use of the rating scale by the team members was
analysed.
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The referral and death STAS recordings were analysed using non
parametric tests, owing to the ordinal scales and the non-normal
distribution of the ratings (Sprent 1989). Wilcoxon's matched
pairs signed-ranks test was used to compare the ratings of each
item in the first and last weeks of care. The probability level
for statistical significance was 0.05.
5.5 Criterion validity of STAS: interviews with patients and
family members (FMs)
5.5.1 Study Population
Teams
The study of criterion validity was carried out in two teams, A
and E. Both of these are community based teams, working in
patients' homes and in the hospital. The teams were chosen
because their patients remained in care for longer than those
referred to the hospital based teams (median time in care for
team A - 7 weeks, for team B - 3 weeks) and would be more likely
to be available for interview.
Eligible patients and FMs
Consenting patients at home and in the care of the teams were
interviewed. Contact was made after 2-4 weeks of team care to
minimise interference with staff work and to allow staff time to
develop their relationship with the patient before a new person
visited. It was recognised that some patients would be too ill for
interview, or might have died before interview. Patients were
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not contacted if the support team considered that the patient was
too ill. The numbers of and reasons for non interview were
recorded.
5.5.2 Method of contacting patients
The methods used to contact patients differed slightly between
the two teams, because of team preferences. Team A patients
were asked by team members if an external researcher could
telephone or contact them by post, to explain the study. Team E
patients were telephoned directly by the researcher who had been
given a list of patients in care. Patients were asked if they had
an FM who would be prepared to assist in the study and separately
answer similar questions.
Confidentiality was maintained and patients or FMs not wishing to
participate were not contacted again. The patient's general
practitioner was notified before the visit, and methods were approved
by local ethical committees.
5.5.3 Questionnaire and Interview
The questionnaire included seven STAS items (four patient and
family items - 'pain control', 'other symptom control', 'patient
anxiety', 'family anxiety': and three service items - 'wasted
time', 'practical aid', 'communication between professionals and
patient and family'). The number of STAS items was limited
because:
(a) the questionnaire had to be kept short for routine use with
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ill patients;
(b) the support teams had already found that some items (e.g.
'financial' and 'spiritual') could rarely be assessed after
only one contact, and
(c) there were ethical objections to routinely asking patients
to assess the items 'insight', 'planning' and 'predictability',
as these were potentially distressing.
Two standard questionnaires were used, each dealing with the
seven items: one for patients' self-ratings, and the second for
FM ratings. Patients and Fms were interviewed simultaneously, but
in separate rooms, by the researcher and a trained volunteer. The
questions used the same rating definitions as in STAS. The
question for pain control (patient's questionnaire) is shown in
table 5.1.	 Appendix F shows the patient's questionnaire in full,
appendix G the FM's questionnaire. The questionnaires also
included the patient's and FMs views of the team, and their
ratings of communication with the team.
Support teams separately recorded weekly STAS ratings on
patients from referral to death.
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Table 5.1	 Patient questionnaire excerpt - patient ratings for
'pain' in the last week.
SYMPTOMS IN THE LAST WEEK
a) PAIN
Have you have any pain?	 Yes / No
If NO please go on to section (c), if YES please continue
b) What effect did your pain have on you? Please ring one
of the below.
0 = none
1 = Occasional or grumbling single or few pains(aches).
You are not bothered to be rid of the pain.
2 = Moderate distress, occasional bad days.
3 = Severe pain present often. Activities and
concentration markedly affected by pain.
4 = Severe and continuous overwhelming pain Unable
to think of anything else.
79
5.5.5 Analysis for criterion validity
The patient and FM ratings were compared with the corresponding
team ratings. FM ratings were also compared with patient ratings:
to provide an estimate of the validity of FM ratings. As far as
possible, the date of assessment was matched exactly. Patient and
FM ratings occurred on the same day, but a team rating may have
been made up to 3 days earlier or later than the patient rating.
Team ratings were completed on a regular day and time each week;
patients and FMs were interviewed on a date and at a time they
found convenient.
Severity of items and differences between raters
Median (inter-quartile ranges) ratings, and mean (95%
Confidence Interval) ratings, where appropriate for the near
normally distributed items, were calculated for patient, family
and support team ratings, and Wilcoxon matched pairs signed ranks
test was used to test for differences between ratings.
Agreement
The results report the proportion of cases where team ratings
were exactly equal to the patient's rating, were within the
bounds of +1 or -1 score, and where team ratings fell beyond
these bounds. Cohen's Kappa (weighted) was calculated (Bartko
and Carpenter 1976, Fleiss 1981). Kappa tests for agreement
between pairs of ratings, but corrects for chance agreement.
Chance agreement is the agreement that would be observed if two
raters assigned ratings at random. Kappa is the most commonly
used and recommended coefficient to estimate the agreement
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between two raters (Grove et al 1981). Weighted Kappa is used
when the relative seriousness of different kinds of disagreement
can be specified (Fleiss 1981, Soeken and Prescott 1986). This
is appropriate for testing STAS. A disagreement of 3 points was
considered more serious than a disagreement of 2 points, which
was considered more serious than a disagreement of 1 point. The
level of acceptable Kappa was set in advance at 0.3 or above -
the level used in the development of the QL index (Spitzer 1981).
Kappa should be interpreted with caution when most ratings are
one score (as for the three service items), as it then gives
greater emphasis to the few ratings which do not agree
(Spitznagel and Helzer 1985). Few disagreements may be very
important in a screening test (Shrout et al 1987) but are less
relevant in this study.
The analysis was repeated for the team versus FM ratings and
patient versus FM ratings.
Correlations
An important test was for correlations between the ratings of
different individuals, to determine if one rater reflected
another's rating. The data were ordinal but assessments of
symptom and pain control and patient and family anxiety were near
normally distributed and these four items were tested for both
parametric (Pearson) and non-parametric (Spearman) correlation
coefficients. However, assessments of the three service items
showed a J shaped distribution which could not be transformed to
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a normal distribution, and so these were tested using only
Spearman correlation coefficients (Siegel 1956).
Probability
A probability of p < 0.05 was taken as significant (two-tailed
tests except for Spearman correlations which were one tailed, in
the light of the positive or negative values of the coefficient).
5.6 Construct validity: STAS compared with the HRCA-QL
5.6.1 Differences between HRCA-QL and STAS
HRCA-QL and STAS measure different things. 	 STAS is
geared to solving patient and family problems, for example,
symptoms, anxieties and service issues. The HRCA-QL provides a
quick assessment of the quality of life of patients ranging from
people who are well and recently diagnosed, to those with severe
symptoms. Three HRCA-QL items - 'mobility', 'daily living' and
'health' - are geared to living rather than dying. The scores of
these items deteriorate as part of the normal process of dying,
especially during the last 4-6 weeks of life, the time when
patients received palliative care (Morris et al 1986 and 1987).
HRCA-QL ratings correlate with patient survival (Addington-Hall
et al 1990).
5.6.2 Hypotheses of construct validity: the nature of
correlations between STAS and HRCA-QL
These differences led to the following hypothesis of the
circumstances and nature of correlations found (and not found)
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between STAS and HRCA-QL:
1. There would be significant negative correlations between STAS
and HRCA-QL for items which were similar, i.e. between the
patient orientated STAS items (pain control, symptom control,
patient anxiety) and the HRCA-QL items, e.g. between 'symptom
control' (STAS) and 'health' (HRCA-QL), and between 'patient
anxiety' (STAS) and 'outlook'
2. There would be few significant negative correlations between
STAS items which were concerned with services and HRCA-QL
items, because the HRCA-QL does not include service items.
(Discriminant validity)
3. Correlations would be greatest for patients early in care,
and would be low or nil in patients near death. (In patients
near to their death most score 0 for HRCA-QL items, and there
is little variance in the scores.)
Correlations would be negative because a deterioration in HRCA-
QL is indicated by a reduction in score: a deterioration in STAS
is indicated by an increase.
5.6.3 Collection of data
For consecutive patients referred to team A during 17 months,
team members recorded weekly assessments according to STAS and to
HRCA-QL. The scores were entered into the patient records,
first STAS and then HRCA-QL.
(HRCA-QL). (Convergent validity)
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5.6.4 Analysis for construct validity
The data was ordinal and in terminally ill patients the HRCA-QL
index scores showed a skewed or J shaped distribution (Spitzer et
al 1981). Therefore, non parametric tests were used. Mean and
median HRCA-QL and STAS scores were calculated, and Wilcoxon
matched-pairs signed-ranks test was used to test for differences
between the scores of patients at referral and discharge or
death.
The analysis tested for Spearman correlations between the HRCA-QL
and STAS ratings for patients in their first week of care and in
the week when death occurred: first, for all patients and then
separately, for patients who were in care for more than four
weeks before they died. It tested for correlations between a
STAS sub-total (summing six items - 'symptom control', 'patient
anxiety', 'family anxiety', 'patient insight', 'family insight'
and 'spiritual' - all similar in concept to the five HRCA-QL
items) and the HRCA-QL total.
A probability of p < 0.01 was taken as significant. This is
higher than for criterion validity due to the larger sample size
anticipated and to avoid type one errors, due to the number of
tests performed.
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5.7 Methods to test reliability of the STAS
Reliability was tested in two ways, using the test-retest method,
and by measuring internal consistency.
5.7.1 Test-retest.
Practical issues and need for simulated patients
Test-retest reliability was assessed by comparing team ratings of
the same patients. It was not practical for members of one team
simultaneously to assess the same patients, and less so for
members of different teams to attempt this. Therefore, written
descriptions of patients (simulated patients) were abstracted
from team notes, their weekly meetings, and observation of their
work.	 The descriptions often repeated the words of previous
patients. Team members recorded STAS assessments based on the
information given in these descriptions. An excerpt from one
simulated patient is shown in table 5.2. Full details of 10
simulated patients are shown in appendix I. Two data sets were
then collected.
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Table 5.2 Excerpt from simulated patient no. 20, first four
paragraphs.
SIMULATED PATIENT NO.20.
Mrs E. is a 52 year old British widow referred by her general
practitioner for support, especially for the 16 year old daughter
who lives with Mrs E. in the council house.
Mrs E. presented one month ago with multiple liver secondaries
from an unknown primary. She is now deteriorating. She has
another daughter and a son, both with young families, and both
living within three miles.
When you visit Mrs E. is lying on the bed in her night clothes.
She is propped up against a back support because her back aches
at times. She is not bothered by this because position relieves
the ache. She complains of night sweats as her only symptom.
Twice in the last week at night she has had to change the sheets,
although she went back to sleep after. During the day she is
fine.
She asks you a lot of questions about her illness. She was
puzzled that at first the hospital doctors were trying to find
her "cancer", but now they had given up. She says she found it
difficult to ask them questions. They would answer (rather
coldly and factually) if she asked, but they seemed so busy that
she didn't feel able to. Her own doctor, although wanting to
help, hadn't even been told she was discharged 3 days ago. She
had telephoned him and he had been very surprised. He had had to
telephone the hospital to find out what medication she had been
put on. That meant that for two hours one morning she was on the
telephone to the surgery trying to sort out her medication and
she found this very tiring.
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Test-retest 1.
Pairs of team members, from four different teams, completed
ratings on 40 different simulated patients, covering a wide range
of problems. The analysis reports the proportion of cases where
ratings were equal, and within a boundary of +1 or -1 score, the
Cohen's Kappa (pre-set at level 0.3) and Spearman correlations
(Bartko and Carpenter 1976, Fleiss 1981, Siegel 1956).
Test-retest 2
Nine team members (2 social workers, 4 nurse specialists and 3
doctors) all completed ratings on five further simulated
patients. The analysis calculates the proportion where scores
were equal to the most commonly recorded ratings, and the
intraclass correlation coefficients (ICC). The latter tested if
the variance of the ratings was less than the variance of the
scores of different patients (Bartko 1976, Bartko and Carpenter
1976). An ICC above zero indicates that the test is satisfied.
The maximum coefficient of 1 is obtained if all the raters agree
exactly and the individual patients have different scores.
Significance
In all tests, a high level of significance was set for acceptable
reliability : p ( 0.005 (two-tailed tests: Cohen's Kappa and ICC;
one-tailed tests: Spearman correlations).
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5.7.2 Internal consistency: split-half reliability and
Cronbadh's alpha
Data collection for internal consistency
Data collected for construct validity, in section 5.6.3, was used
for this analysis. This consisted of STAS ratings and HRCA-QL
ratings of patients referred to team A over 17 months.
Analysis
To assess the reliability of STAS at different times in a
patient's trajectory during care, split-half reliability,
and Cronbach's alpha were calculated for three data sets:
a) all ratings, on all patients, at all stages in care,
b) ratings made on patients at referral
c) ratings made on patients in their week of death.
The reliability of STAS was compared to that calculated for HRCA-
QL.
STAS items were entered into the analysis in the order collected
by teams.
5.8 Testing the use of STAS: audit of care for the five support
teams
5.8.1 Teams and period of audit
The audit was carried out in five cancer support teams A - E
(described in section 4.3.1).	 Consecutive patients newly
referred and accepted into care during a minimum six month
period, were entered into the study and followed up until death
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or discharge. Team A recorded data for 17 months, team B and C
for six months each, teams D and E for eight months each. Single
episodes of advice, given over the telephone or by a visit, were
not included in this audit because teams recorded very few
details on these patients.
5.8.2 Data collection
Demographic, social, clinical and death details were recorded as
for the pilot study (see section 5.4). The data collected was
extended to include details of the patient's accommodation
tenure and mode of access to their home - to provide some
information on social circumstances. Details of the main family
member or carer included: their relation to the patient, whether
they were in full-time employment, part-time employment, no job
outside the home, or were retired, and their Karnof sky
performance status (Karnofsky et al 1948, see appendix H) to
indicate their mobility.
To encourage teams to record the information standard clinical
records were used, with pre-coded sections. However, to allow
teams to maintain their individual identities, the designs of
each teams' notes were maintained as far as possible. Appendix K
shows the notes for the support teams.
The five teams chose to record STAS ratings at referral and then
weekly until death or discharge. The STAS rating forms were
generally kept at the back of team notes, so these could be
found quickly. The patient's Karnof sky ratings, place of care
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(home, hospital or hospice), the team contact and key-worker,
were also recorded at referral and then weekly until
death/discharge.
5.8.3 Analysis of audit data
Data handling
The data was coded and entered onto a relational data base,
Scientific Information Retrieval (SIR), with five records per
patient, which had already been designed and tested with pilot
data. This system facilitated the handling of complicated data
sets, where patients spent varying numbers of weeks in care, and
so had different amounts of weekly data. Data was verified and
added to the data base in small amounts as it was collected from
the teams. The SIR commands perform basic statistical and
computing procedures and produce pre-coded files for quick and
easy use with statistical packages (e.g. Statistics Package for
Social Sciences (SPSSX)).
Characteristics of patients and families in care
The social, demographic, mode of referral, diagnostic and
discharge and death characteristics of the patients referred
were reported and compared between the different teams and with
the OPCS records of mortality from neoplasms in matching areas
for matching time periods. Chi-squared was used for the
analysis of contingency tables. In the larger tables, if more
than 20 percent of cells had an expected frequency of less than
five, or if any cells had an expected frequency of one or less,
go
categories were combined (Bradford Hill 1977). (Burke et al 1985
suggested that this rule can be ignored when n > 40. Therefore,
any instances where combining categories altered the results were
noted.)
Use of STAB by teams
To consider the use of STAS by teams the analysis considers the
amount of time patients needed to be in care before all 17 STAS
items were assessed. The proportions of late assessments (item
missed at first contact but then assessed at a late point in
care) and missed assessments (item missed throughout care) were
compared for the teams.
STAB ratings during care and the effectiveness of teams
To assess the main problems of patients, the proportions of
patients with high and low ratings for the 17 STAS items were
calculated. The analysis considered, separately, the
majority of patients who remained in care until death, and the
minority who were discharged. Ratings for each STAS item were
reported for the week of referral, week 2 (2nd week of care), two
weeks before death (death-2) and the week of death or discharge.
To calculate the ratings in the weeks prior to late assessments
the first recorded score for that item was used. Wilcoxon's
matched-pairs signed-ranks test was used to test for significant
differences between weeks (Siegel 1956).
Data on main symptoms was categorised according to the patient's
main symptom for each week. Because the items 'symptom control'
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and 'pain control' are near normally distributed, the mean (95%
confidence intervals) ratings of these items are plotted, to
illustrate changes in score during care (Boneau 1960).
A probability of less than 0.05 was taken as significant, using
two-tailed tests.
Total ratings of all STAS items
Teams were asked if they could weight items in order of
importance. The properties of a total STAS rating, summing all
items, was considered as teams had found this useful in day to
day practice. The analysis tested for correlations between
individual items and the totalled rating in patients at referral
and death, and reports changes in the totalled score during care.
Significance for correlations was set at p ( 0.001 (one tailed
tests) - to reduce the change of type one errors due to the
number of tests undertaken.
Repeat of internal consistency analysis
The analysis described in section 5.7.2 was repeated on the STAS
ratings collected from all five teams. The reliability
coefficient, using the split-half method with Spearman-Brown's
correction, and Cronbach's alpha were calculated for STAS on all
assessments during care, and separately for the weeks of referral
and death.
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6. RESULTS.
6.1 The Support Team Assessment Schedule - 17 items of
palliative care: items, ratings, face validity and initial
testing.
6.1.1. Items developed
From the areas of work and literature review, team A initially
agreed 14 items of palliative care which represented their
goals.
The areas of work identified by teams are shown in appendix B,
and included seven areas: assessment, emotional support, co-
ordination, advice and education, symptom control, organisation
of facilities and bereavement support. Areas of work were
relevant to several items, for example the area of work
'organisation of facilities' resulted in the items: 'practical
aid', 'financial', 'wasted time' and 'planning'. However, items
were not developed for the bereavement work, as STAS concentrated
on care before death.
Items and literature of the goals of palliative care
An item 'symptom control' was developed to reflect the goals of
palliative care to control pain and physical symptoms (Saunders
1978, Parkes 1979a). The recognition that pain has physical,
emotional, spiritual and social components led to STAS including
items in these areas.
Items named 'patient anxiety' and 'family anxiety' reflected the
goals to support the patient and family, as the unit of care,
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both to reduce their anxieties and to support stages of grief,
anger or despair (Saunders 1978, Parkes 1979a, Mount and Scott
1983, Mor and Masterson-Allen 1987).
Weisman (1977) defined 'appropriate death' as 'an absence of
suffering, preservation of important relationships, an interval
for anticipatory grief, relief of remaining conflicts, belief in
timeliness, exercise of feasible options and activities, and
consistency with physical limitations, all within the scope of
one's ego ideal'. Recently, Kellehear (1990) described the
features of the modern 'good death' as awareness of dying, social
adjustments and personal preparations, public preparations
(legal, financial, religious, funeral, medical), work or
activities reduced, and farewells. Items of 'patient insight',
'family insight', 'planning' and 'predictability' relate to the
later parts of these definitions, and to teams' goals to help
patients to achieve as full an understanding of their disease as
they wished.
In Britain, the role of palliative care in supporting, advising
and educating other professionals is stressed (Working Group on
Terminal Care 1980, James 1988). Practitioners identified
education needs for symptom control and patient and family
support (Haines and Booroff 1986). The items 'advising
professionals' and 'professional anxiety' were developed to
measure these goals.
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The three items dealing with communication were developed because
of evidence that palliative care needs good communication.
Communication is needed both between all professional staff
caring for the dying patient, to ensure liaison and to prevent
duplication or delay; and from doctors and 'nurses, who should
give time to communicate with patients and their families rather
than withdrawing or appearing hurried or abrupt in their
manner. Poor communication is a frequent cause of distress for
patients and families (Cartwright et al 1973, Maguire and
Faulkner 1988a).
Presentations and discussion
The presentations and discussions of STAS suggested that two
further items ('spiritual' and 'communication between patient and
family') were needed. One item (symptom control) was sub-
divided (into pain control and other symptom control) but this
was contentious, and not agreed until stages 2 and 3 had begun. It
was not felt that any items should be removed. Although staff
would have liked a smaller number of items, they could not agree
on those which were less important.
Final items
Table 6.1 shows the final 17 items included in STAS
and the range of severity from no problem to most severe. The
first 10 STAS items are concerned with the needs of the patient
and family, and include physical, emotional, spiritual, planning
and communication items. The last seven items are concerned with the
provision of services, including social, financial, and co-
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ordination needs, and the needs of other professionals involved
in care. Each definition is termed to show the difficulties as
experienced by the patient and family. These seven service items
are intermediate outcomes, but nevertheless can have a major
impact on the patient and family and are an important part of
support team care in the community. For example, after discharge
from hospital poor communication between professionals can lead
to a general practitioner being reluctant to prescribe drugs for
a patient because he/she has not been properly informed by the
hospital; or a patient may suffer because community services have
not been organised. Teams aim to improve communication between
professionals by co-ordinating care.
6.1.2 Ratings
Ordinal rating scales were preferred to a visual analogue scales
by staff as this enabled them to define various interim
points; they also believed that this would reduce variations
between assessments. Seven point (0-6) scales were chosen for the
pilot study as it seemed to the team that these best reflected
the detailed assessments they made. However, when piloted
severe scores for the service items were seldom recorded, so
subsequently scales had five points (0-4).
High scores indicated high levels of patient need, low scores
indicated low needs; table 6.2 and 6.3 show the complete ratings
the items 'pain' and 'practical aid', appendix C shows the ratings
for all items.
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Communication
between patient
and family
Practical aid
Financial
Wasted time
Communication
between
professionals
Professional
anxiety
Advising
professionals
Table 6.1. Definitions of the 17 items in the Support Team Assessment Schedule (STAS)
DEFINITION
	
RANGE best - worst
Pain control
	
Effect of pain(s) on the patient. 	 None - severe and continuous, unable to
concentrate, eat, sleep or describe.
Symptom control Effect of symptom(s) on the patient None - severe and continuous, unable to
concentrate, eat, sleep or describe.
Patient anxiety	 Effect of anxiety on the patient	 None - severe and continuous, unable to
concentrate, sleep or describe.
Patient insight
Family anxiety
Family insight
Predictability
Planning
Spiritual
Patient's knowledge of his/her
prognosis.
Effect of anxiety on the family*.
Family's* knowledge of prognosis.
Patient and family's* need to know
likely future events and time
scale related to the team's
ability to provide this information.
Further need for the patient, as
desired, to organise his/her
affairs and special meetings.
Effect of any crises in beliefs, faith
or religious practices on the
patient
Depth and openness of
communication between patient and
family'.
Further need for practical aid at
home reflecting the difficulty for
patient and family* without aids.
Further need for benefits reflecting
the difficulty for patient and family*
without benefits.
Amount of patient's time lost for
tests which could have been avoided,
the patient not wishing to attend.
Speed, accuracy and depth of
Information communicated between
other professionals" reflecting any
difficulties for patient and family*.
Effect of anxiety on other
professionals" reflecting any
difficulties for patient and family*.
Amount and speed of advice needed
for other professionals.
Full knowledge of prognosis - not knowing
he/she has cancer.
None - severe and continuous unable to
concentrate, sleep or describe
Full knowledge of prognosis - expecting to
become completely well.
Future events dearly predicted or stable - no
idea of likely disease progression and future
arrangements.
Completed or unnecessary - major decisions
outstanding, patient at a loss where to begin.
Content In own beliefs - distraught with
uncertainty or guilt, and in chaos how to
resolve this.
Communicating openly and honestly -
both pretending.
None needed - patient incapacitated without
basic aids.
No benefits due - many entitled, patient and
family with no money and in chem.
No time lost - several days wasted.
Full information with any changes explained -
avoiding answering all questions and visiting.
Correct messages to all involved on the same
day - no communication or idea of who else
is involved.
None - overwhelming anxiety with inappropriate
action.
No advice needed or previous advice
implemented - major difficulties unrecognised
by key workers.
Communication Depth of information given to patient
professionals to and family', when they require this,
patient and family from other professionals".
• Family = the patient's nearest carer.
** Other professionals = the other involved professionals including: General Practitioner, District Nurse, Social Worker,
Hospital Staff.
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Table 6.2 Definition and ratings of STAS item pain control.
Pain control Effect of his/her pain on the patient.
RATING
	 DEFINITION
0 = none
1	 Occasional or grumbling single pain. Patient is not
bothered to be rid of symptom.
2 = Moderate distress, occasional bad days, pain limits some
activity possible within extent of disease
3 = Severe pain present often. Activities and concentration
markedly affected by pain.
4 = Severe and continuous overwhelming pain. Unable to think of
other matters.
Table 6.3 Definition and ratings of STAS item practical aid
Practical aid = Further need for practical aids at home,
reflecting the difficulty for patient and family
without aids.
RATING
	
DEFINITION
0 = None needed.
1 = One aid desirable, not urgent, patient managing at present.
2 = One aid needed urgently ie. the next day, or a few aids needed
soon, patient or family experiencing some difficulty.
3 = Aids needed badly, some improvisation possible.
4 = Patient incapacitated without basic aids.
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6.1.3 Missed, late and not applicable assessments
Staff were allowed to miss item ratings until they could make a
'late' assessment. This was likely to occur for some patients
for items such as 'insight' and 'financial' when the team member
might not wish to enquire too deeply until after two or more
visits. Occasionally items were missed throughout care, if the
team members were unable to discuss the item with the patient or
family. These assessments were classified as follows:
a 'late assessment' = the item was missed at first contact, but
was assessed at a later point in care;
a 'missed assessment'= the item was never assessed during care.
To calculate the total score for all STAS items in the weeks
prior to late assessments the first recorded score for that item
was used.
A rating of 'not applicable' was recorded for family insight and
family anxiety if the patient had no family or carer who could be
assessed. Not applicable ratings were omitted from the analysis.
6.1.3 Timing and frequency of assessments
Most teams hold weekly review meetings of patients and families
in care. The most efficient method of recording STAS ratings was
at these weekly meetings, rating the condition of the patient
and family over the past week. This ensured that team members
did not forget a recording, and enabled them to discuss the
assessment with other team members. However, patients sometimes
varied in their condition from day to day. When this occurred
team members found it difficult to estimate ratings over the
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whole week. More frequent recording was tested and found to be
too time consuming and unpopular. Therefore, some of the STAS
definitions were adapted to take account of a patient's average
condition over the week (e.g. number of days where a problem had
occurred). Team members learned to estimate average conditions,
although they continued to express some frustration that the
STAS did not detect variations in condition from day to day.
6.1.4 Results of pilot study and testing in other teams:
practicality
STAS was used successfully for one year and applied to
all patients in the care of team A. The team found STAS
applicable and suitable for practice. Each patient and family
was assessed weekly, at the team's meeting from referral to
death. Results from the pilot study are shown in appendix D and
E. The study was successful in identifying items which the team
rated as most difficult to achieve and cases where the team scored
themselves as not effective.
Time taken to completing ratings
STAS was incorporated into the teams' work. It took staff
between 30 and 90 minutes, at the weekly meetings, to record the
scores on all their current patients (10 - 25 patients for each
team member). Most time was spent on the assessment of new
patients, since the team member would usually discuss this with
colleagues. Thereafter, rating a patient who was stable and had
been in care for several weeks would take only a minute or two to
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complete. Twenty STAS ratings (including 5 first assessments)
were timed; the median time to complete a rating was 2 minutes
(range 1-15).
It was initially proposed that team members would
jointly discuss and score each patient and family during the
weekly team meeting. This was tested in teams A and B and was
found to be not practical, taking over 2 hours to record
assessments for a full caseload.
Many patients kept the same key team worker throughout care and
so each week the same team member was responsible for completing
the STAS ratings. When two or more team workers were involved
they discussed and agreed the ratings.
Value of completing ratings
Staff reported that STAS ratings helped them to clarify the
main problems of a patient and decide on the urgency of their
intervention. Late assessments alerted them to the fact that
they had not assessed this aspect of care and encouraged them to
do so.	 Often, the recording of a patient's STAS rating would
remind the team member to organise some aspect of care or to
liaise with other professionals, which they would attend to
before continuing to record the STAS rating for their next
patient.
Staff reported the greatest difficulties in assessing the item
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'predictability'. This was described as a factor which was
important for patients but difficult to quantify.
6.2 Criterion validation of STAB, against assessments from
patients and their FMs
6.2.1 Patient and FM interviews
A total of 183 patients was contacted for interview: 117
referred between January 1987 and November 1987 to team A and 66
referred between January and end May 1988 to team E. Eighty-four
patients were interviewed at least once; 99 (54 %) referred
patients could not be interviewed, usually because they had
died (table 6.4). Team E had a slightly greater percentage of
refusals, most commonly due to the FMs refusing. This
difference is partly explained by the type of approach used for
interviews. Requests for interview were made by the team members
in team A, but over the telephone in team E, and often the FM answered
the telephone and so had to be asked first. When refusing the FMs
often said that they were very happy and pleased with the
services, but they did not want the patients disturbed by an
interview; two FMs said that they did not want the patient to be
reminded of their disease; and one said that it would tire the
patients to have a visitor.
Sixty-seven FMs were interviewed. The remaining 17 (20%)
patients did not have a FM living with them or nearby who
could be interviewed.
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Table 6.4 Numbers of patients interviewed and reasons for no
interview in the 2 support teams.
REASONS FOR NO INTERVIEW
NUMBER (%) OF PATIENTS
Team A	 Team E
Died in less than three weeks 46 (39) 23 (35)
Too ill for interview 9* (	 8) 5* (	 8)
Patient refused 6 (	 5) 4 (	 6)
FM refused 1 (	 1) 3 (	 5)
General Practitioner refused 1 (	 1) 1 (	 2)
INTERVIEWED 54 (46) 30 (45)
TOTAL 117 (100) 66 (100)
* 7 patients lived for less than 28 days; 2 lived for less than 50
days, 1 patient lived longer but was very weak with a Karnofsky score
(indicating mobility) of 50 at referral and 30 by the week of planned
interview; 2 patients had senile dementia and 2 were severely
depressed.
A further 19 patients in team A and 12 in team E were not at home
for sufficient time for interview.
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Interviews lasted 20 - 40 minutes; the time varied depending
on the interviewee's response and the number of comments s/he
wished to give. Some questions were missed, either because the
respondent felt unable to assess an item, or because it was not
relevant (e.g. 'family anxiety' for people without family). 	 The
item 'pain control', added later, was only included in 66 patient
and 58 FM ratings.
6.2.2 Agreement and correlations between patient and team
Table 6.5 shows the agreement and correlations between the support
team and patient ratings, and, to indicate the severity of each
item, the mean patient ratings. Few problems were identified
for three items - 'wasted time', 'practical aid' and 'communication
from professionals to patient and family'.
Ratings of four items, 'practical aid', 'wasted time', 'pain control'
and 'symptom control', showed high agreement (over 0.9 were equal
or +1/-1), with weighted Kappas greater than 0.3) and significant
although moderate correlations. For the item 'patient anxiety'
agreement was slightly lower: and teams perceived a higher level
of anxiety than patients. However, ratings were correlated, and
for those patients who recorded the highest self-ratings, team
ratings were as high or greater. The Kappa and correlation
coefficient for the item 'communication of professionals to
patient and family' was very low, but here 96% of patients rated
this item as no problem (0 score). Again, in a few cases the
teams perceived difficulties which were not identified by the
patients. The item 'family anxiety' showed the poorest
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agreement. There was a significant and moderate correlation
coefficient for the total scores of all 7 items (rho = 0.66, p
0.0001). Thus, the total team ratings reflected the total patient
ratings.
6.2.3 Agreement and correlations between FMs and team
The agreement and correlations between the team and FM ratings
are shown in Table 6.6.
Levels of agreement were lower than those found between the
patient and team, except for two items: 'communication from
professionals to patient and family' and 'family anxiety'. Where
there were differences, team ratings tended to be lower (i.e.
less severe) than FM ratings. Team and FM ratings were
significantly correlated for all items except one -'wasted time'.
The correlation coefficients were lower (0.20 - 0.66) than those
found between team and patient ratings, except for 'communication
between professionals and patient and family'. The total scores
of seven items were correlated (rho = 0.44, p ( 0.001).
6.2.4 Agreement and correlations between patient and FM ratings
Table 6.7 shows the agreement and correlations between the
patient and FM ratings. The levels of agreement and
correlations were slightly lower than those found between patient
and team for three items, 'pain control', 'symptom control' and
'patient anxiety'. For other items levels of agreement were
similar. Where there were differences FMs tended to report more
1 05
problems than did the patients. Patient and FM ratings were
significantly correlated except for two items: 'wasted time' and
'communication between professionals and patient and family'.
The total scores of seven items were correlated (rho = 0.53, p <
0.001).
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Table 6.5 Team versus patient ratings. The proportion of ratings which were equal or within one
score, the proportion where ratings were different, the weighted kappas and correlation
coefficients.
Proportion	 of	 pairs
Iten	 miter	 Ratings	 Ratings	 Tean rating Team rating
of pairs an.al	 equal or	 < patient	 > patient
+1 or -1	 ratings -1	 rating +1
knighted Speernan
Kama	 Ova
Fterscn
r
Patient
Maan (SD)
Pain control	 66 0. 98 0.97 0.03 0 0.53 0.66 ip, 0.63 P 1.09 (0.98)
4,apton contndl	 76 0.42 0.91 0.05 0.04 0.40 0.59 p 0.53 pi 1.29 (1.06)
Patient arkiety	 76 0.31 0.87 0.03 0.11 O. 0.45 P 0.54 ip 0.78 (1.07)
Family anxiety	 W 0.22 0.77 0.11 0.11 0.12 0.X * 0.28 * 1.41 (1.28)
Practical aid	 76 0.92 0.99 0 0.01 0.78 0.78 1st 0.20 (0.57)
Wasted tine
	 78 0.94 0.96 0.01 0.01 0.48 0.49 P 0.09 (0.40)
Connunicaticn of 74
professionals to
patient and fardly
0.77 0.83 0 0.11 0.03 0.18 0.07 (0.3))
* p < 0.05 Pp c0.l
Table 6.6	 Team versus FM ratings. The proportion of ratings which were equal or within one score,
the proportion where ratings were different, the weighted kappas and correlation coefficients.
Proportion	 of pairs
Item number Ratings Ratings	 Team rating Team rating Weighted Spearman	 Pearson
of pairs equal equal or	 < FM
+1 or -1	 ratings -1
> FM
rating +1
Kappa rho
Pain control 58 0.50 0.84	 0.16 0 0.42 0.66	 #*	 0.62 #*
Symptom control 66 0.23 0.76	 0.24 0 0.13 0.21	 *	 0.21 *
Patient anxiety 65 0.28 0.74	 0.22 0.05 0.18 0.31	 **	 0.32 **
Family anxiety 66 0.32 0.74	 0.21 0.05 0.15 0.20	 $	 0.25 *
Practical aid 67 0.82 0.99	 0 0.01 0.51 0.42	 #
Wasted time 67 0.84 0.91	 0.04 0.04 -0.06 -0.09
Communication of
professionals to
patient and family
63 0.75 0.92	 0.02 0.06 0.23 0.27	 *
$ p = 0.05	 * p < 0.05 ** p < 0.01 # p < 0.001	 #* p < 0.0001
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Table 6.7 FM versus patients ratings. The proportion of ratings which were equal or within one score,
the proportion where ratings were different, the weighted kappas and correlation coefficients.
Proportion	 of	 pairs
Item	 number	 Ratings	 Ratings	 FM rating	 FM rating
of pairs equal	 equal or	 < patient	 > patient
+1 or -1	 ratings -1	 rating +1
Weighted
Kappa
Spearman
rho
Pearson
Pain control
	 53	 0.45	 0.87	 0.02	 0.11 0.44 0.64 #* 0.62	 #*
Symptom control	 59	 0.37	 0.75	 0.05	 0.20 0.27 0.34 * 0.37	 *
Patient anxiety	 58	 0.40	 0.76	 0	 0.24 0.31 0.39 ** 0.48	 #*
Family anxiety	 56	 0.30	 0.73	 0.07	 0.20 0.29 0.39 ** 0.49	 #*
Practical aid	 59	 0.88	 1.00	 0	 0 0.68 0.60 #*
Wasted time	 61	 0.85	 0.93	 0.03	 0.03 -0.05 0.18
Communication	 54	 0.83	 0.98	 0	 0.02 -0.06 -0.07
Professionals to
Patient and family
* p < 0.05	 ** p < 0.01	 # p < 0.001	 #* p < 0.0001
Table 6.8	 Differences between team, FM and patient ratings.
Team versus patient	 Team versus FM FM versus patient
Item	 n	 Wilcoxon	 n	 Wilcoxon n Wilcoxon
Z	 Z Z
Pain control 66 -2.35	 * 58 -3.57 #* 53 -2.54	 *
Symptom control 76 -0.32 66 -2.84 ** 59 -2.77 **
Patient anxiety 76 -4.05 #* 65 -1.11 58 -4.26 #*
Family anxiety 62 -0.14 66 -2.48	 * 56 -1.76
Practical aid 76 -2.20	 * 67 -0.24 59 -1.01
Wasted time 78 -0.54 67 -0.36 61 -0.89
Oannunication 74 -0.15 ** 63 -1.50 54 -1.60
Professionals to
Patient and family
Total 7 items 51 -2.23	 * 55 -2.71 ** 46 1115
* p < 0.05 ** p < 0.01 # p < 0.001 #* p < 0.0001
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6.2.5 Differences between patient, family and team
assessments
The previous sections indicated area where differences between
ratings occurred. The analysis tested if these differences were
significant using Wilcoxon matched pairs signed ranks test. The
results are shown in table 6.8. To demonstrate these
differences, Fig. 6.1 plots the mean (95% confidence intervals)
ratings for the four STAS items which showed near normal
distributions and where most differences were found.
Team and patient differences
Teams tended to identify more problems than patients. Team
ratings were significantly higher than patient ratings for three
items, patient anxiety, practical aid and communications from
professional to patient and family. (For the last two items
the majority of patient ratings were zero). When summed, team
ratings were also significantly higher than patient ratings.
However, for one item, pain control, team ratings were
significantly lower than the patients.
Team and Fm differences
Team ratings tended to be lower than FMs' ratings. Differences
were significant for three items; pain control, other symptom
control and family anxiety, and for the summed score of seven
items.
1 09
FM and patient differences
FMs identified more problems than patients. Often the
team ratings lay between patient and FM ratings (see Fig 6.1).
FM ratings were also significantly higher than patient ratings
for three items: pain control, symptom control and patient
anxiety, and for the summed score of seven items.
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Fig. 6.1
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6.3 Results of Construct Validation using assessments according to
the HRCA-OL Index
6.3.1 Data collected
Weekly assessments according to the HRCA and the STAS were
collected on 179 patients in the care of team A. Of these 16
patients were assessed only once, 33 were discharged, and 3 died
suddenly long before the time expected leaving 128 patients who
remained in care until death. Their time in care ranged from 1
to 75 weeks; mean 9.4 weeks, median 6 weeks. Seventy-four
patients spent more than four weeks in care. The item pain
control was added to the STAS later, during the data collection
and was recorded in 76 patients.
6.3.2 Changes in STAS and RRCA-0, ratings over time
Tables 6.9 and 6.10 show the median (interquartile range) and
mean ratings for the STAS items and the HRCA QL-index, at
referral and at discharge or death, for 128 patients
who died in care and for the 33 who were discharged.
Patients who died in care
In the patients who died in care, between referral and death,
ratings according to STAS improved, while ratings according to
HRCA-QL deteriorated. Fourteen STAS items showed significant
improvements (ie reductions in ratings), and three showed a trend
towards improvement which did not reach significance (table 6.9).
In contrast, ratings for four HRCA-QL showed significant
deteriorations (reductions in score). The item 'support' showed
no change.
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Table 6.9	 Median (inter-quartile (IQ) range) and moan ratings according
to STAS and HRCA-QL for the 128 patients who remained in care until death.
AT
REFERRAL
WEEK OF
DEATH
COMPARISON OF
WEEKS
ITEMS
median	 mean median	 mean WILCOXON TEST
STAS	 (IQ range) (IQ range) Z value P value
Pain control
	 1	 (0-2)	 1.22 0	 (0-1)	 0.74 -2.88	 **
Symptom control	 2	 (0.5-3) 1.95 2	 (1-2)	 1.57 -3.45	 **
Patient anxiety	 1.5 (1-2)	 1.66 1	 (0-2)	 1.20 -3.44	 **
Family anxiety	 2	 (1-3)	 1.96 2	 (1-2)	 1.75 -1.52	 NS
Patient insight
	 1	 (0-2)	 1.26 0	 (0-1)	 0.40 -5.99	 ***
Family insight	 0	 (0-1)	 0.47 0	 (0-0)	 0.12 -4.24	 ***
Predictability	 1	 (1-2)	 1.46 0	 (0-1)	 0.53 -6.63	 ***
Planning	 1	 (0-2)	 1.25 0	 (0-1)	 0.68 -3.77	 **
Practical aid	 0	 (0-1)	 0.82 0	 (0-0)	 0.33 -3.53	 **
Financial	 0	 (0-1)	 0.36 0	 (0-0)	 0.14 -3.11	 **
Wasted time	 0	 (0-0)	 0.15 0	 (0-0)	 0.07 -1.17	 NS
Spiritual	 0	 (0-0)	 0.24 0	 (0-0)	 0.18 -0.13	 NS
Communication	 2	 (0-2)	 1.61
between patient
and family
0.5 (0-2)
	 0.92 -4.69	 ***
Communication	 0	 (0-1)	 0.63
between
professionals
0	 (0-0)	 0.30 -2.62
Communication of	 0.5 (0-2)	 0.94
professionals to
patient and family
0	 (0-0)	 0.23 -5.45	 ***
Professional	 1	 (0-1)	 0.69
anxiety
0	 (0-0)	 0.35 -3.90	 **
Advising	 1	 (0-2)	 1.14
professionals
0	 (0-1)	 0.48 -4.96	 ***
Total 6	 7(5.5-9.5) 7.77 4	 (2-6)	 4.64 -4.36	 ***
STAS items
HRCA-QL
Mobility	 1	 (1-1)	 1.09 0	 (0-1)	 0.45 -6.87	 ***
Daily Living	 1	 (0-1)	 0.98 0	 (0-1)	 0.32 -6.68	 ***
Health	 1	 (0-1)	 0.70 0	 (0-1)	 0.30 -4.89	 ***
Support	 2	 (2-2)	 1.75 2	 (2-2)	 1.74 -0.57	 NS
Outlook	 1	 (1-1)	 1.14 1	 (0-1)	 0.79 -4.17	 ***
QL Total	 6	 (4-7)	 5.66 3	 (2-5)	 3.61 -7.57	 ***
* p < 0.01, ** p < 0.005, *** p < 0.00005 Wilcoxon signed ranks
test, comparing ratings in weeks of referral and death. NS = not
significant.
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AT
REFERRAL
median	 mean
(IQ range)
Pain control	 1	 (1-2) 1.20
Symptom control	 2	 (1-2) 1.50
Patient anxiety	 2	 (1-3) 1.94
Family anxiety	 2	 (2-3) 2.18
Patient insight	 1	 (0-2) 1.00
Family insight	 0	 (0-1) 0.52
Predictability	 1	 (0-2) 1.13
Planning	 2 (1-2.5) 1.68
Practical aid	 0	 (0-0) 0.39
Financial	 0	 (0-0) 0.21
Wasted time	 0	 (0-0) 0.47
Spiritual	 0	 (0-0) 0.42
Communication	 1	 (0-3) 1.48
between patient
and family
Communication	 0 (0-0.5) 0.47
between
professionals
Communication of 0	 (0-1) 0.68
professionals to
patient and family
Professional	 1	 (0-2) 1.25
anxiety
Advising	 1.5 (0-2) 1.47
professionals
WEEK OF
DISCHARGE
median	 mean
(IQ range)
0.5 (0-1) 0.78
1	 (1-2) 1.42
2	 (1-2) 1.57
1	 (0-2) 1.43
0	 (0-1) 0.46
0	 (0-0) 0.09
0	 (0-1) 0.69
0	 (0-2) 1.12
0	 (0-0) 0.10
0	 (0-0) 0.19
0	 (0-0) 0.27
0	 (0-0) 0.09
0.5 (0-2) 1.40
0	 (0-0) 0.33
0	 (0-0) 0.21
0	 (0-1) 0.63
COMPARISON OF
WEEKS
WILCOXON TEST
value P value
-1.86
	
0.06
-0.06
	
NS
-1.82
	
0.07
-2.45
	
0.01
-2.37
	
0.02
-2.02
	
0.04
-2.34
	
0.02
-1.47
	
NS
-1.78
	
0.07
-0.55
	
NS
-1.83
	
0.07
-1.34
	
NS
-0.42
	
NS
	
-1.10	 NS
	
-2.52	 0.01
	
-2.39	 0.02
* *0	 (0-1) 0.57	 -3.01
ITEMS
STAS
Table 6.10 Median (inter-quartile (IQ) range) and mean ratings according
to STAS and HRCA-QL for the 33 discharged patients.
Total 6	 9 (6-12) 8.71	 7	 (3-8) 5.86	 -1.75	 0.08
STAS items
HRCA-QL 
Mobility	 1.5 (1-2) 1.47	 1	 (1-2) 1.41	 -0.84	 NS
Daily Living	 1.5 (1-2) 1.37	 1	 (1-2) 1.14	 -2.20	 0.03
Health	 1	 (1-1) 1.00	 1	 (1-1) 0.97	 -0.00	 NS
Support	 1	 (1-2) 1.27	 2	 (1-2) 1.38	 -1.34	 NS
Outlook	 1	 (1-1) 1.00	 1	 (1-1) 1.10	 -0.80	 NS
QL Total	 6	 (5-8) 6.10	 6	 (5-8) 6.00	 -0.74	 NS
* p < 0.01, ** p < 0.005, Wilcoxon signed ranks test, comparing ratings in
weeks of referral and discharge. NS = not significant.
Where 0.01 < p < 0.10, actual p value is given.
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To compare the scales further, ratings were considered in
patients at different times before dying, irrespective of their
time of referral. This demonstrates the extent which scales are
affected by the process of dying. Fig. 6.2 shows the percentage
of patients with a rating of 2 (best rating) for HRCA-QL items
during the 11 weeks before dying. Note that the number of cases
for analysis reduced in the weeks distant from death: 68 cases
were available at six weeks before death, and 38 at 11 weeks
before death. Again, ratings according to four HRCA-QL items -
mobility, daily living, health, and outlook - deteriorated
towards death. Chi-squared tests for trend were highly
significant (Fig. 6.2).	 This was despite the fact that patients
had spend different amounts of time in support team care.
Deteriorations were most marked in the last 4 weeks before dying
and the four items showed similar trajectories. One item,
support, was different: ratings showed little change. Mean
ratings showed similar trajectories.
Results were different when the percentages of patients with a
rating of 0 (best rating) for STAS items during the 11 weeks
before dying were considered (Figs. 6.3 and 6.4). These showed
varied patterns in patients towards death and any trends
were less marked. For five items - 'predictability', 'family insight',
'patient insight', 'patient anxiety' and 'communication
between patient and family' - there was a trend towards improving
scores towards death. For two items 'advising professionals' and
'professional anxiety' there was a trend towards deteriorating
scores near death. For the remaining ten items there were no
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significant trends. Mean scores showed a similar pattern.
These results support the assumptions, in section 5.6.1, that
STAS and HRCA-QL measure different things and would behave
differently in patients as death approached. These assumptions
were used as the basis for setting hypothesis to test construct
validity.
Patients who were discharged
There were only 33 discharged patients. Between referral and
discharge there were trends towards improvements in ratings for
all STAS items, which rarely reached significance (table 6.10).
For the HRCA-QL, there was a trend towards a deterioration for
one item 'daily living', but no other trends. Therefore, marked
deterioration in the ratings for four HRCA-QL items appeared to
be confined to the effect of dying.
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Percentage of patients rated 2 (best rating)
100
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Fig. 6.2
HRCA-QL item scores in the 11 weeks before death
All patients irrespective of time of referral
11 10 9	 8	 7	 6	 5	 4	 3	 2	 1	 0
WEEK BEFORE DEATH
Mobility	 Daily living	 Health
Support	 Outlook
Chi-squared test for trend
Mobility - chi-squared = 30.50, df=1, p ( 0.000001.
Daily living - chi-squared = 29.31, df=1, p ( 0.000001
Health - chi-squared = 20.09, df=1, p ( 0.000001
Outlook - chi-squared = 14.86, df=1, p = 0.0001.
Support - chi-squared = 2.17, df=1, p = 0.14
	 (NS)
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Percentage of patients rated 0 (best rating)
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Fig. 6.3
STAS item scores in the 11 weeks before death
All patients irrespective of time of referral
011 10 9	 8	 7	 6	 5	 4	 3	 2
	 1
WEEK BEFORE DEATH
Pain control
El Symptom control
Comm. between professionals
Family insight
13 Predictability
[01 Planning
I Practical aid
[§1 Financial
Chi-squared test for trend (test results shown where p < 0.05)
Family insight - chi-squared = 8.21, df=1, p = 0.004.
Predictability - chi-squared = 18.57, df=1, p = 0.00002.
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Fig. 6.4
STAS item scores in the 11 weeks before death
All patients irrespective of time of referral
Percentage of patients rated 0 (best rating)
100
	 4--	 4
60
--o-
40 
•1:1
20
0
11 10 9
	
8	 7	 6	 5	 4	 3
	
2
	
1
	
0
WEEK BEFORE DEATH
Patient anxiety
El Family anxiety
Wasted time
Spiritual
Comm. between patient & family
Patient insight
a Comm. professionals to patient
El Professional anxiety
Advising professionals
Chi-squared test for trend (test results shown where p C 0.05)
•
Patient anxiety
Communication between
patient and family
Patient insight
Professional anxiety
Advising professionals
- chi-squared = 7.90, df=1, p = 0.005.
- chi-squared = 4.80, df=1, p = 0.03.
- chi-squared = 9.50, df=1, p = 0.002.
- chi-squared = 4.42, df=1, p = 0.03.
- chi-squared = 12.80, df=1, p = 0.0003
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6.3.3 Correlations between STAS and EIRCA-QL
The remaining analysis considers the correlations between STAS
and HRCA-QL items in the 128 patients who died in care. The
number of discharged patients was too small for this analysis.
Table 6.11 shows the significant correlations found in:
a) all 128 patients, at referral
b) the 74 patients who were in care for more than four weeks, at
referral and,
c) all 128 patients, at death.
a) Hypothesis 1 - Negative correlations between items which were
similar
In patients at referral, highly significant (p 0.0005) negative
correlations were found between the scores of 3 STAS items
('symptom control', 'patient anxiety' and 'family anxiety') and
the STAS sub-total, and 2 HRCA-QL items ('health' and
'outlook') and the HRCA-QL total (table 6.11). This supported
hypothesis 1 of the strongest correlations where the indices were
similar.
b) Hypothesis 3 - correlations highest in patients early in care.
The correlation coefficients were larger in the group of 74
patients who were in care for more than 4 weeks before dying. As
predicted, the strongest correlations found between STAS and
HRCA-QL items were in these data, between patient anxiety (STAS)
and outlook (HRCA-QL), rho = -0.70, and symptom control (STAS)
and health (HRCA-QL), rho = -0.64.
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In patients at death, there were fewer correlations between the
patient orientated STAS items and the HRCA-QL index. These
findings further supported hypothesis 3.
	
STAS items - 'pain
control', 'symptom control' and 'patient anxiety' - showed
significant negative correlations (rho = -0.39, -0.25, and -0.28
respectively, all p ( 0.005) with the HRCA-QL item 'support'
(the one item least likely to deteriorate at death). High
ratings for the STAS item 'family anxiety', were associated low
ratings for the HRCA-QL item 'outlook', but the Spearman rho was
lower (rho = -0.25, p ( 0.005). The sub-total of 6 STAS items
was not significantly correlated with the total HRCA-QL score in
patients at death.
Positive correlations 
Weak positive correlations were found, in patients near death,
between 2 STAS items: 'patient insight' and 'predictability',
and 2 HRCA-QL items: 'mobility' and 'daily living' (table 6.11).
Thus, the more a patient was mobile and able to care for his/her
own needs, the worse was his/her insight and the greater the need
to predict the course of the disease. This finding agreed with
the experience of many clinicians, but were not predicted.
c) Hypothesis 2 - few correlations between HRCA-QL and STAS
service orientated items
Lower and less significant negative correlations were found
between the SPAS service items and items in the HRCA-QL index,
supporting hypothesis 2. At referral, where most correlations
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were found, the items 'health' and 'outlook'(HRCA-QL) were
correlated with the items 'planning', 'communication of
professionals to patient and family', and 'advising
professionals' (STAS) (rho ranging between -0.27 and -0.21, both
p ( 0.01). 'Communication between professionals' (STAS item)
was correlated with 'health' (HRCA-QL) and 'professional anxiety'
(STAS) was correlated with 'outlook' (HRCA-QL). 'Practical aid'
(STAS) was also correlated with the HRCA-QL items 'mobility' and
'daily living'.
These weak associations between STAS service items and 'health'
and 'outlook' (as measured by the HRCA-QL index) made sense to
clinicians, who would expect a patient referred in poor health
to require more services. Similarly, patients with poor mobility
or unable to self care (as indicated by the HRCA-QL items
'mobility' and 'daily living') might have a higher requirement
for practical aids (indicated by a high score on the STAS item
'practical aid').
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Table 6.11 Spearman correlations (rho) between STAS items and the NRCA-014. index, at referral
and in the week of death, for all 128 patients who died in care, and at referral in the 74
patients who remained in care for more than 4 weeks.
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6.4. Results of reliability of the STAS:
6.4.1 Assessments of simulated patients
The results of 40 paired assessments, which tested patients with
widely ranging problems and severity, are shown in table 6.12.
Ratings for 16 of the 17 items were equal or +1/-1 score for 0.88
or more of the cases. For these 16 items, the tests for
agreement, corrected for chance agreement using Cohen's Kappa
(weighted), showed levels well above the pre-set level of 0.3
(Kappa ranged 0.48-0.87) and were highly significant (p <
0.0005). The paired assessments were correlated, Spearman's rho
ranged between 0.65 and 0.94, p < 0.0005. One item,
'predictability', showed lower levels of agreement and
correlations, and did not reach the pre-set standards for
reliability.
Where missed assessments were recorded, the pairs commonly agreed
on a missed assessment.
Table 6.13 shows the results from testing for agreement between 9
raters on 5 patients. Again there was good agreement for 16
items, all except 'predictability'. 	 Ratings for the 16 items
were equal or +1/-1 score for 0.89 or more of the cases. The
ratings given by the teams for some of the patients are shown in
appendix J (tables J.1 to J.5). These are ratings of five of the
simulated patients described appendix I. All the intraclass
correlation coefficients (ICCs) showed significantly less
variance between the raters assessments than between different
patients, with moderate and high coefficients ranging 0.41 - 0.95.
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Table 6.12 40 paired assessments. Proportion of pairs where ratings were equal, equal or +1 or -1,
weighted kappas and correlations.
Correlation of total scores of 17 items, Spearman rho . 0.95 p < 0.0005, Pearson r = 0.95 p < 0.000005 (n.40)
Item Ratings Ratings Weighted Spearman MISSED ASSESSMENTS
equal equal or Kappa rho Number Nunber agreed
+1 or -1
Pain control 40	 0.8 1.0 0.87	 0* 0.93
	 IP 0 -
Syrnqbam control 40	 0.73 1.0 0.83	 i* 0.93	 #* 0 -
Patient anxiety 40	 0.38 0.98 0.55	 f* 0.79	 f* 0 -
Family anxiety 29	 0.45 0.97 0.59	 I* 0.79	 #* 11 11
Patient insight 39	 0.59 0.92 0.62	 f* 0.73	 f* 1 1
Family insight 27	 0.70 0.93 0.68	 IP 0.78	 if* 13 12
Predictability 39	 0.34 0.74 0.25	 0 0.35	 * 1 1
Planning 37	 0.62 0.95 0.60	 1* 0.75	 I* 3 3
Practical aid 35	 0.63 1.0 0.71	 1* 0.86	 i* 5 4
Financial 33	 0.70 0.97 0.73	 #* 0.79	 IP 7 7
Wasted time 33	 0.88 0.97 0.79	 #* 0.91	 #* 7 3
Spiritual 24	 0.83 0.92 0.81	 #* 0.90	 #* 16 13
Communication between
patient and family 29	 0.45 0.90 0.59	 #* 0.81	 #* 11 8
Communication between
professionals 37	 0.78 1.0 0.84	 I* 0.94	 #* 3 1
Communication from
professionals to
patient and family 34	 0.71 0.97 0.75	 #* 0.84	 it* 6 1
Professional anxiety 40	 0.6 0.98 0.50	 I* 0.68
	 #* 0 -
Advising	 professionals 40	 0.48 0.88 0.48	 1* 0.65
	 #* 0
* p < 0.05	 ** p < 0.01 0 p < 0.005 #* p < 0.0005
#*
#*
Table 6.13 Nine teams ratings of five patients. Proportion of ratings
which were equal to the most commonly recorded ratings, or equal or +1 or -1,
and intraclass correlations coefficients.
Item
	
Ratings
	 Ratings equal Intracl ass correlation
equal	 or +1 or -1	 coefficient
Pain control
Symptom control
Patient anxiety
Family anxiety
Patient insight
Family insight
Predictability
Planning
Practical aid
Financial
Wasted time
Spiritual
Ccamunication between
patient and family
Communication between
professionals
Communication from
professionals to
patient and family
Professional anxiety
Advising professionals
0.87 1.0 0.95
0.8 1.0 0.93
0.6 0.97 0.81
0.69 0.97 0.87
0.71 0.93 0.74
0.61 0.94 0.73
0.53 0.73 0.35
0.76 1.0 0.82
0.75 1.0 0.84
0.82 0.96 0.90
0.95 0.98 0.66
0.90 0.93 0.89
0.64 0.89 0.78
0.8 0.98 0.87
0.75 1.0 0.86
0.78 0.98 0.41
0.51 0.93 0.68
# p < 0.005	 #* p < 0.0005
6.4.2 Internal consistency
Table 6.14 shows the split half reliability Spearman Brown
coefficients and Cronbach's alpha for STAS ratings at referral,
at death or discharge, and on all weeks (combined) made on the
the 179 patients assessed by team A. The number of cases where
all 17 STAS items could be analysed was only 34 at referral and
35 at death because the items 'spiritual' and 'family insight'
had frequently been missed, and the item 'pain control' was added
to STAS later and so was not recorded in all cases. To analyse
the homogenicity of STAS but include the majority of cases,
internal consistency was also reported in shortened scales
omitting these 3 items, as follows:
a) 16 STAS items (omitting 'spiritual')
b) 15 items (omitting 'spiritual' and 'pain control') and
c) 14 items (omitting 'spiritual', 'pain control' and 'family
insight').
Internal consistency of STAS at referral and death
In ratings at referral and in those at death, levels of
reliability according to all tests were moderately high for
measure with 14-17 items, with coefficients ranging 0.68 - 0.89
for the various combinations of items. The levels are similar to
those found in the development of Spitzer's QL index, described
as 'high' for a 5 item measure, where Cronbach's alpha = 0.775.
Levels of reliability were similar in the full 17 items and the
16 items, and very slightly lower when 15 and 14 items were
tested.
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Internal consistency of STAS in all interim weeks
When ratings from all weeks in care were considered the internal
consistency was slightly lower.
Internal consistency of HRCA-QL
Coefficients ranged 0.35 - 0.77 and were lower than those found
for SPAS and lower that those found by Spitzer in the development
of the QL index (see table 6.15).
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Table 6.14 Standardised item Cronbach's alpha and split-half
reliability using equal length Spearman-Brown for STAS: applied to
different weeks of care.
Week reliability tested and
scale - items included
At Referral
Spearman
Brown
Cronbach's
Alpha
STAS - all	 items 34 0.76 0.74
STAS - 16 items:	 except	 spiritual 75 0.81 0.77
STAS - 15 items:	 except	 spiritual
and pain control
127 0.75 0.73
STAS - 14 items:	 except	 spiritual
pain control	 and family	 insight
129 0.72 0.71
At death or discharge
STAS - all	 items 33 0.87 0.82
STAS - 16 items	 : except	 spiritual 73 0.81 0.82
STAS - 15 items
	 : except	 spiritual
and pain control
122 0.71 0.76
STAS - 14 items	 : except	 spiritual 122 0.71 0.75
pain control and family insight
All interim	 weeks:	 note - more than one assessment per patient
STAS - all items 310 0.51 0.57
STAS - 16 items	 : except	 spiritual 557 0.70 0.66
STAS - 15
and
items
	 : except	 spiritual
pain control
938 0.67 0.70
STAS - 14 items	 : except	 spiritual 950 0.64 0.68
pain control and family insight
Table	 6.15	 Standardised	 item Cronbach's	 alpha	 and split-half	 reliability
using equal	 length Spearman-Brown,	 for the HRCA-QL	 index:	 applied	 to
different	 weeks of care.
Week reliability	 tested n	 Spearman	 Cronbach's
Brown	 Alpha
At Referral 186	 0.36 0.62
At death/discharge 181	 0.35 0.67
All	 interim	 weeks:
note - more than one assessment
per patient
1134	 0.47 0.71
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6.5 Results: characteristics of patients and FMs referred to the
five teams during the audit.
6.5.1 Demographic and personal characteristics of patients
During the study 581 patients were referred to the teams. Of
these, 311 (54%) were male and 270 (46%) female, mean age was 66
years (median 67 years) range 19 - 92 years (table 6.16). Most
patients were of British origin, 430 (81%), 44 (8%) were Irish,
12 (2%) other European, and 43 (7%) other nationalities (missing
52). Of those who declared religious views, 215 (53%) were Church
of England, 109 (27%) Roman Catholic, 19 (5%) Jewish, 40 (10%)
other religion and 23 (6%) agnostic or atheist (missing	 175,
30% of all patients).
Tables 6.16 and 6.17 and Fig. 6.5 show these characteristics
for the different teams. Teams A and E were referred most
patients (192 and 126 respectively), but in all teams data on 80
or more patients was collected. The ages of patients
referred to teams B and C were significantly lower than those
referred to the other teams (table 6.16). There were no
significant differences between the teams in the proportions of
men and women referred. Fig. 6.5 shows that teams C and E (New
Town and Outer London teams) saw mostly British patients (96 and
94% respectively) whereas the inner London teams had 24 - 28% of
patients who were of other national origins.
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Table	 6.16 Age and sex of patients referred to five teams
Team AGE SEX n (2) Total
mean (952 confidence median range Men Women referred
Interval)
A 67.6 (66.1-69.0) 67 32 - 92 111 (58) 81 (48) 192
B 63.0 (60.0-66.0) 64 19 - 89 44 (55) 36 (45) 80
C 62.2 (59.3-65.2) 63 35 - 86 39 (49) 41 (51) 80
D 66.8 (64.5-69.1) 68 32 - 88 54 (52) 49 (48) 103
E 66.0 (64.0-67.9) 67 37 - 90 63 (50) 63 (50) 126
All cases 65.8 (64.8-66.7) 67 19 - 92 311 (54) 270 (47) 581
One way analysis of variance of age:
F ratio = 4.26, df = 4 (between groups), 561 (within groups), p = 0.002.
Chi-squared of sex distribution . 2.90, df = 4, p = not significant.
Table 6.17 Religions of patients referred to the five teams
Team Church Roman Jewish Other Agnostic/ Not	 Total
of England Catholic Religion atheist recorded referred
A 149 65(44) 43(29) 14(9) 15(10) 12(8) 43	 192
62 37 (60) 17 (27) 1	 (2) 7	 (11) - 18	 80
57 41	 (72) 9(16) 1(2) 4	 (7) 2(4) 23	 80
39 15 (40) 20 (51) - 2	 (5) 2 (5) 64	 103
99 57 (58) 20 (20) 3 (3) 12	 (12) 7 (7) 27	 126
All cases 406 215 (53) 109 (27) 19	 (5) 40 (10) 23 (6) 175	 581
Chi-squared = 34.08, df = 12, p = 0.0007 (of Church of England,
Roman Catholic, other religion (including Jewish), or
agnostic/atheist)
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Whether religious faith was recorded or not varied from team to
team (table 6.17). Team D recorded the faith in only 38% of
patients, whereas other teams recorded faith in 71-79%. Teams
C, B and E had the largest proportion of patients whose faith was
Church of England (58-72%): the Roman Catholic faith was also
common in teams D, A and B (27-51%). These figures reflected the
national origins of patients, although conclusions cannot be
drawn for team D owing to missing data. (National origin was
recorded in a higher proportion, 66%, for team D.)
Patient's accommodation
Although social class was not recorded, the type of accommodation
provides information on social circumstances. The tenancy of
patients' accommodation was: 43% council, 40% owner-occupied, 9%
private rented, 2% hostel, 1% warden aided and 5% other
(including nursing homes). Fig. 6.6 shows that owner occupation
was common for teams E (79%) and C (60%) (Outer London and New
Town) but more rare in the Inner London teams, especially team A
(12%). Team D had the largest proportion of private rented
accommodation (29%). One hundred and twenty one patients (27%)
lived in accommodation where the outside access was by stairs
with no lift (table 6.18). This was a particular feature of
inner London teams (A,B,D). The relationship of accommodation
type and access is shown in table 6.19: private rented and
council accommodation had the highest proportions (55% and 38%)
where access was by stairs only.
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Tenancy of patients referred to the five teams
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Table 6.18 Access to the patients' homes for the five teams
ACCESS n(%)
Team Ground By lift By stairs Not	 Total Proportion
floor or stairs only recorded referred recorded
A 167 48 (29) 46 (28) 73 (44) 25	 192 78%
8 54 25 (46) 11	 (20) 18 (33) 26	 80 78%
C 61 54 (89) 1	 (2) 6 (10) 19	 80 71%
D 38 22 (58) 5 (13) 11	 (29) 65	 103 38%
E 121 108 (89) - 13	 (11) 5	 126 79%
All cases 441 257 (58) 63 (14) 121	 (27) 140	 581 70%
Chi-squared = 137.9, df=8, p < 0.00005
Table 6.19 Access to the accommodation for patients with
different tenancies
ACCESS	 n(%)
Tenancy n Ground
floor
By lift	 By stairs
or stairs	 only
Owner occupied 175 155 (89) 1	 (1)	 19	 (11)
Private rented 38 11	 (29) 6 (16)	 21	 (55)
Council 181 67 (37) 46 (25)	 68 (38)
Other 28 17 (61) 6 (21)	 5 (18)
Total 422 250 (59) 59 (14)	 113 (27)
missing = 159:
unknown.
note in some cases access was known but tenancy was
Chi squared = 123, df = 6, p < 0.00001
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Patient's status
The current status of the patients was: 337 (59%) married, 119
(21%) widowed, 64 (11%) single (always), 41 (7%) divorced or
separated and 6 (1%) changing status during the care (e.g.
patients who got married) (14 missing). Table 6.20 shows how
status varied between teams: teams A, C and D had the highest
percentage of widowed patients (24-25%) (despite team C having
younger patients than A and D) and A,B and D had many single
patients (15-16%).
Forty-eight percent of patients lived with one other person.
Twenty-three percent lived alone, this was lowest in team E (9%)
and highest in teams A (30%) and D (32%) (Fig. 6.7).
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Table 6.20 Status of patients referred to five teams
STATUS n(%)
Team
Married/	 Widowed
partnered
Divorced/
separated
Single Changing Total
A 100 (52) 46 (24) 13 (7) 30 (16) 3 (2) 192
El 50 (63) 9 (11) 8 (10) 13 (16) / 80
C 49 (65) 18 (24) 5 (7) 3 (4) / 75
D 48 (51) 23 (25) 8 (9) 14 (15) 1 (1) 94
E 90 (71) 23 (18) 7 (6) 4 (3) 2 (2) 126
All cases 337 (60) 119 (21) 41 (7) 64 (11) 6 (1) 567*
* missing = 14
Chi-squared = 30.7, df = 12, p = 0.002 (omitting 'changing' from the analysis)
Fig. 6.7
Number of people the patients lived with
Chi-squared • 34.17, df • 12, p • 0.0008 (missing • 37)
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6.5.2 The nearest family member or carer
A nearest family member or carer (FM) could be identified for 546
patients (96%, missing = 12). Twenty-three patients (4%) had no
FM: this was highest for teams A (6%) and B (8%). In contrast,
only 1 patient referred to team E had no carer (Fig. 6.8). The
most common FM was a wife (36% of patients), followed by a
husband, 22%, and a daughter, 13%. Other carers were: sister
3.7%, brother 1.2%, friend 4.4%, other 7.7%.
To examine whether the FMs would be able to provide care for the
patient, the employment of FMs and their Karnof sky Performance
Status was recorded at first assessment. Thirty-eight percent of
FMs had full-time paid employment outside the home and 8% had
part-time employment, however this information was missed in 101
patients. Fig. 6.9 shows that team E had the highest proportion
of FMs with full or part-time employment (47%). Of patients
referred to each team, between 42.3% (team E) and 56.5% (team A)
had FMs who were retired or had no paid employment and could be
at home with them during the day.
A few FM were disabled and could not have cared for the patient:
some even needed the patient to care for them. Forty (8.2%)
carers had Karnof sky ratings of 80 - 60, indicating they were
usually unable to carry out normal activities, and 7 (1.4%)
carers were severely disabled (Karnofsky ratings 30 - 50)
(missing = 35).
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Fig. 6.8
Main carers of patients
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6.5.3 Clinical characteristics of patients
All patients except two had cancer (one patient had motor neurone
disease and one had AIDS). The most common primary diagnoses
were cancers of gastrointestinal tract (28%), lung and bronchus
(23%), genitourinary tract (18%) and breast (10%) (table 6.21).
The percentage of different cancers varied between teams, and to
examine this in more detail the cancers referred were compared
with local mortality from cancer. Table 6.22 shows the number of
deaths from cancer among local residents during the study period
for each team. The referral rates per 100 resident cancer deaths
were remarkably similar, 33 for teams A - D and lower, 23 for
team E (table 6.23). However, unlike teams A - D, team E did not
serve the whole of their health district, because another (older)
team served a part of it. Mortality rates for the locality
served by team E were not available.
The number of expected referrals, for different primary cancers in
each team, was calculated from the number of resident deaths
during the study period (OPCS data) multiplied by the referral
rate for all cancers to that team. This was compared with the
observed number of referrals. Table 6.23 shows the ratio of
observed / expected referrals for different primary cancers.
Team B had far fewer lung cancer patients than would be
expected (observed/expected (0/E) = 0.39). It transpired that in
the district of team B there was a separate services of home
support for all patients with continuing lung problems, including
those with lung cancer. Many lung cancer patients were referred
to this service.
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In three teams there were more referrals than expected of cancers
of the ear, nose and throat (0/E ranged 2.21 - 4.15). Cancer of
the lymphatic system were referred less than would be expected in
four teams.
The primary cancer or its metastasis was the main cause of
symptoms: 265 (47%) and 276 (49%) of patients, respectively.
Other diseases, not related to the cancer, were the main cause of
symptoms for few patients (22 patients - 4%) (missing = 18).
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Table 6.21 Cancers of patients referred to the five teams.
PRIMARY	 CANCER	 n(%)
Team	 n	 Lung	 Gastro-	 Genital-	 Ear, nose Breast Lymphatic Other	 Primary
Intestinal urinary
	 & throat	 cancers unknown
A	 192	 55 (29) 54 (28) 	 28 (15) 14 (7)	 15 (8) 8 (4)	 6 (3)	 12 (6)
8	 78	 10 (13) 24(31)	 20 (26)	 4(5)	 6 (8) 3(4)	 4 (5)	 7 (9)
C	 77	 14(18) 13(17)	 19(25)	 3(4)	 10 (13) 4(5)	 8(10)	 6(8)
D	 100*	 29 (29) 26 (26)	 16 (16)	 2 (2)	 10 (10) 6 (6)	 7 (7)	 3 (3)
E	 126+	 23(18) 41 (33)	 19(15)	 1 (1)
	
16(13)	 3(2)	 12(10)	 10(8)
All cases 573	 131 (23) 158 (28)	 102 (18) 24 (4)	 57 (10) 24 (4)	 37 (7) 38 (7)
missing = 8
* Includes one patient with HIV/AIDS
+ Includes one patient with motor neurone disease
Table 6.22 Numbers of residents who died of cancer in each team's health district, during the study period.
NUmbers are estimated from OPCS data for 1 year, (1988)
NUMBER OF DEATHS FRCM CANCERS DURING STUDY PERIOD
Team Period of Lung Gastro- Genito- Ear, nose Breast Lymphatic Other All cancers
data collection intestinal urinary & throat cancers
A 17 months 170.0 162.9 93.5 9.9	 59.5 51.0 58.1 613.4
B 6 months 77.0 51.5 37.5 5.5	 23.5 15.5 25.5 236.5
C 6 months 55.5 73.5 33.0 2.5	 26.0 17.0 25.0 234.0
D 8 months 97.3 78.7 47.3 7.3	 24.7 12.7 34.0 303.3
E 8 months 124.7 152.7 90.7 9.3	 55.3 32.0 73.3 544.7
Table 6.23 Observed / expected referrals for each cancer type based on each team's referral rate.
Expected referral rate calculated from number of OPCS deaths in study period x individual team's referral
rate for all cancers.
Team Referral rate	 OBSERVED / EXPECTED FOR EACH CANCER
per 100 resident
cancer deaths	 Lung	 Gastro-	 Genito- Ear, nose Breast Lymphatic Other
(all types)	 intestinal urinary & throat	 cancers
A 33.30 1.03 1.06 0.96 4.51 0.88 0.50 0.86
B 32.98 0.39 1.41 1.62 2.21 0.77 0.59 1.28
C 32.91 0.77 0.54 1.75 3.65 1.17 0.72 1.61
D 32.97 0.90 1.00 1.03 0.83 1.23 1.44 0.94
E 23.13 0.80 1.16 0.91 0.46 1.25 0.41 1.24
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6.5.4 Source of referral
Patients were referred by: general practitioners (GPs) (25%),
radiotherapists (18%), surgeons (19%), physicians
(15%), medical oncologists (3%), and others, mostly ward nurses,
(20%). Teams B and E accepted referrals only from consultants or
GPs and therefore had no referrals in the 'other' category,
whereas most (59%) referrals to team C were from nurses (Fig.
6.10). The community based teams received most referrals from
general practitioners (team E, 56% and team A, 24%). Only 2
patients were referred by GPs to team B.
The most common first two reasons for referral were: symptom
control (1st or 2nd reason in 284 (50%) patients) and home
support (1st or 2nd reason in 159 (28%)), followed by patient
support or relief of anxiety (1st or 2nd reason in 137 (24%)),
and family support or relief of anxiety (1st or 2nd reason in 133
(23%).
Time from cancer diagnosed to referral
Nineteen percent patients were referred within one month of their
diagnosis of cancer, only eight percent were greater than five
years from diagnosis. In all teams there was a mix of patients
at all times after diagnosis (Fig. 6.11), although the community
based teams were referred the lowest percentage who were within
one month of diagnosis (18% for team A, 10% team E).
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6.5.5 Place of care
Two hundred and sixty patients (53%) were at home when referred,
172 (36%) were in hospital, 50 patients (10%) were transferring
between hospital and home and two patients were transferring
between hospice and home (n = 484, as this was only recorded for
patients who had STAS ratings subsequently recorded).
Of the 473 patients for whom place of death was recorded (in a
high proportion of the discharged patients this was not known),
202 patients (43%) died at home, 191 (40%) died in hospital, 72
(15%) died in a hospice and 8 (2%) died in nursing homes and
elsewhere.
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6.6 Audit results: STAS ratings during care by five teams
6.6.1 Patients included in audit
STAS ratings were commenced for 487 patients (see table 6.24).
Team D had staff shortages, and for six months was reduced to
only one nurse rather than two, shortly after they began data
collection. Team D wished to remain in the study and was keen to
collect the demographic and clinical data on patients, but wanted
to stop collecting the audit data until staffing levels returned
to normal.	 This was agreed. In a few other cases patients
referred for care died before they could be assessed. For 53
(10.9%) patients, STAS ratings were recorded only at referral,
and the patients then died or were discharged before a second
assessment was made. This was most common in the hospital based
teams (B,C and D). Two or more STAS ratings were recorded in the
remaining 434 (89.1%) patients: 98 were subsequently discharged
and not re-admitted during the study, two died suddenly of
diseases other than their cancer, and 334 were in team care at
death. Table 6.24 shows these figures for the different teams.
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Table 6.24 Number of patients in each team who commenced audit, died or were discharged
after one rating or who had 2 or more ratings completed before death or discharge.
number of patients (Z of those for whom STAS ratings were commenced)
Team Total
referred
STAS ratings
comnenced
Discharged
or died after
2 or more ratings completed
referral rating total died discharged
A 192 191 17	 (8.9) 174 (91.1) 131	 (68.6) 43 (22.5)
8 80 ao 13 (16.3) 67 (83.8) 38 (47.5) 28 (35.0)*
C ao 65 10 (15.4) 55 (84.6) 49 (75.4) 5	 (7.7)*
D 103 27 ** 4 (14.8) 23 (85.2) 16 (59.3) 7 (25.9)
E 126 124 9	 (7.3) 115 (92.7) 100 (80.6) 15 (12.1)
All cases 581 487 53 (10.9) 434 (89.1) 334 (68.6) 98 (20.1)
* A further one patient in the care of team 13 and one in the care of team C died suddenly,
not from their cancer.
** Number low because team stopped audit for six months awing to staff shortages.
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6.6.2 Full assessments of all 17 STAB items
Full assessments, where ratings for all 17 STAS items were
recorded, were found for only 82 (16.8%) patients at referral. A
further 58 (11.9%) patients were fully assessed by the end of the
second week of care, and 46 (9.4%) were fully assessed after
this. However, 301 (61.8%) patients never had a full assessment
recorded before death or discharge.
There were significant differences between teams. Fig. 6.12
shows the proportion of patients with full assessments at
different stages during care. Team B recorded a full
assessment for only one patient at referral, and increased this
to nine patients only slowly. Teams C and D recorded full
assessments in over 40% of patients at referral, and were able to
improve this to over 55%.
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Cumulative percentage of patients in each team who had all
17 STAS items recorded at different stages during care
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Chi-squared comparing the number of full assessments first
completed, at referral, weeks 1-2, weeks 3+ or never = 92.4,
df=12, p < 0.00005.
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6.6.3 Late and missed STAS assessments
The failure to record a full assessment was often due to ratings
for the item 'spiritual' being missed. This item was missed
throughout care in 49.5% of patients and was assessed late
(missed at first contact but then assessed later during care) in
a further 22.4%. Four other items - 'financial', 'family
insight', 'family anxiety' and 'communication between patient and
family' - were quite commonly assessed late (20.3-24.4% of
patients) and were missed in 9.9 - 16.6%. The remaining items
were occasionally assessed late (3.9 - 17.1%) but were missed in
less than 9.5% of patients (table 6.25).
There were significant differences between the teams in the
pattern of missed and late assessments for six items (tables 6.26
to 6.31). Team B recorded the highest proportion of late and
missed assessments for the items i spiritual l (table 6.26) and
'financial' (table 6.27). In contrast, team C only missed
assessments for the item 'spiritual' in 15.4% of patients,
considerably lower than any other team, and team D recorded no
missed assessments for the item 'financial'. However, team B had
the lowest proportion of late and missed assessments for the item
'planning' (table 6.28).
Team B and D, both hospital based, recorded more late and missed
assessments than other teams for those items concerned with the
family - 'family anxiety' (table 6.29), 'family insight' (table
3.30) and 'communication between patient and family'(table
3.31). Perhaps their hospital base made it more difficult for
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them to meet family members. However, team C, also hospital
based, did not share their difficulties.
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Table 6.25 STAS ratings which were assessed late (missed at
first contact but then assessed later during care) or were missed
throughout care, in the 487 patients included in the audit.
Assessed late Missed throughout
care
Item n (%) n (%)
Pain control 26 (5.3) 2 (0.4)
Symptom control 21 (4.3) 3 (0.6)
Patient anxiety 37 (7.6) 14 (2.9)
Family anxiety 99 (20.3) 50 (10.3)
Patient insight 69 (14.2) 46 (9.5)
Family insight 107 (22.0) 48 (9.9)
Predictability 44 (9.0) 6 (1.2)
Planning 84 (17.3) 34 (7.0)
Practical aid 43 (8.8) 16 (3.3)
Financial 119 (24.4) 81 (16.6)
Wasted time 36 (7.4) 15 (3.1)
Spiritual 109 (22.4) 241 (49.5)
Communication between
patient and family
115 (23.6) 58 (11.9)
Communication between
professionals
23 (4.7) 7 (1.4)
Communication from
professionals to
patient and family
43 (8.8) 12 (2.5)
Professional anxiety 19 (3.9) 2 (0.4)
Advising professionals 25 (5.1) 6 (1.2)
Table 6.26 STAS item 'spiritual'. Late and missed assessments
for the five teams.
Team n
Assessed
at referral
n (2)
Assessed
late
n (2)
Missed throughout
care
n (2)
A 191 41 (21.5) 41 (21.5) 109 (57.1)
B 80 7 (8.8) 12 (15.0) 61 (76.3)
C 65 46 (70.8) 9 (13.8) 10 (15.4)
D 27 8 (29.6) 10 (37.0) 9 (33.3)
E 124 35 (28.2) 37 (29.8) 52 (41.9)
Chi-squared = 97.45, DF = 8, p < 0.00005
Table 6.27 STAS item 'financial'. Late and missed assessments
for the five teams.
Team n
Assessed
at referral
n (%)
Assessed
late
n (%)
Missed throughout
care
n (%)
A 191 121 (63.4) 45 (23.6) 25 (13.1)
B 80 28 (35.0) 28 (35.0) 24 (30.0)
C 65 54 (83.1) 6 (9.2) 5 (7.7)
D 27 20 (74.1) 7 (25.9) 0
E 124 64 (51.6) 33 (26.6) 27 (21.8)
Chi-squared = 46.76, DF = 8, p < 0.00005
Table 6.28 STAS item 'planning'. Late and missed assessments
for the five teams.
Team n
Assessed
at referral
n (2)
Assessed
late
n (%)
Missed throughout
care
n (%)
A 191 137 (72.8) 32 (16.8) 20 (10.5)
B 80 76 (95.0) 3 (3.8) 1 (1.3)
C 65 56 (86.2) 8 (12.3) 1 (1.5)
D 27 19 (70.4) 8 (29.6) 0
E 124 79 (63.7) 33 (26.6) 12 (9.7)
Chi-squared = 38.67, DF = 8, p < 0.00005
Table 6.29 STAS item 'family anxiety'. Late and missed
assessments for the five teams.
Team n
Assessed	 Assessed
at referral	 late
n (%)	 n (%)
Missed throughout
care
n (%)
A 191 128 (67.0) 43 (22.5) 20 (10.5)
B 80 35 (43.8) 30 (37.5) 15 (18.8)
C 65 53 (81.5) 5 (7.7) 7 (10.8)
D 27 18 (66.7) 7 (25.9) 2 (7.4)
E 124 104 (83.9) 14 (11.3) 6 (4.8)
Chi-squared = 44.85,	 DF = 8, p < 0.00005
Table 6.30 STAS item 'family insight'. Late and missed assessments
for the five teams.
Team n
Assessed
at referral
n (2)
Assessed
late
n (2)
Missed throughout
care
n (2)
A 191 123 (64.4) 48 (25.1) 20 (10.5)
B 80 38 (47.5) 28 (35.0) 14 (17.5)
C 65 54 (83.1) 5 (7.1) 6 (9.2)
D 27 18 (66.7) 7 (25.9) 2 (7.4)
E 124 99 (79.8) 19 (15.3) 6 (4.8)
Chi-squared = 33.96, DF w 8, p < 0.00005
Table 6.31 STAS item 'communication between patient and family'.
Late and missed assessments for the five teams.
Team n
Assessed
at referral
n (2)
Assessed
late
n (2)
Missed throughout
care
n (2)
A 191 125 (65.4) 46 (24.1) 20 (10.5)
8 80 31 (38.8) 30 (37.5) 19 (23.8)
C 65 48 (73.8) 9 (13.8) 8 (12.3)
D 27 16 (59.3) 8 (29.6) 3 (11.1)
E 124 94 (75.8) 22 (17.7) 8 (6.5)
Chi-squared = 35.98, DF = 8, p < 0.00005
6.6.4 Severity of the 17 STAS items during care
The following sections describes the severity of STAS ratings,
first for the 334 patients who were in care at their death, and
then second for the 98 patients who were discharged. 	 Missed
assessments were excluded from the analysis. To calculate the
score in weeks prior to a late assessment the score first
recorded for that item was used. The data from all teams is
considered together.
The 334 patients who died in care
The 334 patients spent a mean of 7.8 weeks in care, median 5
weeks (inter-quartile range 2-10 weeks). Figs. 6.13 and 6.14
show the percentages of patients with scores of 0 (no problems)
through to 4 (most severe), for these patients at referral, in
their second week of care and at death. Items are listed in
order of severity at referral.
At referral
At referral, high proportions (22-33%) of patients had severe
problems (rated 3 or 4) for four items, 'family anxiety', 'symptom
control', 'patient anxiety' and 'communication between patient
and family'.	 For another four items - 'planning', 'patient insight',
'pain control', and 'predictability'- between 17% and 18% of
patients had severe problems (rated 3 or 4). For the remaining nine
items - seven concerned with the services, plus 'spiritual' and
'family insight' - there were usually mild problems or none and
less than 10% were rated 3 or 4.
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Second week of care (week 2)
By week 2, for all items, fewer patients had severe ratings and
more were rated zero (no problems). Compared to ratings at
referral, differences were significant for 15 items, all except
'financial' and 'spiritual' (Wilcoxon Z ranged -2.11 to -7.95,
table 6.32). The four items 'family anxiety', 'symptom control',
'patient anxiety' and 'communication between patient and family'
remained relatively severe: 9-21% were rated 3 or 4. For
other items, 11% or less were rated 3 or 4, and 62-97%
were rated 0 or 1 (nil or mild problems).
At death
At death, three items - 'family anxiety', 'symptom control' and
'patient anxiety' - continued to be the most severe. The proportion
of patients with severe ratings (score 3 or 4) increased,
compared to week 2, to 29%, 25% and 15%, respectively. The
percentage of patients with severe ratings for the item
'practical aid' also increased to 4% at death, compared to only
1% in week 2 (Fig. 6.14)
Ratings for other items were similar to, or slightly lower than,
ratings in week 2. Ratings at death were lower than ratings at
referral for all items (Wilcoxon Z ranged -2.16, p = 0.03, for
'family anxiety', to Z = -9.91, p ( 0.00005 for
'predictability'), see table 6.32.
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Table 6.32 Wilcoxon matched-pairs signed-ranks test for referral versus week 2 ratings
and for referral versus death ratings. The 334 patients who died in care.
Wilcoxon matched-pairs signed-ranks test
referral v week 2
	
referral v death
Item	 n pairs Z	 p value	 n pairs Z	 p value
Pain control	 211	 -5.94 p < 0.00005	 241	 -5.51 p < 0.00005
Symptom control	 287	 -5.83 p < 0.00005	 322	 -5.34 p < 0.00005
Patient anxiety	 279	 -6.27 p < 0.00005	 308	 -7.06 p < 0.00005
Family anxiety	 264	 -3.42 p = 0.0006	 294	 -2.16 p = 0.03
Patient insight	 269	 -2.24 p = 0.03	 288	 -8.23 p < 0.00005
Family insight	 260	 -2.11 p = 0.03	 291	 -7.61 p < 0.00005
Predictability	 288	 -4.11 p < 0.00005	 322	 -9.91 p < 0.00005
Planning	 263	 -5.18 p < 0.00005	 304	 -8.11 p 4 0.00005
Practical aid	 276	 -3.93 p = 0.0001	 316	 -5.59 p < 0.00005
Financial	 242	 -0.85 NS	 276	 -5.01 p < 0.00005
Wasted time	 278	 -2.50 p = 0.01	 315	 -3.81 p = 0.0001
Spiritual	 146	 -1.19 NS	 162	 -2.68 p = 0.007
Communication between	 249	 -3.85 p = 0.0001	 277	 -7.30 p < 0.00005
patient and family
Communication between	 287	 -3.73 p = 0.0002	 322	 -4.68 p < 0.00005
professionals
Communication from	 280	 -5.14 p < 0.00005 	 315	 -8.11 p < 0.00005
professionals to
patient and family
Professional anxiety	 288	 -6.99 p < 0.00005 	 325	 -5.73 p < 0.00005
Advising professionals 	 285	 -7.95 p < 0.00005 	 319	 -7.90 p < 0.00005
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The 98 patients who were discharged
Patients who were discharged spent a similar amount of time in
care to those who had died, mean = 9.2 weeks (median = 4 weeks,
inter-quartile range = 2-10 weeks). Figs. 6.15 and 6.16 show the
percentages of patients with scores of 0 (no problems) through to
4 (most severe), for patients at referral, in week 2 and at
discharge.
Ratings at referral were of similar severity to those in the 334
patients who died in care. Ratings had improved by week 2, again
in a similar pattern to those in the group of 334 patients.
Differences between referral and week 2 were significant for 12
out of 17 items, but note that there was a much smaller number of
patients in this analysis (table 6.33). Unlike the changes
between week 2 and death, where ratings increased for some items,
in the 98 discharged patients ratings reduced between week 2 and
discharge. The percentages of patients with severe (3 or 4)
ratings for the items 'family anxiety', 'symptom control',
'patient anxiety' and 'communication between patient and family'
were 16, 14, 13, and 13, respectively. Differences between
referral and discharge were significant for 14 out to 17 items,
all except 'financial', 'spiritual' and 'communication between
patient and family'.
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Table 6.33 Wilcoxon matched-pairs signed-ranks test for referral versus week 2 ratings
and for referral versus discharge ratings. The 98 patients who were discharged.
Wilcoxon matched-pairs signed-ranks test
referral v week 2	 referral v discharge
Item n pairs	 Z	 p value n pairs Z	 p value
Pain control 50	 -2.98	 p = 0.003 57 -3.14	 p = 0.002
Symptom control 81	 -3.02	 p = 0.003 93 -3.62	 p = 0.0003
Patient anxiety 76	 -2.89	 p = 0.004 92 -3.12	 p = 0.002
Family anxiety 57	 -3.14	 p = 0.002 65 -4.52	 p < 0.00005
Patient insight 74	 -2.95	 p = 0.003 84 -4.83	 p < 0.00005
Family insight 61	 -2.31	 p = 0.02 69 -2.53	 p = 0.01
Predictability 80	 -2.99	 p = 0.003 91 -5.01	 p < 0.00005
Planning 77	 -2.86	 p = 0.004 87 -4.63	 p < 0.00005
Practical aid 80	 -2.42	 p = 0.02 90 -2.68	 p • 0.007
Financial 64	 -0.32	 NS 78 -1.36	 NS
Wasted time 81	 -0.30	 NS 92 -2.37	 p • 0.02
Spiritual 33	 -1.34	 NS 37 -1.60	 NS
Communication between
patient and family
59	 -0.44	 NS 66 -1.42	 NS
Communication between
professionals
80	 -1.26	 NS 92 -2.03	 p = 0.04
Communication from
professionals to
patient and family
78	 -2.87	 p = 0.004 89 -4.43	 p < 0.00005
Professional anxiety 81	 -2.18	 p = 0.03 92 -3.73	 p = 0.0002
Advising professionals 79	 -3.32	 p = 0.0009 91 -4.67	 p < 0.00005
NS = not significant
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6.6.5 Changing symptoms during care in the 334 patients who died
in care
The ratings of the item 'symptom control' and the record of a main
symptom each week allows analysis of the changing main symptoms
during care. Pain control was rated as a separate item, so
ratings for this can be compared with other items. The analysis
considers the 334 patients who died in care, the number of
discharged patients with individual symptoms was not large enough
for this analysis.
Fig. 6.17 shows the eight symptoms (other than pain) most
commonly recorded as the main symptom at referral and at death.
The most frequent main symptoms were weakness (recorded in 17.1%
at referral and 16.7% at death) and dyspnoea (14.0% at referral
and 15.5% at death). 	 Between referral and death, vomiting,
nausea and constipation were recorded less frequently as main
symptoms, and the number of patients with no symptoms increased.
However, confusion became more frequent, and depression and
anorexia remained largely unchanged.
The ratings for three common main symptoms, dyspnoea, weakness
and nausea and vomiting (combined) are shown in Figs. 6.18 to
6.20. Fig. 6.21 shows the ratings for pain control. Ratings
for symptom control and pain control were near normally
distributed (see Figs. 6.13 and 6.14). Therefore, to demonstrate
changes in score during care, mean (95% confidence intervals)
ratings were plotted for patients with these main symptoms at
referral, week 2, death - 2 (two weeks before death) and death.
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T-test was used to test for differences between the ratings in
different weeks (pooled variance method).
Teams apparently failed to alleviate both dyspnoea and weakness,
for there was no significant difference between ratings at
referral and week 2, death-2 or death (T ranged 0.64 to -1.68,
p ranged 0.5 to 0.1). Ratings for nausea and vomiting (combined)
were significantly lower in the weeks of death-2 and death
compared to referral (Fig. 6.20).
Fig. 6.21 shows how the ratings for the item 'pain control'
were very different from these three symptoms. Ratings had
improved markedly by week 2, compared to referral, and this
was maintained until death.
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Dyspnoea as the main symptom
Mean (95% Confidence Interval) symptom control rating
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Weakness as the main symptom
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Mean (95% Confidence Interval) ratings for symptom control
Referral versus death-2, T.-2.54, p=0.01
Referral versus death, T.-3.61, p.0.001
Mean rating (8, 95% Confidence Interval)
3
1
0
Referral week 2
Week in care
0 Mean	 El upper 95% Cl
Death -2 Death
C lower 95% CI
1 68
12:0 Mean
Fig. 6.21
Mean (95% Confidence Interval) ratings for pain control
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6.6.6 Properties of a total score of STAS items
Trajectories of patients' total STAS scores during care
Teams found it useful to calculate a total score by summing all
STAS items. They used this to provide a quick assessment of the
severity of a case. Because the items 'spiritual' and
'financial' were frequently missed or assessed late, it was
agreed to calculate a total score by summing 15 items, omitting
these two. The maximum possible total score was therefore 60.
Fig. 6.22 shows the trajectory of one patient during
care: the total STAS ratings are shown against weeks in care.
Changes in score can be linked to events, such as chemotherapy
treatment or hospitalisation. This patient's history is given
below the figure.
Changes in total score during care
Total scores, summing 15 items, could be calculated for up to 197
(59%) of patients who died in care. Total scores were normally
distributed. Table 6.34 shows the mean (95% confidence interval)
median, and range of total scores in patients at referral, week 2
and at death. Compared with scores at referral, total scores
were significantly lower in week 2 (Wilcoxon matched-pairs
signed-ranks test, Z = -8.04, p < 0.00005) and at death (Wilcoxon
Z = -9.04, p < 0.00005). Patients varied in the extent of
improvement, and some did not improve during care. Between
referral and death, 82% of patients showed an improvement in
total score, 16% a deterioration, and 2% did not change. In the
week of death, 10 out of 172 patients (6%) had total scores of 20
170
or above, which the teams considered to be clinically severe.
The corresponding figure for the week of referral was 33% (65 out
of 197 patients).
Properties of a total score
Teams were asked if they could weight the severity of STAS items
to assist the calculation of a total score. However, they were
unable to agree on weights, or even an order STAS items with the
most important first.
Table 6.35 shows the correlation coefficients between the total
STAS score and individual STAS items in patients at referral and
death. Items are presented in order of highest correlation
coefficients at referral. At referral, the items representing the
anxiety of the patient and family, and communication, showed the
strongest correlations with the total score (Spearman rho ranges
0.55-0.61). For five items, 'pain control', 'symptom control', and
three service items correlations were weak (Spearman rho ranges
0.39-0.15) At death, the pattern changed. The items 'patient
anxiety', 'family anxiety' were even more strongly correlated with
the total score (Spearman rho = 0.73 and 0.75, respectively),
but, unlike at referral, the items 'pain control' and symptom
control' were moderately correlated with the total score
(Spearman rho = 0.56 and 0.54 respectively).
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Fig. 6.22
STAS total scores for one patient from referral to death.
Total score 60
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Patient history
This was a 62 year old lady with a squamous cell carcinoma of the
lung, who had recently begun a course of Iphosphamide
chemotherapy. On referral to the team her main problems were
symptom control, she had pain, but was vomiting when given
opioids. She and her husband were very anxious, but had full
insight and few problems with service co-ordination. The total
score at referral was 25. When her pain and vomiting were
controlled using subcutaneous morphine and anti-emetics, and her
anxiety and that of her husband diminished, her total score fell
to seven and she was discharged home. At home she was put on
oral medication, but then was readmitted to hospital for
chemotherapy, during which her total scores rose due to her, and
her husband's, anxiety prior to treatment. She also developed
symptoms of depression. Subsequently, she was discharged home,
her problems were alleviated and remained low throughout the few
weeks until her death at home.
'few
probiems
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Table 6.34	 Total score of 15 STAS items (all except 'financial'
and 'spiritual') at referral, week 2, and at death.
TOTAL SCORE OF 15 STAS ITEMS
Week mean (952 Confidence) median minimum maximum
Interval)
At referral 197 16.5 (15.5-17.5) 16 1 39
Week 2 168 12.1 (11.2-13.1) 11 0 32
Death 172 9.4 (	 8.4-10.3) 9 o 34
Table 6.35 Correlations between STAS total score of 15 items with individual STAS
items in patients at referral and death. Items are listed in order of size of
correlation at referral.
Item
REFERRAL
n	 Spearman
rho	 p
DEATH
n	 Spearman
rho	 p
Order of
correlations
at death
(highest first)
Communication from
professionals to
patient and family
197 0.61 0.0005 172 0.51 0.0005 8
Family anxiety 197 0.60 0.0005 172 0.73 0.0005 2
Patient anxiety 197 0.59 0.0005 172 0.75 0.0005 1
Communication between
professionals
197 0.55 0.0005 172 0.48 0.0005 9
Predictability 197 0.55 0.0005 172 0.54 0.0005 4
Patient insight 197 0.51 0.0005 172 0.43 0.0005 12
Planning 197 0.50 0.0005 172 0.47 0.0005 10
Professional anxiety 197 0.49 0.0005 172 0.51 0.0005 7
Advising professionals 197 0.48 0.0005 172 0.47 0.0005 11
Family insight 197 0.48 0.0005 172 0.29 0.0005 15
Communication between
patient and family
197 0.46 0.0005 172 0.51 0.0005 6
Spiritual 121 0.43 0.0005 101 0.31 0.001 13
Symptom control 197 0.39 0.0005 172 0.54 0.0005 5
Practical aid 197 0.31 0.0005 172 0.29 0.0005 14
Pain control 197 0.27 0.0005 172 0.56 0.0005 3
Wasted time 197 0.18 0.006 172 0.21 0.003 17
Financial 180 0.15 0.02 158 0.21 0.004 16
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6.6.7 Internal consistency
Table 6.37 shows the results of the internal consistency analysis
for the 487 patients who had STAS ratings recorded. The analysis
considers ratings at referral, and at death or discharge, for all
items, and to exclude items where missed ratings were common, 15
items (except 'spiritual' and 'pain control') and 14 items (also
excluding 'financial'). Family insight was included in this
analysis, because unlike in team A, enough recordings were
available.
Levels of internal consistency were similar to those found when
only one team had been considered. Thus the use of STAS more
widely in five teams had not affected its homogenicity.
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0.74
0.73
0.74
0.80
0.77
0.78
Table 6.37 Standardised item Cronbach's alpha and split-half
reliability using equal length Spearman-Brown for STAS: applied to
different weeks of care.
Week reliability tested and	 Spearman Cronbach's
scale - items included
	
Brown	 Alpha
At Referral
STAS - all items	 144	 0.68
STAS - 15 items: except spiritual 	 314	 0.68
and pain control
STAS - 14 items: except spiritual 	 349	 0.65
pain control and financial
At death or discharge
STAS - all items	 120	 0.74
STAS - 15 items : except spiritual	 279	 0.69
and pain control
STAS - 14 items : except spiritual
	 309	 0.71
pain control and financial
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7. DISCUSSION
7.1 The Support Team Assessment Schedule (STAS): content
The first objective of this study was to develop items which
would be suitable as outcome measures for palliative care. Items
should reflect the work and goals of support teams. Previously,
measures of palliative care usually focused on parts of care,
such as pain or symptom control or emotional distress (see Parkes
1985, Kane et al 1984). In STAS broader measures of physical,
emotional, social and service problems were developed, to assess
both the patient and their family member or friend. This
reflected the wider goals of support teams, including their role
in co-ordinating and advising other services.
The patient-orientated STAS items are similar to those included
in other instruments which assess cancer and terminally ill
patients (e.g. the Cancer Inventory of Problem Situations, Schag
et al 1983, and an Initial Assessment of Suffering in Terminal
Illness, MacAdam and Smith 1987); but the STAS is different in
that it considers the patient and family as the unit of care, and
so includes items concerned with the family. This is an
essential component of support team care and palliative care
(National Association of Health Authorities 1987, Saunders 1978).
Unlike Wallston et al's (1988) measure of the quality of death,
STAS attempted to reflect the extent which each item was a
problem to an individual patient and their family, taking their
wishes into account.
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7.1.1 Limitations of the STAS items
STAS includes 17 items across a wide range of palliative care,
but detailed information on each item, for example, the type of
pain or the severity of other individual symptoms, is not included.
This would have been too time consuming to collect. Some
clinicians wish to separately measure symptoms such as dyspnoea,
weakness, nausea, vomiting, pressure sores, anorexia and
constipation. The definition of the STAS item 'symptom control'
could be adapted to measure individual symptoms. A first draft of
definitions for individual symptoms is being tested by home care
teams in Belfast and Dublin.
7.1.2 Psychological and social aspects
The psychological and social aspects of STAS could be expanded in
a similar way, to include more information. In STAS, depression
was recorded when this was considered to be a patient's main
symptom, and was the main symptom in 1.7% of patients at
referral and 1.0% at death. However, depression has been found
in 21% or more cancer patients. Moderate or severe depression
was found in 16 out of 75 (21%) women one year after mastectomy
by Maguire et al (1978). Hopwood et al (1991) found 56 out of
211 (27%) women with advanced breast cancer were probable cases
of an anxiety state and/or a depressive illness, assessed by the
Hospital Anxiety and Depression Scale. Bereaved relatives
reported that depression was present in 54% patients in the last
week of life (Addington-Hall et al 1991), and in 38% of patients
in the last year of life (Seale 1991a). Patients may have
several symptoms, including depression. Discussion of this
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study's findings with team meqbers, suggests that depression may
be present, but often was not recorded because it was not the
main symptom.
Other psychological aspects, such as anger, loss, fear, shock,
withdrawal, guilt, confusion and anticipatory grief also occur in
terminal cancer, but are not measured by STAS (Cassidy 1986).
Out of 192 patients referred to 12 hospice services in the U.K.
professionals recorded the following psychological and social
problems: in patients, anxiety 62%, depression 36%, anger 14%,
withdrawal 26%, denial 21%, guilt 2%, mental confusion 21%; in
carers, anxiety 63%, depression 16%, anger 16%, withdrawal 6%,
denial 9%, guilt 7%; and social problems: financial 14%,
accommodation 21%, isolation 27%, domestic discord 14%, and care
for dependents 8%. One or more emotional problems were reported
in 67% of patients and 50% of carers (McCarthy 1990).
STAS includes only the more common psychological and social
problems: patient anxiety, family anxiety, patient insight,
family insight, financial and practical aids. Communication
between patient and family may reflect domestic discord. For
STAS to include further aspects, new items would be needed.
Adding depression, as a separate item, would be useful given its
low prevalence as the main symptom.
Many studies have reported only the presence or absence of
depression and other psychological aspects, rather than severity.
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The reports of professionals (as in McCarthy 1991) or the reports
of family members (as in Seale 1991a and Addington-Hall et al
1991) were based on the respondents' own understanding of each
term and recordings made in clinical practice. Only occasionally
were standardised validated measures used. Many measures, for
example the Hospital Anxiety and Depression Scale, or the Beck
Depression Inventory, as discussed in the literature review,
include some items which may not be suitable in palliative care.
To develop further psychological items in STAS considerable
testing would be required.
7.1.3 Other aspects of support team work not included in STAS
STAS reflects the patient and family orientated work of support
teams, but not their other work, including bereavement care,
formal education of other health professionals, and self-
management of their service.
Finally, the STAS items are problem orientated and do not
measure 'positive aspects' of dying to which the hospice movement
often aspires. For example, the item 'wasted time' measures
the amount of time a patient lost, but does not measure how
'productively' the patient uses their remaining time, rather than
waiting for death. A chaplain suggested that the item
'spiritual' should also measure the amount which the patient
gives, in spiritual terms, to the team.
7.1.4 Features of a good death which are not measured by STAS
The items were generated to measure the goals of support teams
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when helping patients and families achieve a 'good' or
'appropriate' death. The STAS item 'planning' measures personal
preparations, public preparations, and farewells, which were
listed by Kellehear (1990) as features of a 'good death'. The
feature 'awareness of dying' (Kellehear 1990) is measured by the
STAS item 'insight'. However, Kellehear also proposed that 'good
death' include a reduction in work and activities. This is not
measured by STAS, and was not perceived as a goal by support
teams.
STAS measures first parts of Weisman's (1977) definition of
appropriate death (.i.e. absence of suffering, preservation of
important relationships, relief of remaining conflicts), but it
does not measure the later aspects - 'belief in timeliness,
exercise of feasible options and activities, and consistency with
physical limitations, all within the scope of one's ego ideal'.
These features are highly individual. Great care would be
needed to ensure that the team's view of 'good dying' was not
imposed upon the patients, rather than Saunders' (1978)
suggestion of: 'helping the patient to find his own way of dying,
his own death'. STAS items can be regarded as pre-requisites for
a patient (and family) to find his/her own way of dying. Without
pain control, symptom control, good communication, the
possibility for planning as the patient wishes etc., then a 'good
death' within the patient and family's desires, cannot be
achieved.
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7.1.5 The wonder is, not that the field of stars is so vast, but
that man has measured it. (Anatole France, Garden of Epicurus)
This quotation suggests the danger of over-confidence in human's
ability to accurately measure. The total impact of palliative
care probably cannot be measured. Mount and Scott (1983) likened
measuring hospice care to measuring the beauty of a rose. They
commented:
'Consider the rose. You can weigh it, photograph it,
categorise it, measure its height, petal size and number of
thorns, not to mention the ratio or thorns to height. The
mean and standard deviation of the measures can then be
determined.... The colour may be determined by spectroscopic
analysis; the chemical composition defined, the light
refraction from the dew drop on the petal measured and aroma
quantified (perhaps a group of descriptors similar to the
Melzack Pain Ratings Index could be devised) 	
... Although we would like to measure the beauty of a rose
or to quantify the sense of fulfilment of a dying person we
do not yet have the tools'.
Therefore, it would be surprising if STAS did not have weaknesses
and omissions. One has to achieve a balance between limiting the
number of items to those which the team or researcher can record
and analyse, and developing a measure which covers the total
impact. Teams can rarely record more than 17 items on a regular
basis, and ideally, as shown in the later sections of this
discussion, they prefer fewer items.
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Another difficulty in adding STAS items is that these may range
into areas beyond the competence of all members of the multi-
disciplinary support team. STAS was designed so that any team
member - social worker, doctor, nurse or other - could assess
each item as part of the normal course of work. Providing a
detailed assessment of symptom, psychological or social items,
rather than just identifying a level of severity among common
items, might prove difficult for team members without specialist
training in this area. In practice, if the patient has mainly
symptom problems then a doctor is usually the key worker and
records the assessment, whereas if the problems are mainly
social, the social worker would usually be the key worker. This
would result in the specialised items being recorded for only
those patients with problems.
7.2 Validity and reliability of STAS
This thesis also aimed to develop a measure which was valid and
reliable. Face validity and content validity were demonstrated
through presentations and discussions of STAS by palliative
professionals, and by use of STAS in five settings.
7.2.1 Bias in recordings
STAS used assessments made directly by professionals and there
may have been recording bias by the support teams. This problem
is found in many medical and clinical audits which rely on
ordinary clinical records. Hospital and community staff may give
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different assessments of quality of life and symptoms compared
with dying patients themselves (Slevin et al 1988, Mercier et al
1987, Wilkes 1984). Furthermore, as the team members become
familiar with patients and their problems they may tend to rate
the severity of items less severely.
To reduce bias in STAS recordings team members were encouraged to
discuss their assessments together at the weekly meetings. They
recognised that STAS offered an insight into the pattern of
work and could indicate areas where care might be improved.
Three points support the view that teams were making objective,
rather than biased, assessments: they recorded different levels
of need in different patients; changes in item ratings differed
between patients, and could deteriorate despite team
interventions (especially in the last week); and there was an
association between STAS scores and service events (e.g.
hospitalisation). However, these findings cannot rule out the
possibility of systematic bias.
7.2.2 Criterion validity
Ratings of STAS items by patients, Fms and team members showed
moderate agreements and correlations, but one view was clearly
not an absolute reflection of another. The STAS item 'family
anxiety' showed the lowest validity, suggesting that teams need
to improve these assessments. Correlations between patient and
team were similar to those between patient and FM, found in this
study and others (r or rho ranged 0.40 - 0.63, see Hinton 1979,
Slevin et al 1988). Thus, ratings from team members and FMs
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appear to be equally close to patient's self-ratings.
Who is the ultimate criterion: patient, FM or team?
The results provide further information on the relationship
between patient, FM and team assessments. This question of the
ultimate criterion was raised in the literature review. Patients
are proposed as the most valid assessors of their quality of life
and health status (Baum et al 1990), providing they are well
enough to respond to questions. However, the differences found
in this work between patient, FM and support team shows that each
has a different perspective. FMs tended to identify most
problems, and patients the least, with the team ratings often
between these two views. It may be that the patients wished to
'put on a brave face', and under-reported their problems. For
the item 'patient anxiety', patients' self-reports were
especially low. The validity of patient reports of their
psychological state is often questioned, and in this area,
psychological or psychiatric self-rating instruments are
validated against a clinician's judgement (see Hill et al 1989
for a recent example). Similarly, when interviewing
elderly or frail patients traditional interview material may be
insufficient. Clark and Bowling (1990) found that observational
methods were necessary to discriminate between long stay ward and
nursing home care for elderly people. Spitzer (1987) argued that
indices can be based on observation of a patient 'without
eliciting information from the patient about how he or she feels
at a given point in time'; and that there is good agreement
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between these clinical observations and patient reports.
Patient reports have also been criticised because their scope of
assessment is limited to their own experience, and they are
unaware of the variation which can occur, or the circumstances of
other individuals.
	
Chimbira et al 1980 demonstrated that
women's estimates of their menstrual blood loss as having been
heavy, medium or light, bore no correlation with the actual blood
loss measured, and suggests that this is because women have only
their own expectations and experience as a criterion. Calman
(1984) also suggests that a subject's view of quality of life is
affected by their own expectations, hopes and past experience.
The results of criterion validity suggest that for the purposes
of audit and measuring effectiveness, the STAS is sufficiently
valid. However, given the drawbacks of all assessors, each study
must choose the view most suitable for its aims.
7.2.3 Construct validity
Correlations between STAS and HRCA-QL supported the prior
hypotheses of construct validity. There was convergent validity,
demonstrated by correlations between STAS and HRCA-QL where items
were similar for patients early in care. A STAS sub-scale of six
items was correlated with the HRCA-QL total (rho = -0.45). The
strongest correlations were between 'patient anxiety' (STAS) and
outlook (HRCA-QL) and between 'other symptom control i (STAS) and
health (HRCA-QL) in patients who were more than four weeks before
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death (rho = -0.70 and rho = -0.64). Discriminant validity was
demonstrated by the few weak correlations between the service
items in STAS and HRCA-QL items. However, some unpredicted
correlations were found. These made sense to clinicians, who
would expect a patient referred in poor health, as indicated by
HRCA-QL, to require more services, as indicated by STAS.
Similarly, patients with poor mobility and ability to self care,
as indicated by the HRCA-QL, had a greater need for practical
aids, as indicated by STAS, at referral.
However, this thesis does not recommend HRCA-QL to measure cancer
palliative care. Scores according to four out of the five
items deteriorated in the last 11 weeks of life, irrespective of
the patient's point of referral. At death most patients were
rated zero. Only one item, support, was different, probably
because it is affected partly by the number of FMs (and this
rarely changes over a few weeks) and partly by the amount they
visit the patient. Scores according to STAS did not show this
deterioration towards death. These findings do not support the
view of the National Hospice Study, that HRCA-QL is the best
available measure for palliative care. The study suggests that
STAS may be a more sensitive and appropriate measure.
7.2.4 Limitations of the validation
There are several criticisms of this validation of STAS:
1) The tests of face and content validity used the views of
professionals and did not systematically collect the views of
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patients and family members. The views of the general public
were not collected. It would have been practically difficult to
recruit and consult directly with a representative sample of
dying patients. However, the STAS items were developed using the
published and research evidence of the views of dying patients
and their families.
2) In the criterion validation, because direct interviews with
patients and FMs were used, only 7 of the 17 STAS items were
compared. The validation of STAS against HRCA-QL concentrated on
the patient-orientated items many of which overlapped with those
considered in the interviews with patients and FMs. Interviews
with other caring staff, or direct observation during care, would
be needed to validate the other items.
3) Interviews were obtained with only half of all the patients in
care. Similar research with dying patients has also found
this problem (Ward 1985, Lunt and Neale 1985). Measurement of
care of the dying which relies on information from patient
interviews may be seriously affected by non-response bias.
However, by using STAS, assessments can be completed on all
patients in care, including those who are very sick and those who
do not have family members.
4) Patients and FMs were interviewed once. Too few patients
survived for a second interview to determine if changes according
to STAS were also reported by patients and families.
5) The HRCA-QL index showed decreasing correlation with STAS
items as death approached. It is possible that this lack of
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correlation could be due only to a lack of congruence and
differences in variance between the two measures: we do not know
whether the HRCA-QL index and STAS have matching intervals
throughout the whole span of their ratings.
6) STAS was compared only with one other instrument. It was not
possible to compare STAS with other measures in this work because
of the amount of time teams had available to make ratings. In
hindsight, given the very low variation in HRCA-QL ratings at
death, it would have been worth attempting to persuade the teams
each to use one other measure in addition to STAS. When teams
were recruited to the study it had not appeared they would agree
to this, but greater efforts could have been made to persuade
them.
It would be useful to compare STAS with the Hospital Anxiety and
Depression Scale and the Cancer Inventory of Problem Situations
or the Rotterdam Symptom Checklist despite their limitations and
the uncertainly of normal responses in dying patients. Scales
completed by external assessors might also be used. This would
be a more expensive study and would be limited even more by
missing data. Therefore, it is reasonable to delay such work
until first studies have shown that STAS has acceptable validity,
reliability and practicality. There may be some value in
comparing STAS with new measures such as the 'Initial Assessment
of Suffering in Terminal Illness', although such comparisons
should wait until these measures have demonstrated validity and
reliability.
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The development of STAS did follow the stages outlined by
Streiner and Norman (1989) and did meet the minimum criteria for
validity suggested by Spitzer (1987):
a) the characteristics for validity and reliability were declared
in advance
b) face and content validity were enhanced in development by
invoking the views of professionals and interested groups
c) validity was tested with the types of patients among whom the
STAS will eventually be used
d) construct validity considered convergent and discriminant
validity.
7.2.5 Reliability
Enhancing reliability
To enhance reliability teams starting to use the STAS spent the
first month of use discussing the STAS assessments for patients
during the weekly meeting. As only new referrals were recruited
to the study, the number of patients gradually increased. After
the first month, when about half of patients in care were
included in the audit, the teams discussed scores most relevant
to management and those they were unsure of. During the training
period and the subsequent ten scoring sessions, the researcher
assisted any team member who was uncertain, and listened to the
discussion of the scores. Clinical examples of individual scores
were available to the teams.
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When selecting the appropriate STAS ratings the patient's key
worker consulted their own booklet containing the agreed
definitions for each item. The booklet was developed during the
pilot study, when it was clear this helped team members to make
rapid assessments and improved their reliability.
Test-retest reliability
The criteria for test-retest reliability were satisfied for 16
out of 17 items, with Cohen's Kappa ranging 0.48-0.87, Spearman
correlation coefficients ranging 0.65-0.94, and intraclass
correlation coefficients ranging 0.41-0.95. Levels were similar
to those accepted by Selby et al (1984) and to those recommended
by Nunnally (1978). The items 'pain control' and 'symptom
control' were amongst the most reliable in all tests, whereas the
items 'professional anxiety' and 'advising professionals' were
the least, although acceptable. 	 As recommended by Spitzer
(1987) reliability was verified by those for whom STAS was
intended to be used.
The item 'predictability' did not reach the pre-set standards
for reliability. Doctors and nurses cannot accurately predict
survival (Forster and Lynn 1988, Evans and McCarthy 1985) and it
may be that this item - which measured the prognostic needs of
the patient and family - cannot be reliably assessed because of
these difficulties in prognostication.
The results of the test-retest reliability were similar in the 40
patients covering a wide range of problems and severity, and in
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the five patients with nine raters. Numbers were small but there
was no discernible pattern of one staff group (e.g. doctors)
rating differently from another staff group (e.g. nurses).
Internal consistency
Levels of internal consistency for ratings at death and at
referral were similar to those found in other measures of a
similar size, e.g. the Beck depression inventory (21 items),
Cronbach's alpha = 0.81 (in non psychiatric patients) (Bowling
1991) or the Meaning of Life Scale (15 items), Cronbach's alpha =
0.78 (Warner and Williams 1987). Levels were higher than for
the Symptoms of Anxiety and Depression Scale (Split half
reliability = 0.61-0.69, Bedford et al 1976) and for the HRCA-QL
index when tested in this analysis, but lower than the Sickness
Impact Profile (0.81-0.97, Bergner et al 1976), although this
measure has many more items than STAS (which would increase
Cronbach's alpha).	 The levels for STAS are acceptable,
especially because STAS contained diverse components of physical,
emotional and social circumstances.
Levels of internal consistency were similar in the full 17 STAS
items and the 16 items, and very slightly lower when 15 and 14
items were tested. This small difference could be due simply to
the higher number of items tested, because increasing the number
of items in a measure can increase the internal consistency
recorded.
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The internal consistency of STAS was higher when ratings were
considered at only one point in care, e.g. at referral or at
death, than when all weeks were combined. This is not surprising.
The relationship between the STAS items would be expected to vary
at different times in care, and this would reduce the
homogenicity when ratings at all times were analysed. This
finding has implications if the number of STAS items were to be
reduced. Any principle component or factor analysis attempting
to identify key items reflecting the total STAS would need to
consider the differing relationship between SPAS items at
different points in care.
7.2.6 Limitations of the reliability testing
There may have been interrater variation due to differences in
the content of interviews of different staff: this would not be
detected through testing with simulated patients. This aspect of
reliability is very difficult to assess (Fleiss 1981, Nunnally
1978), and in this study could only have been tested if
patients had been interviewed by different staff. As discussed
in the methods, this was not possible. However, the use of
written descriptions may have provided the assessors with too
much standard information. One way of avoiding this would have
been to use tape recorded interviews (although this would have
excluded visual information) or video recorded interviews. The
latter would have been the ideal approach, but it was beyond the
budget of this study and may not have been acceptable to patients
who were in distress.
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7.3 Practicality and value of using STAS
A further objective of this study was to test the practicality of
the measure. The STAS was readily included within the work of
support teams. On average it took less than an extra hour per
week to record the ratings, which is less that the amount of time
reported for several other audits (see Shaw 1989 for examples).
This does not include the time needed to discuss the results
and to plan future actions. However, teams would have liked fewer
items, especially those with the most patients in care and shorter
survivals of patients, who found STAS impinged on an already busy
week.
An important benefit of using STAS was that it systematised
thinking about the objectives and outcomes of care. By recording
the measures themselves, teams found that they were able to
improve their practice and thus complete the audit cycle.
The educational value was further demonstrated in the findings of
poor control of dyspnoea. The results prompted teams to review
their practice and to develop a protocol for patients with
dyspnoea, based on a review of effective treatments. An algorithm
to predict the patients at risk of terminal dyspnoea was
formulated using data from the audit. One team then began
treatment using the new protocol, and audited this using the
STAS. The need to review the relief of family anxiety is now
being considered.
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7.4 Use of STAS in determinating the effectiveness of care:
results of the audit
The final objective of this thesis was to determine if STAS could
be used to assess the effectiveness of care in different support
teams, and to show when and where care was not effective. The
results of the audit show that STAS provided valuable information
on effectiveness.
7.4.1 Ability of teams to assess items
Missed assessments provide an insight into effectiveness, because
it seemed likely that if teams were unable to assess an item they
would be unlikely to meet the patient's or family's needs for
that item.
Support teams found most difficulty in assessing financial and
spiritual needs and frequently missed these assessments. Yet
these elements of care are frequently stressed in palliative care
literature (Saunders 1978, Mount and Scott 1983) and their
potential rating was considered useful by at least some (if not
all) members of the teams. Often team members expressed little
confidence in their ability to assess spiritual needs, and they
may need more training. There were differences between teams in
items which could not be assessed, and one team in particular
failed to assess these items, whereas another was very successful
in completing the item 'spiritual', and another team was very
successful in completing the item 'financial'.
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Two hospital based teams missed the highest proportion of ratings
relating to the family's needs. In discussion, these teams
realised that often they had been unable to meet the FMs and had
concentrated on the patient. The results suggest that these teams
were failing to meet the hospice goal of considering the patient
and family as the unit of care.
7.4.2 Changes in STAS ratings during care: effectiveness
There were significant improvements between referral and death
for all STAS items. Although a large number of statistical tests
were performed levels of significance were high (often p <
0.00005), making it unlikely that the differences found could have
occurred by chance. The results support other studies showing
improvements during support team care (Parkes 1980, Zimmer et al
1984, McCusker and Stoddard 1987). However, of four items
showing a high initial need for care, three - symptom control,
patient anxiety and family anxiety - improved by the second week
of care but became more severe again in the last week of the
patient's life. Teams were less effective in controlling these
aspects, and they will need to test different interventions if
care is to improve. Patients who were discharged showed a
similar pattern of problems at referral but had less severe
problems at discharge than those who died.
During care the total STAS ratings improved for the majority
(82%) of patients, but deteriorated for one patient in six (16%).
However, at death only 6% of patients had ratings which were
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greater than 20, considered by teams to be clinically 'severe'.
This compared to 33% at referral.
Pain was effectively controlled in most patients. Few studies
have considered the degree of pain control by support teams.
Parkes (1985) in a retrospective comparison of home, hospital and
hospice care for cancer patients found that bereaved spouses
reported higher levels of pain for patients at home, even when a
support team had been involved in care. This study showed that
pain control was improved after two weeks of support team care,
and this was maintained until death.
However, the symptoms of dyspnoea and weakness were not improved
during care - their prevalence as main symptoms and their
severity were unchanged during care. This supported findings
from the pilot study which had also indicated that dyspnoea was
uncontrolled at death (see Appendix E which shows the results
from the pilot study and compares these with other research). The
prevalence of confusion as the main symptom increased during
care. Studies of hospice care have tended to report the
prevalence of symptoms on referral for care, and have rarely
looked at subsequent control, except for pain (for examples see
Hockley et al 1988, Wilkes 1984, Saunders 1978).
7.4.3 Limitations of effectiveness data
The results do not show whether patients would have fared better,
or worse still, without support team intervention. This study
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was not designed to test such hypotheses. The results do not
show that teams caused the changes in a patient's condition. It
is possible that events beyond the teams' control caused an
improvement or a deterioration. Some items, for example 'patient
insight', 'family insight' and 'predictability' may normally
improve as death approaches. The analysis in section 6.2.3,
which shows improvements for five STAS items in the 11 weeks before
death irrespective of time in support team care, supports
this theory. Teams noticed that occasionally ratings were
dramatically altered by external events, for example the death of
the nearest carer. Thus, the study was unable to measure
outcomes, as defined by Donabedian (1980), which eliminate other
causes for change.
The results do show where the goals of teams were effectively
achieved and indicated where teams were not effective. The study
also showed the difference between the actual outcome and the
desired outcome, by showing items which remained severe at death.
In a different study design, STAS could be used to assess
palliative care in comparative settings, although such a study
would have to overcome the difficulties of ensuring that
representative patients were recruited, and that measurements
were recorded equally in both groups.
The reaction of teams to completing STAS ratings is likely to
result in a Hawthorne effect. Completing assessments made teams
aware of items which remained severe. They would attempt to
improve these problems, and thus their effectiveness may be
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improved due to their participation in the audit. Teams valued
the fact that STAS helped them to clarify problems and target
their intervention. This educational and clinical benefit of
STAS competed with the scientific need to measure true
effectiveness. Because the audit was aimed to be
educational, this Hawthorne effect was accepted. In other
circumstances, where this effect would seriously reduce the value
of the results, STAS ratings would need to be recorded by an
independent observer.
A further problem was that previous ratings were known to team
members when making assessments. These were not hidden for
practical reasons: it would have been very time consuming to
collect ratings from the team members each week. Teams wanted to
see changes in score over time and use this information in their
immediate working practice. It is possible that this made teams
more likely to record a change in score. However, observation of
the teams showed that when discussing patients they might agree
that the patient's condition had changed slightly, but not
sufficiently to record a different score. Guyatt et al 1989, in
a randomised trial, found that if subjects knew their previous
responses this did not affect the rating recorded.
Finally, for those items where a large number of ratings were
zero, for example 'wasted time', STAS may have been
insufficiently sensitive to change. It may be useful to re-grade
the ratings for these items, expanding the definitions currently
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within zero into the gradings of 0,1,2 and compressing the higher
ratings into 3 and 4. However, it is very difficult to produce a
measure which is both sensitive to small degrees of change and
has a high degree of test-retest reliability, because these
requirements tend to be mutually exclusive (Miller 1992).
7.4.4 Setting the results into the context of audit
Audit requires that standards are set. In this study it was
accepted that the ideal standard for each item was a score of
zero. This could be achieved for some items, but clearly not
all. It may be that in repeating the audit the team would wish
to set more realistic standards for some items. For example, a
possible standard for family anxiety might be that less than 20%
of families have ratings which are severe at death.
The work followed the requirements for formal audit (Shaw 1989).
The STAS items formed the explicit criteria for outcomes,
objective measurement was made of all patients, the results were
reviewed by the team and other palliative care professionals and
corrective action for some areas has been identified.
7.4.5 Utility of 17 STAS items for audit
Of the 17 STAS items, two may be less useful for audit.
'Patient insight' and 'family insight' are not goals which the
teams always seek to improve, despite these being included by
Kellehear (1990) in the features of a good death. Recent
evidence suggested that patients and families should determine
the pace at which their insight develops (Maguire and Faulkner
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1988b). Observation showed that the teams created opportunities
for diagnosis and prognosis to be discussed, but they would not
seek actively to alter insight unless the patient asked for
information. Nevertheless, teams have been reluctant to remove
these items from STAS, as they find a record of insight
valuable in working practice.
7.4.5 Total STAS rating.
Although teams found a total STAS rating valuable, the simple
summing of STAS items may not be appropriate: a rating of 3 for
different items may not be of equal significance. For example, it
might be argued that 'pain control' is more important than
'financial'. Teams were asked if they could weight the importance
of STAS items. They were unable to agree on weights, or even an
order of STAS items. They argued that the relative importance of
items varied from patient to patient. STAS definitions had
attempted to take this into account by including, in most, the
effect of the problem on the patient. Thus, to some extent,
these reflected the importance of each item to each patient.
This is supported by evidence from the audit results. The most
severe items - family anxiety, patient anxiety, and symptom
control - were in accordance with the common experience of
palliative care that symptom control and anxiety of the patient
and family are the most prominent needs of patients.	 The total
ratings were also most strongly correlated with these items.
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7.5 Future work
This work represents the first stages in developing a measure and
the results found here would need to be replicated by testing
STAS in other support teams, and repeating the work on validity
and reliability. As discussed, it would be helpful to compare
STAS with other measures, and to discuss its content more widely,
including if possible patient representatives.
The weighting of items to develop a total score, and the
reduction of STAS to a few key items could be considered further
through consultation with team staff and further analysis of
these results using principle components or factor analysis.
Teams have indicated they would like to record fewer items.
However, the analysis would have to take into account the
changing relationships of STAS items during care. Discussion with
the teams has indicated core items are most useful in practice -
pain control, symptom control, patient anxiety, family anxiety,
patient insight, family insight, one or two of the communication
items, and practical aid. (These items also had the more rigorous
testing of validity.) Any reduction of STAS should aim to
include items of immediate utility, because this will encourage
accurate recording.
An alternative to reducing the number of items would be to reduce
the frequency of recordings from weekly to fortnightly or even
only at referral and death. This may be advisable, for it has
proved difficult to analyse the data from interim weeks, because
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patients spent different amounts of time in care. How much
recording time this would save is not clear: the ratings for
interim weeks were the easiest and quickest to complete. Teams
would also need a system to indicate when a rating was due for
completion.
Analysis of the STAS ratings against further information on the
process and structure of care could begin to answer some of the
questions posed in the literature review of: what kinds of
palliative interventions, by whom, for what patients and families
are most effective. The characteristics of patients referred
showed that teams saw very different groups of patients, and
districts will clearly wish to ensure that they have a service
which is accessible to those patients who will benefit most.
7.6 Adaptations of STAS
STAS has been recently adapted to audit the care of patients with
HIV/AIDS, using fortnightly recording. The approach is also
being used to develop instruments to audit other community
services, since many of the items (e.g. symptom control, family
anxiety, practical aid, communication) are relevant to many
different services.
STAS was also used in a study to determine whether all patients
in need of palliative care within the district were receiving it.
Barnett and McCarthy (1987) identified patients using cancer
registries and assessed these using the STAS. Although some
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patients were well cared for by the existing primary medical care
services, others remained in severe difficulties undiscovered by
both general practitioners and hospital doctors.
Nottcut and Jacoby (personal communication), in Norfolk,
recorded STAS assessments on patients and FMs using an
independent researcher who observed the visits made by the
support team. Their ratings were very similar to those found in
this work, and similar aspects of work were most and least
effective.
In-patient hospices have considered which items of STAS would be
most relevant to their work. Symptom items would need to be
extended, but service items relating to home care and the
advisory nature of support teams are not needed. The Working
Group of the Research Unit of the Royal College of Physicians
(1991) recommended STAS as a measure for in-patient hospices and
support teams to determine whether they successfully addressed the
problems on admission.
STAS has made a beginning in an area where measurement is
difficult, and it contains core elements important to palliative
care which can be assessed by the multi-disciplinary support
team. Approximately ten home care or in-patient units are
now considering how they can test or use the STAS, either in its
full form, or a reduced form, or with extra items they wish to
develop (for example see Mant 1991). Providing any changes
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attempt to ensure validity and reliability, eventually a small
array of useful measures, covering various dimensions of
palliative care, may develop. Different measures will suit the
different purpose of the investigator, as for quality of life
measures in cancer patients.
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8. SUMMARY OF CONCLUSIONS
1. STAS items are suitable as outcome measures for palliative
care and they reflect many of the patient and family orientated
goals of support teams, although all aspects of a good or
appropriate death are not included.
2. STAS items have face, content and consensus validity
3. STAS has reasonable criterion validity when compared with
ratings from patient and FMs, although only 7 out of 17 items
were tested.
4. STAS is demonstrated to have both convergent and discriminant
validity when testing construct validity by comparing STAS
ratings with those according to the HRCA-QL.
5. Inter-rater reliability for STAS is acceptable for 16 out of
17 items, but the item 'predictability' should be removed unless
its reliability can be improved.
6. STAS has reasonable internal consistency for a scale of this
size and diversity.
7. STAS is practical for use by support teams and recordings can
be made as part of normal care.
8. STAS ratings discriminate between patients with many and few
problems and indicate where teams are not effective.
9. The characteristics of patients referred to teams varied
significantly.
205
10. During care ratings for all items improved significantly,
but three items - family anxiety, symptom control, and patient
anxiety - remained severe at death, and deteriorated between the
second week of care and death.
11. Teams found most difficulty in assessing spiritual and
financial items and some staff may need further training in
these.
12. Dyspnoea and weakness were not controlled by support teams.
13. There were differences between the assessments of patients,
FMs and support teams. Patients usually gave the least
severe ratings and FMS the most severe.
14. The HRCA-QL is not recommended to measure palliative care.
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Appendix A
Meetings where study methods, STAS, and findings from pilot study
were presented and discussed
Annual Scientific meeting of the Society for Social Medicine,
Liverpool (1985).
Symposium. Recent Advances in Terminal Care, Leicester (1986).
Workshop: 'How do we evaluate our work?', Leicester (1986).
Grand round, University College Hospital, London (1986).
St Joseph's Hospice, London (1986).
Help the Hospices executive committee (1986).
Day Conference 'New Frontiers in Epidemiology and Community
Medicine', The Royal Society of Medicine, London (1987).
The Wales and West Hospice Care Symposium, Cardiff (1987).
Workshop of Hospital Support Teams, St Christopher's Hospice,
London (1987).
'Good Practices in Terminal Care Seminar', North East Thames
Regional Health Authority, London (1987).
Prince and Princess of Wales Hospice First International
Conference on Multidisciplinary Aspects of Terminal Care,
Glasgow (1987).
Psychiatrists in Terminal Care Group, Leicester (1987).
Ty Olwen Hospice, Swansea (1987).
Countess Mountbatten Hospice, Southampton (1987).
'Care of the Dying' study day: The Queen's Institute, London
(1987).
There were also informal meetings with other hospice teams.
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Appendix B
Areas of work of support teams
Summary Description - Team A
Population receiving Support Team Care
Terminally ill cancer patients (and their carers/relatives)
living in the health district, who are referred by a hospital
consultant, general practitioner, or by hospital or community
staff with the consultant or general practitioners' consent.
Members of Team
2 nursing sisters specialised in oncology
1 social worker
1 part-time clinical assistant (5 sessions per week)
1 secretary/administrator
1 consultant in radiotherapy "in charge" (1 session per week)
Methods of Working
Multidisciplinary team approach:
- individual or joint visits to patients and
relatives/carers
- combined policy discussions, after visits, on
assessment, and future needs
- formal weekly group review of all cases
- shared work-load and problems
- mutual support.
Areas of work
1. Working Assessment:
- performed by all team members
- for all patients and families/friends,
- continual
of - strength and weakness
- previous coping mechanisms
- needs
2gaide - how much to do, whether need involvement
- influences, input of 2-7, which and when
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2. Emotional Support:
- performed by all team members
- for family and patient
3. Co-ordination:
- performed by all team members
- for patient and family and professionals
Work	 - liaise between patient and Dr./nurse/ward, etc.
- patient's "mouth-piece"
- give health professionals information patient
has chosen not to give
4. Symptom Control:
- performed mainly by 2 Sisters and Doctor
- for all patients
- listen to origin of symptoms
- medication
5. Organisation of Facilities:
- performed mainly by social workers and nurses
- for all patients and families
- to provide practical needs and financial benefits.
6. Bereavement Counselling:
- performed mainly by social workers
- follow-up of family
7. Advice and Education:
- performed by all team members
- for other health professionals and social workers, etc on all
aspects as above
- for family and patient.
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Appendix C
SUPPORT TEAM ASSESSMENT SCHEDULE
GENERAL POINTS 
The problem and need for improvement is scored on a 5 point (0-4)
scale at first contact, then weekly until death.
High scores indicate many problems, low scores few problems.
Family = the patient's nearest carer.
Other professionals = the other involved professionals including
General Practitioner, District Nurse, Social Worker, Hospital
Staff.
Record 9 if you are unable to assess an item to indicate a missing
score.
Record 8 if the item is not applicable. (E.g. When scoring family
anxiety if there is no carer.) This indicates a different missing
score.
Do not include 8s or 9s when calculating a total score. If 9 is
recorded use the first available score for that item. If 8 is
recorded assume the score for that item is zero.
Dr. Irene Higginson
Department of Community Medicine,
University College London,
66 - 72 Gower Street,
London.
WC1E 6EA
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PAIN CONTROL 
Effect of his/her pain on the patient.
0 = none
1 = Occasional or grumbling single pain. Patient is not
bothered to be rid of symptom.
2 = Moderate distress, occasional bad days, pain limits some
activity possible within extent of disease
3 = Severe pain present often. Activities and concentration
markedly affected by pain.
4 = Severe and continuous overwhelming pain. Unable to think of
other matters.
OTHER SYMPTOM CONTROL
Effect of his/her symptoms on the patient (not including pain).
0 = none
1 = Occasional or grumbling single or few symptom(s). Patient
has usual activity and is not bothered to be rid of symptom.
2 = Moderate distress, occasional bad days, symptoms limit some
activity possible within extent of disease
3 = Severe symptom(s) present often. Activities and
concentration markedly affected by symptom(s).
4 = Severe and continuous overwhelming symptom(s). Unable to
think of other matters.
PATIENT ANXIETY 
Effect of his/her anxiety on the patient.
0 = None
1 = Worry over changes. No physical or behavioural symptoms of
anxiety. Concentration not affected.
2 = Waiting for changes or problems: on edge. Occasional
physical or behavioural symptoms of anxiety.
3 = Anxious often. Physical/behavioural symptoms. Concentration
markedly affected.
4 = Completely and continuously preoccupied with anxiety and
worries. Unable to think of other matters.
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FAMILY ANXIETY 
Effect of anxiety on the family.
0 = None
1 = Worry over changes. No physical or behavioural symptoms of
anxiety. Concentration not affected.
2 = Waiting for changes or problems: on edge. Occasional
physical or behavioural symptoms of anxiety.
3 = Anxious often. Physical/behavioural symptoms. Concentration
markedly affected.
4 = Completely and continuously preoccupied with anxiety and
worries. Unable to think of other matters.
PATIENT INSIGHT 
Patient's awareness of his/her prognosis.
0 = Full awareness of prognosis.
1 = Prognosis over or under estimated by up to 200%. E.g.
Thinking the prognosis is 6 months when it is likely to be
2-3.
2 = Uncertain over becoming well or long prognosis. E.g. 'Some
people with this die and I might too soon.'
3 = Unrealistic. E.g. Expecting to return to normal activity or
work for a year when the prognosis is only 3 months.
4 = Expecting to become completely well.
FAMILY INSIGHT
Family's awareness of the prognosis.
0 = Full awareness of prognosis.
1 = Prognosis over or under estimated by up to 200%. E.g.
Thinking the prognosis is 6 months when it is likely to
be 2-3.
2 = Uncertain over patient becoming well or long prognosis. E.g.
' Some people with this die and he/she might too.'
3 = Unrealistic. E.g. Expecting to return to normal activity or
work for a year when the time scale is only 3 months.
4 = Expecting the patient to become completely well.
225
PREDICTABILITY (Need to predict)
Patient and family's need to know likely future events, sequence
and time scale related to the team's ability to provide this
information.
0 = Patient and family need no more information now or in near
future: team able to predict future needs or unnecessary.
1 = Sequence of events unclear, prognosis and major events
predicted.
2 = Prognosis within range and patient or family need to know
exactly. May also need more information on sequence of
events. E.g. Family can manage at home for 2 weeks but not
for 4 weeks.
3 = Prognosis unpredictable over several months , likely events
and problems unclear. Patient or family need this
information
4 = No idea of likely disease progression, future needs or
arrangements. Patient or family need some information.
PLANNING
Further need for the patient, as desired, to organize his/her
affairs and special meetings.
0 = Completed or unnecessary.
1	 1 aspect needs planning, not urgent, may be already
underway.
2	 1 aspect needs planning urgently / several aspects with some
time available, may have been discussed.
3 = Major decisions to be made, urgent, patient has time to
contribute and may have begun to think of these.
4 = Major decisions outstanding, muddled, very little time to
plan or make arrangements. E.g. Deterioration or death
imminent.
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PRACTICAL AID
Further need for practical aids at home, reflecting the
difficulty for patient and family without aids.
0 = None needed.
1 = 1 aid desirable, not urgent, patient managing present.
2 = 1 aid needed urgently ie. the next day, or a few aids needed
soon, patient or family experiencing some difficulty.
3 = Aids needed badly, some improvisation possible.
4 = Patient incapacitated without basic aids.
FINANCIAL
Further need for entitled benefits, reflecting the difficulty for
patient and family without benefits.
0 = All entitled benefits received, managing.
1 = 1 benefit desirable, patient and family managing, matter may
be in hand.
2 = 1 benefit required urgently / several benefits desirable,
patient and family experiencing difficulties in managing.
3 = Urgent need for several benefits, barely managing.
4 = Not managing, entitled to many benefits, in chaos and none
in hand.
WASTED TIME
Amount of patient's time lost for tests or appointments which
could have been avoided, the patient not wishing to attend.
0 = No time lost.
1 = 1 - 3 hours lost. E.g. Trip for prescription which tired
patient.
2 = Half to one day wasted. E.g. Out-patient appointment.
3 = One + day wasted.
4 = Two + days wasted. E.g. Unnecessary or prolonged admission,
results lost and repeated etc.
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SPIRITUAL
Effect of any crises in beliefs, faiths or religious practices on
the patient.
0 = Content in own spiritual beliefs, without feelings of guilt
or punishment over illness. Any denomination or agnostic.
1 . Occasional doubts or unrealistic expectations. Patient able
to resolve their feelings themselves.
2 = Uncertain, sometimes troubled. Doubts. Patient unable to
resolve their feelings/problems themselves.
3 = Uncertain and guilty. Many be troubles, have conflicts,
worry.
4 = Distraught with uncertainty or guilt over beliefs. In chaos
as to how to remedy situation.
COMMUNICATION BETWEEN PATIENT AND FAMILY
Depth and openness of communication between patient and family.
0 = Communicating openly and honestly. Verbally and non verbally.
1 = Communicating openly at some times or with some family
members.
2 . Acknowledge condition but discussion does not satisfy either
the patient or family who feels full implications are not
discussed.
3 = Out of step, all discussions guarded.
4 = Pretending.
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COMMUNICATION BETWEEN PROFESSIONALS
Speed, accuracy and depth of information communicated between
other professionals, reflecting any difficulties for patient and
family.
0 = Detailed correct messages to all involved on the same day.
1 = Correct messages between key professionals, minor
inaccuracies and delays between others.
2 = Small changes in management not communicated / major changes
delayed for over 1 day, between key professionals.
3 = Delay of several days - 1 week before major changes
notified. E.g. Hospital to General Practitioner.
4 = Prolonged delays or no communication, professionals unsure
of which other professionals are visiting and when.
COMMUNICATION PROFESSIONAL TO PATIENT AND FAMILY
Depth of information given to patient and family, when they
require this, from other professionals.
0 = Full information. Patient and family feel free to ask.
1 = Information communicated but not clearly understood.
2 = Facts given on request, patient or family would have liked
more information.
3 = Evasive, avoids true picture or some questions.
4 = Avoids answering questions or visiting / gives incorrect
information which distresses patient and family.
PROFESSIONAL ANXIETY 
Effect of anxiety on other professionals reflecting any
difficulties this causes for patient and family.
0 = None.
1 = 1 professional anxious. No inappropriate action.
2 = 1 or more professional(s) anxious, beginning to lose
objectivity.
3 = Professional(s) stressed, multiple telephone calls,
inappropriate action.
4 = Multiple indiscriminate referrals / want patient taken over
/ total paralysis.
229
ADVISING PROFESSIONALS 
Amount and speed of advice needed for other professionals.
0 = No further advice needed.
1 = 1 professional needs advising within one week.
2 = 1 professional needs advising in 1-2 days / 2 +
professionals need advising within one week.
3 = Urgent / immediate advice needed for several professionals.
4 = Major difficulties of patient and family not recognised by
key professionals.
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Appendix F
Questionnaire used when interviewing patients to collect
independent STAS ratings
Department of Community Medicine
UNIVERSITY COLLEGE LONDON AND
THE MIDDLESEX HOSPITAL MEDICAL SCHOOL
66-2 GOWER STREET LONDON WC1E 6EA
STRICTLY CONFIDENTIAL
We are working in several health districts trying to find out more about
people's health problems and their need for health services. This survey
will help in planning health services for the future.
We have contacted you because we are particularly interested in people
who have had recent contact with the support team or with the hospital.
In this booklet there are a series of questions about any symptoms you
have and any worries you or your family face. 	 There are also questions
about the services you are in contact with. Please answer as many
questions as you can. Even if you are only able to complete a few
questions the information will still be very useful.
The information you give is in strictest confidence. Your views and
opinions will be recorded anonymously. The researchers who are
interviewing people are Irene Higginson (a medical doctor) and Jan Lloyd (a
nurse volunteer).
We would like to thank you very much for taking the time and trouble to
help us in this survey.
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Date of surveyBACKGROUND INFORMATION 
1. What is your age? 	
2. What is your occupation? 	
3. When did you last have contact with:
a) the support team? 	
b) your family doctor? 	
c) your hospital doctor(s)? 	
The next section asks how you have been over the last week
Please answer referring to the last week, only:.
4. SYMPTOMS IN THE LAST WEEK
a) PAIN
Have you have any pain? 	 Yes / No
If NO please go on to section (c), if YES please continue
b) What effect did your pain have on you? Please ring one
of the below.
0 = none
1 = Occasional or grumbling single or few pains(achess.
You aro tint both!red to be rid of the wain.
2 = Moderate distress, occasional had days.
3 = Severe pain present often. Activities and
concentration markedly affected by pain.
4 = Severe and continuous overwhelming pain Unable
tic think of anything else.
c) OTHER SYMPTOMS 
Have you have any other symptoms? 	 Yes / No
If NO please go un to question 5, if YES please continue
d) What was your main symptom (not including pain)?
- Ctn
2
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d What effect did your anxiet y havr! on You? Please ring one of
the	 below.
0 = none
1 = Worry over any changes.	 Not affected in any other way. IA
2 = Feel you are waiting for changes or problems to happen.
This. affects your concentration sometimes.
3 = Anxious often. Concentration markedly affected.
Sometimes it makes you feel queer, gives you symptoms.
4 = Continuously preoccupied. 	 It completely absorbs you,
can't	 think about	 -inything else.
e) Were there any other symptoms? If so what were they? 	 I S -
Zia
f) What effect did these symptoms (not including any pain) have on you?
Please ring one of the below.
0 = none
1 = Occasional or grumbling single or few symptom(s). You
are not bothered to be rid of the symptom.
2 = Moderate distress, occasional bad days.
3 = Severe symptom(s) present often. Activities and
concentration markedly affected by symptom(s).
4 = Severe and continuous overwhelming symptom(s). Unable
to think of anything else.
I LL
5. ANXIETY IN THE LAST WEEK
a) Have you have any anxiety or worries?	 Yes	 No
If NO please go on to question 6, if YES please continue
b) What was the main cause for your anxiety?
c) Were there any other problems ? If so what were these?	
PLEASE TURN TO NEXT PAGE..
3
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3es
3.
3s...
3.4
6. This question is about your NEAREST FAMILY MEMBER OR CARER,
please go on to question 7 if this does not apply to you.
a) Who is your nearest family member or carer? Please ring:
Is he/she your: wife / husband / daughter / son / sister /
brother / friend / other relation /
none of these: 	
b) What is his / her occupation? 	
Think about the last week, only. 
c) Do you think he/she had any anxiety or worries? 	 Yes / No
If NO please go on to question 7, if YES please continue
d) What was the main cause for his/her anxiety? 	
e) Were tnere any other problems? If so what were these? 	
f) What effect did his/her anxiety have on him/her? Please ring
one of the below.
0 = none
1 = Worry over any changes. Not affected in an other way.
2 = He shc wa; waiting for chanjo% or prohl , -n; Li hippon.
This affected hiVher concentration snmotinw;.
3 = Anxious often. Concentration markedly affected.
Sometimes it gave him/ her symptoms.
4 = Continuously preoccupied. It completely absorbed
him/her, couldn't think about anything else.
7. ANY TIME WASTED IN APPOINTMENTS OR TESTS. 
a) In the last week do you feel you have wasted any time for
appointments or tests (or a* an inpatient) at the hospital or
with your family doctor?
YES /
If NO please go on to question 8, if YES please continue
b) What was this for?
4
73,
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c) How much time did you waste? Please ring one of the below.
0 :-. No time lost.
1 = 1 - 3 hours lost. Eg. Trip for prescription which tired
you.
2 = Half to one day wasted.
3 = One + day wasted.
4 = Two + days wasted.
8. ARE YOU ABLE TO GET OUT Please ring:
1 = on your own
	 H
2 4 with help
3 = not at all
9. WHO COMES IN TO VISIT YOU AND HOW OFTEN? 
a) Please list below all the people including doctors, nurses,
social workers, friends and family visit you at home and how
often they visit. You don't have to use their name, just say
for example, friend, family doctor, support team etc. The
list below may help you.
Person visiting	 	  Number of times
)er week	 Or	 per month
Relative
Friend
Nurse (other than support team)
Social Worker (other than support team)
Family Doctor
Volunteer
Member of the support team
Other
PLEASE TURN TO NEXT PAGE....
5
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b) Is this enough? Is there anything else you would like?
C) Are there any practical aids or equipment which you think
would help you or your family around the home. (Which you
don't have?)
10.00KMUNICATI0N
a) Who has talked with you about your illness?	 Please tick below:
No—one has discussed illness
Family doctor
Support team
Hospital doctor
Hospital nurses
Your nearest relative/friend
Another family member
A friend
Other
b) Who talked with you first?
The next 2 questions ask about communication in the last week
c) With the Support Team. When you talked with the support te3 7
members in the last t.eek how did You feel at' )nt the
infornaticn they gave to you and your tamii n ahos.t
you u.anted to know	 Please ring one of the below.
0 = Gave full information and you felt free to ask.
1 = Information given but not clearly understood. It
confused you.,
1 = Facts given on request, you would have liked more
information.
3 = Evasive, avoided some questions.
4 = Avoided answering questions or visiting.
6
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d) With other Doctors and Nurses. When you think of other
doctors and nurses with whom you have talked in the last week
how did you feel about the depth of information they gave to
you and your family about anything you wanted to know.
Please ring one of the below.
0 = Gave full information and you felt free to ask.
I • Information given but not clearly understood. It
confused you.
2 = Facts given on request, you would have liked more
information.
3 = Evasive, avoided some questions.
4 = Avoided answering questions or visiting.
11.COMMENTS
a) Do you have any comments about the hospital doctors or
nurses?
b) Do you have any comments about your family doctor or the
district nurses?
i) Do you think your doctor is an easy person to talk to or not?
Easy
Not easy	 2
.ou tnink hels:.e hi, tl-e ti discuss tnings or n t?
Has time
Not	 2
iii)Would you describe him/her as:-
Very understanding
	 1
Fairly understanding	 2
Not very understanding	 3
Or what 	
PLEASE TURN TO NEXT PAGE.—
7
248
iv) Altogether would you describe the care from your family
doctor as: Excellent	 1
Good	 2
Fair
	 3
or Poor	 4
(no Care)
	 5
c) Do you have any comments about the support team?
i) Do you think the support team are easy to talk to or not?
Easy	 1
Not easy 2
ii) Do you think they have time to discuss things or not?
Has time	 1
Not	 2
iii)Would you describe them as:-
Very understanding	 1
Fairly understanding	 2
Not very understanding	 3
Or what 	
iv) Altogether would you describe the care from the support team as:-
1--1
d) Do you think other people would be happy with the support
team?
e) Do you have any other comments?
Excellent 1
Good 2
Fair 3
or Poor 4
(no Care) 5
8
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Appendix G
Questionnaire used when interviewing family members (FMS) to
collect independent STAS rating
Department of Community Medicine
	
C5-1
UNIVERSITY COLLEGE LONDON AND
THE MIDDLESEX HOSPITAL MEDICAL SCHOOL
66-72 GOWER STREET LONDON WC1E 6EA 	 5722
Professor M. G. Marmot	 STRICTLY CONFIDENTIAL
	 Telephone: 01-387 7050
Earn.
Direct Lane: 388-
We are working in your several health districts trying to find out more
about people's health problems and their need for health services. This
survey will help in planning health services for the future.
We have contacted you because we are particularly interested in people
who have had recent contact with the support team or with the hospital. We
•
are interested in the opinions of those who use the service and the
opinions of their close relatives or friends.
In this booklet there are a series of questions about any symptoms your
relative/friend has, and any worries your or he/she faces. There are
also questions about the services he/she is in contact with. Please
answer as many questions as you can. Even if you are only able to
complete a few questions the information will still be very useful.
The information you give is in strictest confidence. Your views and
opinions will be recorded anonymously. The researchers who are
interviewing people are Irene Rigginson (a medical doctor) and Jan Lloyd (a
nurse volunteer).
We would like to thank you very much for taking the time and trouble to
help us in this surve•,.
1
250
BACKGROUND INFORMATION 
	
Date of survey
1. What is your age? 	
2. What is your occupation?
3. When did you last have contact with:
a) the support team? 	
b) your relative/friend's family doctor? .
c) your relative/friend's hospital doctor(s)? 	
THE NEXT SECTION IS ABOUT YOUR RELATIVE / FRIEND 
Tne ouestions ask how he/sne has been over the last week
Please answer referring to the last week, only:
4. SYMPTOMS IN THE LAST WEEK
a) PAIN
Has neishe haa any pain?
	 Yes / No
If NO please go on to section (c), if YES please continue
b) What effect did his/her pain have on him/her? Please
ring one of the below.
0 = none
1.1.- Occasional or grumbling single or few rwinsfaches).
He/she was not bothered to be rid of the pain.
2 = Moderate distress, occasional bad days.
3 = Severe pain present often. Activities and
concentration markedly affected by pain.
4 T Severe and continuous overwhelming pain. Unable
to think of anything else.
c) OTHER SYMPTOMS 
Have he/she have any other symptoms?
	 Yes / No
If NO please go on to question 5, if YES please continue
d) What was his/her main symptom (not including pain)?
2
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e) Were there any other symptoms?	 If so what were they? II- .4
20-2%
2. a.
A:4 -Ws
f) What effect did these symptoms (not including any pain)
have on him/her?	 Please ring one of the below.
0 =	 none
1 =	 Occasional or grumbling single or few symptom(s).
He/she was not bothered to be rid of the symptom.
2 =	 Moderate distress,	 occasional bad days.
3 =	 Severe symptom(s) present often. 	 Activities and
concentration markedly affected by symptom(s).
4 =	 Severe and continuous overwhelming symptom(s). 	 Unable
to think of anything else.
5. ANXIETY IN THE LAST WEEK
Noa) Do you think he /she had any anxiety or worries? 	 Yes
If NO please go on to question 6, if YES please continue
b) What was the main cause for his/her anxiety?
4111.,
c) Were there any other problems? 	 If so what were these?
d) What effect did his/her anxiety ha y,- )n him/her?	 Please
ring one of the belpw.
0 = none
1 = Worry over any changes. Not affected in any other way. 2rt
2 = He/she was waiting_for changes or problems to happen.
This affected his/her concentration sometimes.
_	 3 = Anxious often. Concentration markedly affected.
Sometimes it gave him/ her symptoms.
4 = Continuously preoccupied. 	 It completely absorbed
him/her,	 couldn't	 think about anything else.
PLEASE TURN TO NEXT PAGE..
3
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6. This question is about yourself.
Think about the last week, only. 
a) Have you had any anxiety or worries?
	 Yes / No
If NO please go on to question 7, if YES please continue
b) What was the main cause for your anxiety? 	
c) Were there any other problems? If so what were these? 	
n•
35
d) What effect did your anxiety have on you? 	 Please ring one of
the below.
0 =	 none
1 =	 Worry over any changes.	 Not affected in any other way.
2 =	 Feel you are waiting for changes or problems to happen.
This affects your concentration sometimes.
3 =	 Anxious often. Concentration markedly affected.
Sometimes it makes you feel queer, gives you symptoms.
4 =	 Continuously preoccupied.	 It completely absorbs you,
can't think about anything else.
7. ANY TIME WASTED IN APPOINTMENTS OR TESTS. 
a In tne last wee.< do n ou feel your relattve/friend ha3
any time for appointments or tests (or as an inpatient) at
the hospital or with his/her family doctor?
YES / NO
If NO please go on to question 8, if YES please continue
b) What was this for?
4
253
c) How much time did he/she waste? Please ring one of the below.
0 = No time lost.
1 = 1 - 3 hours lost. Eg. Trip for prescription which tired
him/her.
2 = Half to one day wasted.
3 = One + day wasted.
4 = Two + days wasted.
8. IS HE/SHE ABLE TO GET OUT Please ring:
1 = on his/her own
2 = with help
3 = not at all
	 L,
9. WHO COMES IN TO VISIT YOUR RELATIVE/FRIEND AND H00: OFTEN? 
a) Please list below all the people including doctors, nurses,
social workers, friends and family visit him/her at home and how
often they visit. You don't have to use their name, just say
for example, friend, family doctor, support team etc. The
list below may help you.
Person visiting	 	  Number of times
per week	 or	 per month
Rentive
Friend
Nurse (other than support team)
Social Worker (other than support team)
Family Doctor
Volunteer
Member of the support team
Other
PLEASE TURN TO NEXT PAGE....
5
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a) Who has talked with you about your relative/friend's illness?
Please tick below:
I. 1
%s
64.
No—one has discussed illness
Family doctor
Support team
Hospital doctor
Hospital nurses
Your relative/friend who is ill
Another family member
A friend
Other
b) Who talked with you first?
The next two questions ask about communication in the last week 	 	 41
b) Is this enough? Is there anything else you would like?
c) Are there any practical aids or equipment which you think
• would help you or your relative/friend around the home.
(Which you don't have?)
1.0
10. COMMUNICATION
d) With the Support Team. .hen you talked with the ,upnorr team
members in the last week how did you feel about t . h: depth of
information they gave to you and your relative/friend about anything
you wanted to know? Please ring one of the below.
0	 Gave full information and you felt free to ask.
1	 Information given but not clearly understood. It
confused you.
2 = Facts given on request, you would have liked more
information.
3 = Evasive, avoided some questions.
4 = Avoided answering questions or visiting.
6
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d) With other Doctors and Nurses. When you think of other
doctors and nurses with whom you have talked in the last week
how did you feel about the depth of information they gave to
you and your relative/friend about anything you wanted to know.
Please ring one of the below.
0 = Gave full information and you felt free to ask.
I = Information given but not clearly understood. It
confused you.
2 = Facts given on request, you would have liked more
information.
3 = Evasive, avoided some questions.
Avoided answering questions or visiting.
II.COMENTS
a) Do you have any comments about the hospital doctors or
nurses?
b) Do you have any comments about your relative / friend's
family doctor or the district nurses?
i) Do you think your relative / friend's doctor is an easy person
to talk to or not?	 Easy	 I
Not easy	 2
ii) Do you think no/she has time to discuss things or not?
Has time
	 I
Not	 2
iii)Would you describe him/her as:—
Very understanding 	 1
Fairly understanding	 2
Not .very understanding	 3
Or what 	
PLEASE TURN TO NEXT PAGE....
7
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iv) Altogether would you describe the care from your relative/friend's
family doctor as:	 Excellent	 I
Good	 2
Fair	 3
or Poor	
4 073(no Care)
	
5
c) Do you have any comments about the support team?
i) Do you think the support team are easy to talk to or not?
Easy	 I
Not easy
	 2
ii) Do you think they have time to discuss things or not?
Has time
	 I
Not	 2
iii)Would you describe them as:-
Very understanding
	 I
Fairly understanding	 2
Not very understanding
	
3
Or what 	
iv) Altogether would you describe the care from the support team as:-
Excellent 1
Good 2
Fair 3
or Poor 4
(no Care) 5
d) Do you think other people would be happy with the support
team?
e) Do you have any ocher comments?
8
0,4.
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Appendix H
THE HRCA-OUALITY OF LIFE INDEX 
MOBILITY 
During the past week the patient:
2 = has usually been able to walk (or propel wheelchair) in or
outside of home and not restricted in climbing stairs (or
using elevator if wheelchair bound).
1 = has been able to walk within home, but cannot climb stairs or
walk long distance.
0 = has not been able to walk (or unable to propel wheelchair if
on own)
DAILY LIVING
During the past week the patient:
2 . has been self-reliant in eating, washing, toileting and
dressing, using public transport or driving own car
1 = has been requiring assistance (another person or special
equipment) for daily activities and transport but performing
light tasks
0 = has not been managing personal care nor light tasks and/or
not leaving own home or institution at all
HEALTH
During the past week the patient:
2 = has been appearing to feel well or reporting feeling 'great'
most of the time
1 = has been lacking energy or not feeling entirely 'up to par'
more than just occasionally
0 = has been feeling very ill or 'lousy', seeming weak and washed
out most of the time or was unconscious
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SUPPORT
During the past week the patient:
2 = the patient has been having good relationships with others
and receiving strong support from at least one family member
and/or friend
1 . support received or perceived has been limited from family
and friends and/or by the patient's condition
0 = support from family and friends occurred infrequently or only
when absolutely necessary or patient was unconscious
OUTLOOK
During the past week the patient:
2 = has usually been appearing calm and positive in outlook,
accepting and in control of personal circumstances, including
surroundings
1 = has sometimes been troubled because not fully in control of
personal circumstances or has been having periods of obvious
anxiety or depression
0 . has been seriously confused or very frightened or
consistently anxious and depressed or unconscious
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THE KARNOFSKY INDEX
Modified to exclude 'need for hospitalization' from scores 30 and
20
100 = Normal, no complaints, no evidence of disease
90 = Able to carry on normal activity, minor signs or symptoms
of disease
80 = Normal activity with effort, some signs or symptoms of
disease
70 . Cares for self. Unable to carry on normal activity or to do
active work
60 = Requires occasional assistance, but is able to care for
most of his needs
50 = Requires considerable assistance and frequent care
40 = Disabled, requires special care and assistance
30 = Severely disabled
20 = Very sick, active support necessary
10 = Moribund, fatal process progressing rapidly
0 = Dead
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Appendix I
Descriptions of 10 simulated patients used in reliability
testing.
a) Seven patients where paired ratings were compared.
Simulated Patient to score. No. 2 
Mr S is a 64 year old man with squamous cell carcinoma of the
bronchus diagnosed 4 months ago. There are no known secondaries
but the tumour occupies most of his right lung. He was not
suitable for surgery and was treated with a short course of
radiotherapy. He was referred from the out-patient clinic in
radiotherapy as his shortness of breath had become worse in the
last month. He is also a heavy smoker and has had chronic
bronchitis for years.
The doctor referring him asks for help with symptom control and
support for Mr. S's wife who he says is very anxious and is
saying she 'cannot manage'.
You visit 2 days later. Mr S. lives at home with his wife in a
council flat. They have one daughter living 10 miles away. Mr.
S's main problem is shortness of breath. He is all right at rest
but really can't make it to walk to the toilet or back. One trip
to the toilet leaves him gasping and wheezing for about half an
hour and his wife says he looks terrible. He also has problems
washing and getting out of the bath. Mr. S also has a productive
cough with clear sputum and he gets a sharp pain in his chest
when he coughs. For the last week he says he has been coughing
more, and the pain has been bad some days.
There are no practical aids at home and they have no telephone.
There have been no district nurses going in and Mr. S's wife
tells you tearfully that she just can't manage any more, and why
isn't he getting better?
You ask Mr. S what the doctors told him in the hospital and Mr. S
says that at first he was told he had a shadow on his lung but
then it seemed to get better and since then nobody has told him
anything very much. When his own general practitioner visited
him last week when his cough started to get worse, he'd just said
he was waiting for letters from the hospital and prescribed some
antibiotics. Mr S's wife points out at this point that the
prescriptions are very expensive these days and they really can't
afford it. Mr.S's wife tells you that Mr. S has been really
worried about money and hasn't been sleeping at night. They have
just had a large gas bill which they can't afford to pay and Mr.
S has been losing weight and his clothes don't fit. They have
been receiving no benefits and Mr.S gave up his job when he
became ill.
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As you leave the house, mr.s's wife stops you in the door and
says tearfully "if he's not getting better you won't tell him
will you? I know he's worrying about it but I don't want him to
know, it would kill him".
Will you score what you can in the schedule - Thanks.
Simulated patient to score. No. 4 
Mrs. P.
You are asked to see this 69 year old lady with cancer of the
colon on the ward as they are planning to discharge her next
week. She presented two weeks ago with bowel obstruction and now
has a colostomy. The staff say she is recovering well but at
operation was found to have liver and omental secondaries. Her
liver is in fact very enlarged. The ward staff say Mrs P knows
her diagnosis but does not know the disease is anywhere except
her colon and her husband keeps asking them to promise they won't
tell her. They say she doesn't really ask anything and her and
her husband are a very private couple.
When you visit, Mrs. P has obviously lost quite a lot of weight
and is complaining of anorexia, and especially nausea. She has
no pain. The nausea troubles her most, she says it is there all
the time and she can never quite forget it. It was worst before
she had the operation, then became better, but in the last week
has really troubled her and now she doesn't want to eat at all.
She says that she is still feeling quite weak and is worried
about how she will manage at home. However, the occupational
therapist has visited her home and ordered various practical
aids, and she will have a commode there although Mrs. P thinks
she may not need it. The stoma nurse has also met Mrs P.
She describes her husband as "wonderful" and says he will do
anything for her. He is retired now and at home the whole time.
Her main fear, she says though, is feeling she is a burden to
him and wondering if he will be able to manage. She is worried
too if she will become obstructed again, as she doesn't want to
"go through that again". They have planned a holiday abroad to
visit their only son who lives in Ireland in 3 months' time.
Mrs. P tells you she is hoping to get strong again so she and her
husband can go.
When you ask what the doctors have told her about her illness Mrs
P says they told her she had a growth in her bowel which they
have removed and that she is doing very well. She says she can't
understand why she is still getting the nausea. Then she asks
why you have come to see her.
Just as you are leaving the ward her husband arrives and you have
a quick chat with him on his own. He is quite doubtful about you
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being involved and asks you "exactly what sort of patients do you
care for?". He tells you that Mrs. P doesn't know about the
disease in the liver and he has been trying to convince her that
they managed to remove all of the tumour. He says he realises
this is cancer and that she won't get better. He doesn't think
that she should know and says he keeps encouraging her to get
better, so they can go to visit their family. He says he is very
worried about how they will manage at night. There are
deputising services and before, he says, they had to wait 5 hours
for anyone to visit when she was ill.
Please score what you can on the assessment schedule.
Simulated Patient to score. No 7 
Mr Q is a 50 year old man with small cell carcinoma of the lung
diagnosed 7 months ago. There are secondaries in the liver and
bone. He was treated with chemotherapy and radiotherapy but is
now not responding. He was referred from the out-patient clinic
in radiotherapy because of marked deterioration in the last 2
weeks. He is also a heavy smoker and has chronic bronchitis.
The doctor referring him asks for help with symptom control and
support for the patient and family. They have 3 teenage
daughters, the youngest is 15 years old and still at home. One
17 years is at a technical college living 15 miles away and the
19 year old has recently got married and lives 5 miles away.
One day later the district nurses phone you also to make a
referral for support for the family and symptom control. The
general practitioner is happy for you to be involved. He tells
you he is visiting Mr Q today and you arrange to visit tomorrow.
He says Mr Q and his family know all about the disease and want
him to be cared for at home. Mr Q is now deteriorating rapidly.
Mr and Mrs Q live in their own house in a small estate. You have
another patient 3 doors down.
Mr Q is in bed when you visit. The bed is downstairs, and Mr Q
is lying on a spenco mattress. He has a bed table, commode and
urine bottle next to him.
Mr Q complains of pain in his right side, over the enlarged liver
which radiates into his back. He describes the pain present
nearly all the time. It was moderate until the day before last
and then became worse. Yesterday his GP increased his morphine
dose and he did manage a better night's sleep. The pain began
again at 6.00 am today though. He also tells you that he has
become slightly constipated in the last 2 days, and he would like
something done about this.
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Mr Q and his wife tell you they are only worried by the symptoms,
but they don't know what to expect. Mrs Q says "we keep being on
the look out for problems, on edge really; because we don't want
any symptoms to build up". Mr Q and his wife sit together during
the visit. Mr Q says "I don't want to think about how long I've
got". When Mrs Q goes out of the room for a moment he adds "I'm
just worried about how my wife and daughters will manage".
As Mrs Q comes back into the room she adds "one thing that
worries me is when I go into the kitchen I can't hear if Bill (Mr
Q) calls me. The rest of the time we are OK. The district
nurses are lovely and are coming in every day now to help me with
him; and my daughters visit at least once a day. Our family
doctor says we can call him any time we like and he will come and
visit, and he even told me I could go and see him on my own if I
needed to."
You ask if you can help with anything else? Mr Q says he would
like to know if you can help with a solicitor. This is his
second marriage, he tells you and he does have a son from an
earlier marriage who he wishes to trace and also have something
in his will for. "I have a life insurance," he says, " and I
want to leave a little of what my family will get to my son. I
don't know where to find him though as I haven't seen him for 10
years."
Can you score what you can, thanks.
Simulated patient to score. No.12 
Mi ss C
The general practitioner, Dr. Helpalot, rings you to refer this
75 year old lady who lives alone and has cancer of the pancreas.
Miss C first presented 6 months ago with jaundice, she had a
stent tube inserted and was fairly well until last month her tube
blocked and became infected. This is now resolved, although she
is still on antibiotics. However she is still deteriorating and
feeling weaker. Dr. Helpalot has been visiting Mrs C weekly but
he is just about to go on holiday and would like your help in the
management and he also feels his partner won't be able to visit
very much while he is away.
You visit a week later. Miss C lives in a warden aided flat on
the ground floor. When you arrive the warden (Mrs Jolly) is
having a cup of tea with her. Miss C is able to get up and
about, although she is quite severely crippled with long term
rheumatoid arthritis. She looks pale and slightly jaundiced.
Her only symptom is itching at night. Most nights the itch keeps
her awake for about an hour or more, but she usually manages to
get off to sleep eventually. During the day she is fine and
forgets about it. She has been using some calamine lotion that
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Mrs Jolly got her from the chemist and that has helped. She has
not tried anything else.
Miss C is very relaxed and cheerful. She tells you she has no
more regular appointments with the hospital but she can go back
any time she needs to. Dr. Helpalot and the warden are very kind
and come if there is anything she needs. Her next of kin is a
niece 80 miles away who she hasn't seen for 5 years and who
doesn't know anything about her being ill.
"But Mrs Jolly knows I've got the cancer in my pancreas" she
tells you. "I suppose I should contact my niece as it would be
nice to see her some time. I've been out of touch so long I
don't even know if she is still at that address."
Miss C has bath, mobility and seating aids fitted ages ago
because of her rheumatoid arthritis. She has never had a
telephone and she tells you she could afford one but she is not
sure if she could manage to pull the dials round. However, she
might manage the new push button dials.	 She tells you the
warden is worried about her at night, in case she falls an can't
get up. Her neighbour in the flats does pop in often though.
Please score what you can on the assessment schedule.
Simulated Patient NO.15 
Mrs S. is a 69 year old married lady with adenocarcinoma of the
lung which was diagnosed three months ago. At diagnosis, she was
found to have secondaries in the bone, involving her left femur
and spine. She has had chronic bronchitis for many years
and was not suitable for surgery. Her femur and spine and lung
were treated with radiotherapy. She is now referred by her
general practitioner because of pain in the spine and some
shortness of breath. She is a lady who has had depressive
illness in the past but has a very supportive husband and two
daughters who live round the corner.
When you visit, Mrs S. lives in a council house on the ground
floor. One daughter is there as well as Mr S. Mrs S. tells you
she has a pain in her left leg which has been better in the last
week since her GP started MST Continus. However, she still has
some bad days and was wondering if she could increase the dose.
Also she is short of breath on exertion although she can manage
to get around the house and do some housework. She has
apparently lost quite a lot of weight lately. Her only other
symptoms is loss of appetite, which is beginning to trouble her
occasionally.
They have a telephone but in the bathroom you note that they
probably could do with bath aids although they are managing
fairly well at the moment. Mr S. is retired and is very keen to
care for his wife.
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Mrs S. tells you that she knows that she has cancer and she knows
she knows that she will get worse, but she wants to remain at
home for as long as possible. She tells you that her and her
husband, who have been married for almost 50 years now, talk
about everything.
Mrs S. tells you she is tired of going up to the hospital. She
tells you that they are very nice there but the journey really
wears her out. She went last four days ago. Although the doctor
were very good and saw her quite quickly (so that she only had to
wait for about half an hour) the journey there and back tired her
out for most of the day.
They also have some financial worries. They have just had a
large gas bill that they are going to have problems paying, and
because of Mrs S's weight loss, her clothes don't fit and they
can't really afford to buy any more. They are only just managing
to buy food. They also tell you that they would like very much
to go on holiday together, but can't afford it. The two
daughters both have young families and are unable to help.
They like their general practitioner who has been very involved
in Mrs S's care all along and they say that he has always been
very frank with them. Mr S. does say he is worried sometimes
about whether he will be able to manage at home although his
daughters are very supportive. Mrs S. seems a little bit more
calm. She tells you "I'm not worried about what will happen, -
don't believe in a god but I do know that we all have to go.
However, I am concerned that my husband will be okay".
Will you score what you can in the schedule - thanks.
Simulated Patient. No. 16
Mr V. You were asked to see this 80 year old gentleman with
cancer of the prostate on the ward to advise on symptom control
and home support. He presented five months ago with secondaries
in the bone and has been treated with hormones and radiotherapy.
He lives alone and the ward staff who referred him are worried
about how he will be able to manage. They tell you that they
have told him that he has cancer but he really doesn't seem to be
able to take it in.
Mr V. has 2 children. His son lives about five miles away and
has had a heart attack in the past. His daughter lives nearer
and has a teenage family.
Mr V. lives in a council flat on the third floor. There is a
lift and there is quite a supportive neighbour who has popped
in to see him while he has been on the ward. This time he was
admitted because of bone pain but this has improved now and they
are hoping to discharge him next week.
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When you visit, Mr V. is quite a sprightly man. He has lost a
fair bit of weight but has been walking round the ward and is
self caring. He tells you he's very anxious to get home and
anything you can do to help him he'd be really grateful. He
tells you that he has occasional pain in his back, just a niggle
now and then, but he has had arthritis for years and he doesn't
really bother about it. It was bad a week or so ago, before he
came into hospital but it's a lot better now.
He is a very independent man and tells you that he's had meals
on wheels and home helps offered to him in the past, but he
doesn't want them, thank you very much. He tells you his
neighbour, Mrs K. does give him the odd meal now and then and
that's very nice. He tells you he's not worried about anything
except getting home. When you ask him what the doctors have told
him about his illness, he tells you that they seem to think that
he has cancer in his bones and that's whey he's on
the hormone tablets and the radiotherapy to treat it. He tells
you that he feels he's getting a lot better at the moment and
that the treatment must be obviously working.
He becomes quite sad when he talks about his wife, who died five
years ago. He tells you they had a very close relationship.
He's not very fond of his son who lives five miles away. He
says: "He's a bit of a crook really and he's just waiting for me
to pop off to get my money".
"Mind you.." he adds, "he'll probably go first, as he's already
had one heart attack".
His daughter, whom he gets on better with, comes to visit
him when she can, usually twice a week and he likes his grand-
children very much. However, he tells you that he really
wouldn't want to go and stay with his daughter as they have a
very small flat and with all the teenagers, it can get quite
noisy and crowded. When you ask him what practical things he's
got at home, he becomes very vague and tells you that really he
doesn't want anything at all and that he can manage.
He tells you he likes the hospital ward very much. His own
doctor, he tells you, is nearly his own age as well and has
difficulty managing the stairs to his flat when the lift is
broken so he doesn't visit very much.
He tells you that he wouldn't want to be at home if he was very
ill - he would rather be in hospital. It says he hates the idea
of being a burden to his daughter and neighbour.
Please score what you can on the assessment schedule - thanks.
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Simulated Patient No. 18 
Mr C. is a 75 year old married man who has been recently
diagnosed as having cancer of the lung. Most of the lower lobe
of his right lung is involved. He is referred by the ward who
say that he is getting some pain in his chest but also there are
many social problems as Mr C's wife is severely disabled
following a stroke and he does all the caring for her. When you
visit on the ward, Mr C. tells you that in fact his wife was
admitted at the same time as him because she was unable to manage
at home. He is quite a fit man who has been getting around the
ward, but is complaining of right sided lower chest pain which
occurs when he takes a deep breath. He tells you that sometimes
it doesn't bother him too much but really he would like to be rid
of this.
He tells you that his wife doesn't know that he has got cancer
and he is very worried that he will not be able to look after
her. He tells you that he is upset because he doesn't feel that
the care on the ward where his wife is is as good as it could be
and really he just wants to get better and get out so that he can
look after her. In fact, he has been caring for his wife since
she had her stroke two years ago. His wife is very disabled and
is practically bed bound. She has a speech impairment but he
tells you that she is "All there". You ask about his home and he
tells you that they have lots of practical aids because of his
wife. He actually lifts her in and out of bed and does all the
practical care. He has been receiving attendance allowance for
looking after his wife and a small pension from his work.
You talk about the future with him. He says that he is very
worried about how his wife will be cared for if he gets more ill
and he really doesn't know what they will do. They have no
children and no other close relatives. He says that he hates the
idea of her having to go in somewhere and he wants to manage at
home for as long as possible, looking after her.
When you talk to the ward staff, there seemed to have been some
muddled communication between the two wards where Mr and Mrs C.
are. Mrs C's ward phoned over yesterday and said that the
doctors had been round and said that she could go home. However,
Mr C. is not yet ready to go home, he is still awaiting some more
tests and the doctors are thinking of doing a plural tap as he
has some fluid in his right lung. The ward staff on Mr C's ward
were furious and although they have sorted it out now and Mrs C.
is not going home at the moment, they are worried that there
might be problems again.
Please score what you can on the Assessment Schedule, thank you.
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b) Three patients where nine team members recorded ratings.
qimulated Patient NO.20. 
Mrs E. is a 52 year old British widow referred by her general
practitioner for support, especially for the 16 year old daughter
who lives with Mrs E. in the council house.
Mrs E. presented one month ago with multiple liver secondaries
from an unknown primary. She is now deteriorating. She has
another daughter and a son, both with young families, and both
living within 3 miles.
When you visit Mrs E. is lying on the bed in her night clothes.
She is propped up against a back support because her back aches
at times. She is not bothered by this because position relieves
the ache. She complains of night sweats as her only symptom.
Twice in the last week at night she has had to change the sheets,
although she went back to sleep after. During the day she is
fine.
She asks you a lot of questions about her illness. She was
puzzled that at first the hospital doctors were trying to find
her "cancer", but now they had given up. She says she found it
difficult to ask them questions. They would answer (rather
coldly and factually) if she asked, but they seemed so busy that
she didn't feel able to. Her own doctor, although wanting to
help, hadn't even been told she was discharged 3 days ago. She
had telephoned him and he had been very surprised. He had had to
telephone the hospital to find out what medication she had been
put on. That meant that for two hours one morning she was on the
telephone to the surgery trying to sort out her medication and
she found this very tiring.
You agree to try and get hold of the hospital notes so you can
tell her more about her illness. She says there are a lot of
things to arrange; especially for her youngest daughter as she
doesn't know where her daughter might live. She has discussed
this with her eldest daughter but not her youngest daughter as
she "doesn't want to worry her". She then asks you how long you
think she has got. She says she thinks it might only be a eight
to ten months.
She says she is worried about the future; especially over the
uncertainty of what will happen and when. She was a practising
catholic, but has lapsed in recent years and is wondering whether
she might be able to contact the church. This troubles her at
times.
She has no practical aids at all in the home and district nurses
are needed. She is having a lot of trouble moving and washing
herself, and she doesn't want her daughter to have to do this.
She also finds her bed quite uncomfortable.
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They also have financial worries. She becomes tearful and says
they are at their wits end. In fact her daughter is down at the
Citizen's Advice Bureau at the moment trying to sort out their
income. Mrs E. did temporary secretarial work until one month
ago and now they have no money coming in at all. Her older son
and daughter have been trying to help out but they are short
themselves.
When you arrive back at the office the youngest daughter
telephones. She is very upset. She says her mother won't tell
her what is going on and keeps pretending that she is getting
better, but the daughter can see that she is not. The youngest
daughter says angrily " they keep treating me like a child, as if
I can't understand anything". The daughter says her father had a
terrible death, he died suddenly of a heart attack at home and
was in agony and then went blue and died. She says that she
keeps imagining the same will happen to her mother. "She must be
dying" the daughter says, "she looks so ill, and what will happen
to me then?"
Please score what you can on the assessment schedule.... Thanks.
Simulated Patient to score. No.21 
Mrs G is a 94 year old widow with cancer of the left breast
diagnosed 6 years ago and treated with a mastectomy,
radiotherapy, and tamoxif en. She was well until last month when
she presented with a pathological fracture of her left humerus
which was pinned. She now has widespread bony metastases in her
pelvis, ribs and spine (L3,L4).	 She is referred by the out-
patient department of the breast surgeons who ask for home
support as she lives alone. They tell you Mrs G is happy for you
to visit, and that it is "an early referral and not urgent".
You phone the general practitioner who says he is quite happy for
you to be involved. He tells you Mrs G is a "delightful lady who
knows exactly what is going on". She has no symptoms at the
moment, and has said she doesn't want district nurses. She has a
very good relationship with her home help though.
You visit 4 days later. The house is in a council estate on the
ground floor. Mrs G and her tabby cat greet you at the door.
She is a sprightly cheerful lady who tells you she is quite well
and is managing the cleaning and cooking and getting out to do
the shopping. She demonstrates walking round the house and says
she she a grumbling pain in her back which only happens
occasionally. She is taking Ibuprofen for this, and is quite
happy. She has no other symptoms.
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In the bathroom you notice that she has quite a low bath and no
shower and Mrs G does say she has some problems getting in and
out. She asks if a rail might help. You also notice that Mrs G
does not have a telephone. She says she would like one but
thinks that they are a terrible expense. However, she says that
maybe she could see the point of it if she is ill.
Mrs G tells you that when she was first diagnosed as having
cancer she wrote to her younger sister (82 years old) in Brighton
and to her daughter in Australia. She had thought she was doing
well and it was a great shock to her when her arm broke. However
she says "you've got to go sometime and at my age it will either
be the cancer that gets me or a heart attack. " She adds "Me and
Sammy (the cat) are going to enjoy ourselves to the end though".
Then she shows you a stock of guinness in her cupboard. She says
that her general practitioner suggested she had half a bottle
each night to help her sleep. Apparently she'd been giving a bit
to Sammy to help him sleep tool
She tells you that both her sister and daughter know now that the
"cancer has now spread to my bones" and that her "days are
numbered". Her daughter is visiting England next month and will
be bringing her grandchildren. Mrs G says she has lots of
friends from the local church who come in to see her and the
local priest calls in each week. She adds " he even gave me the
'sacrament for the sick so I'm ready to go any time.
She gets on very well with her general practitioner, and is on
first name terms with him. She has known him for years, she
says, and has his home telephone number in case she has problems.
He calls in anyway every one or two weeks. She describes him as
a lovely down to earth man, who has always been quite straight
with her.
Financially she tells you she is managing OK and has a widows
pension from her husbands company. Towards the end of the
interview Mrs G says she must stay at home for as long as
possible to look after her cat, but she has been thinking that
she might like to eventually go into a hospice if she was not
well enough to manage at home. She wants to take the cat in with
her and says she had arranged with one of her church visitors to
look around a local one. She had a cousin who died in one 30
miles away and she was very impressed.
Can you score what you can on the assessment schedule.
Simulated Patient NO. 22 
Mr F. is a 66 year old married gentleman referred by the
radiotherapy senior registrar for pain control and because of
likely impending deterioration.
271
Mr F. was diagnosed as having a squamous cell carcinoma of the
left bronchus 18 months ago. He was initially treated with
radiotherapy. The radiotherapist have been reviewing him in out-
patients. The general practitioner is happy for you to visit and
says that the radiotherapy registrar telephoned him after the
last out-patient visit to let him know that Mr F. was
deteriorating, and that they wanted to refer to the team. He
says he had asked the family 2 weeks ago if the support team
could be involved and they had said no - they didn't want to be
reminded of Mr F.'s illness. Now they must have changed their
minds. He adds that they are a very private couple, and last
time he dropped in on them at home they were suspicious of why.
He'd left if that they would call him if there were problems.
They live in a private, tree lined road, in a large house.
When you visit Mr F. is in bed. He is complain of severe and
continuous pain in his head, which he says is agony. He has
never known anything like this. He also has been vomiting all
morning. His wife says the headache and nausea or vomiting in
the morning had been getting worse over the last 10 days, but
they didn't mention it to the doctors last time they were seen.
Mr F. tells you if he is going to be like this his wants "to be
put out of his misery".
Mrs F is in tears. She says he didn't like to ask the doctors
about his headache because he was worrying it might be his cancer
again. She says she just "can't cope", and that seeing him
getting weaker is awful. 	 She says she can't understand what is
wrong because they both thought he had been cured.
They have a telephone, but no other practical aids. Mr F. has
been almost completely bed bound and they have had to improvise
using an old vase for a urinal, because he was too weak to get up
to go to the toilet. They were thinking of going our to buy
some aids but didn't know where to go. They have no financial
worries and mrs F. was thinking of getting a private nurse.
They have no close family or friends. They are very angry about
Mr F.'s illness, and are asking why it should happen to them. Mrs
F. tells you she has arranged for a spiritualist to come round,
to make him get better.
As you leave Mrs F says she wished to doctors had never told Mr
F. that he had cancer. She says it has done him no good at all
and she is terrified that he will give up. He has been worrying
all the time since the news and she says she thinks he is better
when he doesn't know. She says "if this is a recurrence of the
cancer you won't tell him will you it would kill him."
Please score what you can on the assessment schedule - thanks.
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Appendix J. Ratings from team members for the 10 simulated
patients.
a) Seven patients where paired ratings were compared
Simulated patient No.2
' STAS ITEMS Rater 1 Rater 2
Pain control 2 2
Symptom control 3 3
Patient anxiety 3 2
Family anxiety 3 3
Patient insight 2 2
Family insight 2 2
Predictability 2 2
Planning 2 3
Practical aid 3 3
Financial 3 2
Wasted time 0 9
Spiritual 9 9
Communication between patient and family 2 3
Communication between professionals 3 3
Communication professionals to patient and
family
3 3
Professional anxiety 2 1
Advising professionals 3 3
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Simulated patient No.4
STAS ITEMS Rater 1 Rater 2
,Pain control 0 0
Symptom control 3 3
Patient anxiety 2 3
Family anxiety 2
,
3
Patient insight 3 3
Family insight 0 1
Predictability 1 ,2
Planning 3 3
Practical aid 0 0
Financial 9 9
Wasted time 0 0
Spiritual 9 9
Communication between patient and family 3 4
Communication between professionals 1 1
Communication professionals to patient and
family
3 3
Professional anxiety 1 1
Advising professionals 3 3
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Simulated patient No.7
STAS ITEMS Rater 1 Rater 2
I
I Pain control 3 2
' Symptom control 2 ,1
Patient anxiety 3 2
Family anxiety 3 2
Patient insight 2 1
Family insight 1 1
. Predictability 1 1
. Planning 2 2
Practical aid 1 1
Financial 0 0
Wasted time 0 9
Spiritual 9 9
Communication between patient and family 2 1
Communication between professionals 1 0
Communication professionals to patient and
family
0 1
Professional anxiety 2 1
Advising professionals 1 0
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Simulated patient No. 12
STAS ITEMS Rater 1 Rater 2
Pain control 0 0
, Symptom control 1 1
1 Patient anxiety 0 0
Family anxiety 9 9
Patient insight 0 0
1 Family insight 9 9
Predictability 1 1
Planning 1 1
Practical aid 0 0
Financial 0 0
Wasted time 0 0
Spiritual 9 9
Communication between patient and family 9 9
Communication between professionals 0 0
Communication professionals to patient and
family
0 0
Professional anxiety 1 1
Advising professionals 0 0
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Simulated patient No.15
STAS ITEMS Rater 1 Rater 2
Pain control 2 2
Symptom control 2 2
Patient anxiety 1 2
Family anxiety 2 1
Patient insight 0 1
Family insight 0 9
Predictability 1 2
Planning 2 2
Practical aid 1 1
Financial 3 3
Wasted time 2 2
Spiritual 0 0
Communication between patient and family 0 0
Communication between professionals 9 9
Communication professionals to patient and
family
0 0
Professional anxiety 1 0
Advising professionals 2 2
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Simulated patient No.16
STAS ITEMS Rater 1 Rater 2
Pain control 2 1
Symptom control 0 0
Patient anxiety 2 1
Family anxiety 9 9
1 Patient insight 3 2
Family insight 9 9
Predictability 3 4
Planning 1 2
Practical aid 9 9
Financial 9 9
Wasted time 0 0
Spiritual 9 9
Communication between patient and family 1 9
Communication between professionals 0 0
Communication professionals to patient and
family
1 1
Professional anxiety 1 1
Advising professionals 1 2
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Simulated patient No.18
STAS ITEMS Rater 1 Rater 2
Pain control 2 2
Symptom control 0 0
Patient anxiety 2 1
Family anxiety 9 9
Patient insight 3 2
Family insight 9 9
Predictability 3 3
Planning 3 3
Practical aid 0 0
Financial 0 0
Wasted time 0 0
Spiritual 9 9
Communication between patient and family 3 4
Communication between professionals 3 2
Communication professionals to patient and
family
3 3
Professional anxiety 2 3
Advising professionals 3 2
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b) Three patients where nine team members recorded ratings
Simulated patient No.20
RATERS
STAS ITEMS 1 2 3 4 5 678 9
Pain control 1 1 1 1 1 1 1 1 1
Symptom control 2 2 1 1 2 2 1 2 2
Patient anxiety 3 2 2 3 3 2 3 4 3_
3Family anxiety 3 4 2 3_ 3 3
,
4 3
Patient insight 2 1 1 2 1 1 1 1 1
Family insight 2 0 2 2 1 1 2 2 1
Predictability 1 3 3 3 1
,
3 1 3 2,
Planning 3 3 3 4 4 3 2 3
Practical aid 3 2 3 3 3 3 3 3
Financial 3 4 3
_
4 4 4 4 4 4_
1Wasted time 1 2 1 1 1 1 1 1
Spiritual 2 2 2
_
2 2 2 2 2 2
Communication between patient and family 3 1 2 1 3 3 1 3 3
Communication between professionals 3 2 3 3 4 3 3 3 3
Communication professionals to patient and
family
2 3 2 3 3 2 4 3 3
Professional anxiety 1 1 1 1 2 1 1 3 1_
3Advising professionals 3 4 3 3 4 2 3 3
'
Simulated patient No.21
RATERS
STAS ITEMS 1 2 3 4 5 6 7 8 9
Pain control 1 1 1 1 1 1 1 1 1
Symptom control 0 0 0 0 . 0 0 0 1 0
Patient anxiety 2 0 1 0 0 0 0 0 0
Family anxiety 1 0 1 0 0  0 0 9 0
Patient insight 0 0 , 0 0 0 0 0 0 0
Family insight 1 0 1 0 0 0 0 9 0
Predictability 1 1 1 1 0 1 0 0 1
Planning 1 1 1 1 1 1 0 1 1
Practical aid 1 2 2 2 2 2 1 1 2
Financial 0 ... 0 0 0
,
. 1	 , 0 0 0 0
Wasted time 0 0 0 0 0 0 0 0 0
Spiritual 0 0 0 0 0 0 0 0 0
Communication between patient and family 1 0 0 0
,	 .
0 1 0 0 0
Communication between professionals 0 0 0 0 0 0 0 0 0
Communication professionals to patient and
family
0 0 0 0 0 0 0 0 0
Professional anxiety 0 0 0 0 1 0 0 0 0
Advising professionals 1 1 2 1 2 2 1 0 1
Simulated patient No.22
RATERS
STAS ITEMS 1 2 3 4 5 6 7 8 9 I
Pain control 4 4 3 4, 4 3 3 4 4
Symptom control 4 3 4 3 3 3 3 4 3
Patient anxiety 2 3 3 3 4 4 3 4 3
Family anxiety 4 4 4 3 4 3 2 4 4
Patient insight 3 3 1 2 4 3 2 2 4
Family insight 1 3 2 2 3 3 2 3 4
Predictability 4 1 2 3 3 1 1 3 1
Planning 3 3 2 3 3 3 2 3 3
Practical aid 3 3 3 3 4 3 4 4 3
Financial 0 0 0 0 0 0 0 0 0
Wasted time 0 2 0 0 0 0 0 0 0
Spiritual 2 4 2 2 2 9 4 9 9
Communication between patient and family 3 4 3 4 4 3 1 4  4
Communication between professionals 1 2 1 1 1 0 1 1 0
Communication professionals to patient and
family
1 0 1 1 2 1 2 1 1
Professional anxiety 0 1 1 1 1 1 1 1 1
Advising professionals 4 3 2 2 2 3 4 3 2
1-o
D.
nit
HOSPITAL NUMBER
HOSPITAL
WARD
OONSULTANTS
OTHER HOSPITAL STAFF
HOSPITAL SOCIAL WORKER
0.P.
ADDRESS
PHONE NO.
DISTRICT NURSES
HV /6V
SOCIAL WORKER
SOCIAL SERVICES / OTHER AGENCIES
Appendix X
Clinical records from teams
Note,
 - these have been reduced to fit within the margins of this
report
Team A
NAME	 SEX M/F
DATE OF BIRTH	 AGE
ADDRESS	 ACCESS ROUTE
Post code 1. av/1	 2. WI	 3. NW5	 4. awe	 5. WC1	 6. wC2	 7. Other-
	 Li
PHONE NUMBER
Status	 1. harried 2. VAdowed	 3. Divorced / Seperated 4. Single	 5. Other
Nationality I. British 2. Irish	 3. Greek	 4. Italian	 5. Asian	 8.	 Other
Religion	 I. C / E	 2. R. Catholic 3. Greek Orthodox 4. Jewish 5. Other Religion
6. Atheist 7. Agnostic
LIVING ALONE
OR LIVING WITH 1 2 3 4 >5 OTHERS
NEAREST CARER
RELAX& I. VAN 2. Husband 3. Daughter 4. Son 5. Sister 6. Brother 7. Friend 8. Other
ADDRESS	 •
IsMt	 1. Part! 2. Full-time
3. No Job / 4. Retired
Caraleralsix
PHONE NUMBER
KEY RELATIVES OR OTHER FRIENDS
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1 I	 I	 I 1 51 n
•n••n•=,
as
—
1—.--I 
SS
1
	1
0.,
r3 —14
0.
El,
5.-Si.
3_8'
1 A:2.-251I
NOTES / OTHER RELEVANT INFORMATION
P. Weeks: frcm to 	 1	 I
55 - S2.	 5.5 - 5 s.
DIAGNOSIS
DATE FIRST DIAONOSED
jirlitS7ASIS
	 1.	 2.
OTHFR  DlARNMSFS  CAIISIN(1  Sit21213
I.
2.
D1SFASF 511E.. rIOST  ACTIYF 1. PRIMARY SITE
2. METASTASIS
3. OIVER DIAGNOSIS
iinRE:ERRED_ BI I. GP 2. Radiotherspist 3. Oncologist 4. Surgeon S. Physician 6. Other
EWE
DATE OF REFERRAL
Time diagnosis to referral: (1) 0-1 mth (2) 1-3 mths CS) 3-6 mths t1) S mths - 1 year iS) 1-2 yrs
(6) 2-3 yrs 0) 3-5 yrs rd 5+ yrs
DATE FIRST SEEN
REASONS FOR REFERRAL 1.
2.
OTHER MAIN PREGLEMS AT REFERRAL
DRUGS AT REFERRAL
284
NAME:
	 TEAM NO: 
DATE OF FIRST ASSESSMENT: 
HISTORY OF PRESENT ILLNESS: 
•
RELEVANT PAST MEDICAL HISTORY:
SOCIAL CIRCUMSTANCES:
ACCOMMODATION: 1. Owner occupied 2. Private rented 3. Council 4. Hostel
5. Other
ACCESS :	 1. Ground floor 2. By lift	 3. By stairs
PSYCHOSOCIAL HISTORY:
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Anaemia
Cyanosis
Oedema
Cachezia
,..	
EXAMINATION:
Appearance:
Mouth:
Pressure Areas:
PROBLEMS:
	 ACTIONS:
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NAME:	 TEAM NO: 
PRESENT CONDITION:
DATE:
WEIGHT
APPETITE
TASTE CHANGE
NAUSEA
VOMITING
DYSPHAGIA
BOWELS
MICTURITION
DISCHARGE
DYSPNOEA
COUGH
SPUTUM
WEAKNESS
HEADACHE
INSOMNIA
BLEEDING
BEDSORES
OEDEMA
MOBILITY
OTHER
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NAME:	 TEAM NO:
RECORD OF PATIENTS INSIGHT AND UNDERSTANDING OF ILLNESS (IN PATIENT'S OWN WORDS
IF POSSIBLE).
Please enter any relevant comments from other members of the family (identify the person concerned!)
DATE:
288
El
DATE
Days from referral to death
2. DIED
HI] $3 .• 10
Elm= of_death	 1. Home
2. Hospital
3. Hospice
a
BEREAVEMENT FOLLOW-UP
_L_NO
REASON
1. No relatives
2. Relatives live out of area
3. Not enough contact
4. Refused
5. No need because__
6. Other
2-YL1
NUMBER OF PEOPLE.
NAMES
Relations to patient 1. Wife
2. Husband
3. Daughter
4. Son
5. Sister
6. Brother
7. Friend
8. Other
17
,
31
2.3
NI
ig
lb
al
NOTES / ADDITIONAL INFORMATION
32-13
L2_- I, 	 J. II1	  ..,
FOLLOW-UP
1. DISCHARBED/PENDINO
DATE
Days from referral to discharge I 1	 1 1
i ...., I
Rea= 1. Left area
OK
2. Non Bloomsbury Resident/ Ward
care only
3. Long term Hospice/Nursing
Home care
4. Refused
5. Disease regressed/Too early
6. Inappropriate because__
7. Other
DATE PLANNED
Number of weeks after loss I
	
II
MODE OF CONTACT 1. Visit
2. Letter
3. Card
4. Telephone
5. Other
DX_	 1. Sister
2. Doctor
3. Social Worker
L.
0 3 i
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4-7
1	
1-3
SHEET NO 1
33-34
35-37
8
DATE
-,
- -
WEEK 0 1 2 3 4 5 6 7 8 910 11
-
12
Pain control
Other symptom control
Patient anxiety
Family anxiety
Patient insight
Family insight
Predictability
Planning
Practical
Financial
Wasted time
Spiritual
Comm between patient dr family
Comm between professionals .
Comm profs to patient di family
Professional anxiety
vising profs
TOTAL
CONTACT WITH TEAM
Key team worker
DAYS IN	 Home 
Hospital
Hospice
OTHER MAIN SYMPTOM
KARNOFSKY
QL Mobility
QL Daily living
QL Health
QL Support
QL Outlook
QL TOTAL
AC
r
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25-26
28-29
43-44
It•
Et,
4-20
I1	 124-1S
21-13
-a
4-1
Eli
LIL
Team B
^
NAME SEX M/F
AGE I I I
POST CODE
Status 1. Married	 2. Widowed	 3. Divorced/Separated
4. Single	 5. Other
Nationality 1. British	 2. Irish	 3. Greek	 4. Italian
5. Asian	 6. W. Indian	 7. African	 8. Other
Religion 1. C/E	 2. R. Catholic	 3. Greek Orthodox
4. Jewish	 5. Other Religion
6. Atheist	 7. Agnostic
Living alone
or living with	 1	 2	 3	 4	 5 Others
NEAREST CARER 
1. Wife
	
2. Husband	 3. Daughter	 4. Son	 5. Sister
6. Brother 7. Friend	 8. Other
Carer's Work 1. Part-time	 2. Full-time	 3. No job	 4. Retired
Carer's Karnofsky
G.P.
Address:
Hospital:
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Date first diagnosed 2740
13-34.
31 -31.
Other diagnoses causing symptoms 
1.
2.
II
11
Date of Referral 
6A— So
2.
DIAGNOSIS
Metastatis	 1.	 2.	 bo
DISEASE SITE MOST ACTIVE
1. Primary site	 2. Metastatis	 3. Other diagnosis
	
03;
Referred by
1. GP
	 2. Radiotherapist
	
3. Oncologist	 4. Surgeon
5. Physician 6. Other 	 31
Name of Referrer
39-61
Time diagnosis to referral
(1) 0 - 1 mth	 (2) 1 - 3 mths	 (3) 3 - 6 mths	 (4) 6mths - 1 year	 [11] 46
(5) 1 - 2 years	 (6) 2 - 3 years	 (7) 3 - 5 years	 (8) 5+ years
REASONS FOR REFERRAL	 1.	 [1:111-01
SOCIAL CIRCUMSTANCES
ACCOMMODATION:
1. Owner occupied 2. Private rented 3. Council 4. Hostel 5. Other
ACCESS:
1. Ground Floor
	 2. By lift	 3. By stairs
S-52-
292
1-3
2. DIED
DATE
Days from referral to death
PIED_ aLdealh	 1. Home
2. Hospital
3. Hospice
LI
ELI
FOI LOW-UP 
1. DISCHAREIED/PENDINO
DATE
Days from referral to discharge 1 1 , 1 1
Roam 1. Left area Els
2. Not resident in home care
area/ Ward care only
3. Long term Hospice/Nursing
Home care
4. Refused
5. Disease recruessed/Too early
6. Inappropriate because....
7. Other
BEREAVEMENT FOLLOW-UP
_L_Ita 2.1E35 11
REASON NUMBER OF PEOPLE.
I. No relatives NAMES
2. Relatives live out of area Relations to patient
	 I. Wife 20
2. Husband 2.
3. Not enough contect
	 3. Daughter
4. Son
.2
as
4. Refused	 5. Sister
6. Brother
as
.w.mnnnn5. No need because	 7. Friend
8. Other
1nn••n
6. Other 21
DATE PLANNED
Number of weeks after loss
MODE OF CONTACT 1. Visit
2. Letter
3. Card
4. Telephone
5. Other
13.Y_
	 1. Sister
2. Doctor
3. Social Worker
NOTES / ADDITIONAL INFORMATION
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3 I $.3
r -,
1 I
5
-2.L.
,vrt
'34
. 3-t-
,ts
DATE
WEEK 0 i 2 3 5 6 lo I I	 12..
Pain control
Other symptom control
Patient anxiety
Family anxiety
Patient insight
Family insight
Predictability
Planning
Practical
Financial
Wasted time
Spiritual
Comm. between patient & family
Comm. between professionals.
Comm. profs to patient & family
Professional anxiety
Advising profs.
TOTAL
CONTACT WITH TEAM
Key team worker
DAYS IN Home
Hospital
Hospim
OTHER MAIN SYMPTOM
KARI4OFSKY
i.i.4i4-..: ... .
.
.
.
. .
..
...-...-.
......
. ..	 ......
...
.
Teem anxiety
COMMENTS
.	
.
..
___....
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atus	 1. Married
tionality I. British
6. W. Indian
1.
6.
C/E
Athiest
ligion
53-54
to LLII
55-56
P. Weeks: from
Team C
Date of first contact
Request for help/Referral Form
.p Requested By 
	
Designation 	
Behalf Of 
	 Location Hospital 	
Community 	
D.A  U 
0.P  D	
i Contact Was Made	 Initiated by Requestor
	
Initiated by Self
	
ASONS FOR REFERRAL 1.
2.
tient's Name 	 Age 	 Telephone Number 	
dress 	
2. Widowed	 3. Divorced/Separated 4. Single 5. Other
2. Irish	 3. Greek	 4. Italian 5. Asian
7. African	 8. Other
2. R.Catholic 3. Greek Orthodox	 4. Jewish 5. Other
7. Agnostic
VING ALONE
LIVING WITH 1 2 3 4 >5 OTHERS
!y Person/Next of Kin 	 Telephone Number
lATION 1. Wife 2. Husband 3. Daughter 4. Son 5. Sister 6. Brother
7. Friend 8. Other
1. Part/ 2. Full-time 3. No Job/ 4. Retired
	
Carer's Karnofskyl	 i	
1	
I
	
I I	 _1
	 Telephone Number 	
Lse 	
 District Nurse 	
her 	
AGNOSIS
	
DATE FIRST DIAGNOSED
F,TASTASIS	 1.	 2.
CHER DIAGNOSIS CAUSING SYMPTOMS 1. 	 2.
[SEASE SITE MOST ACTIVE 1. PRIMARY SITE 2. METASTASIS 3. OTHER DIAGNOSIS
IRK
6ae diagnosis to referral (1) 0-1
(5) 1-2
:COMMODATION: 1. Owner occupied
5. Other
mth (2) 1-3 mths (3) 3-6 mths (4) 6 mths-1 year
yrs (6) 2-3 yrs (7) 3-5 yrs (8) 5+ yrs
2. Private rented 3. Council 4. Hostel
:CESS:	 1. Ground floor	 2. By lift	 3. By stairs
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SUMMARY OF WORK
iith whom did you work? Patient/Family/Requestor/Other Staff
Other Staff: Cons./Jnr Doctor/Sister/Staff Nurse/SEN/Student Nurse/S.W./
G.P./D.N./Health Visitor/Home Help/Agency Nurse/Priest/Other
]ow many times did you see the patient alone?
Bow many times did you see the patient with staff?
How many times was contact made by telephone?
How many times did staff contact us?
How many times did you contact the staff?
In Hospital
	 At Home 
I	 I	 I	 I
I	 I	 I
I	 I
In Hospital
	
At Home 
I	 I
I 	 I	 I	 I
DISCHARGED/PENDING	 DATE	
Reason 1. Left area 2. Non-Resident/Ward care only
3. Long term Hospice/Nursing Home 	 4. Refused 5. Disease regressed/Too early
6. Inappropriate because 	  7. Other
1. Home
DIED From Cancer/Other
SUDDEN DEATH Yes/No
Where did the patient die?
BEREAVEMENT FOLLOW-UP
Date
2. Hospital	 3. Hospice
1.
1.
2.
3.
4.
5.
6.
NO
REASON
No relatives
Relatives live out of area
Not enough contact
Refused
No need because 	
Other
2. YES	 NUMBER OF PEOPLE
NAMES
Relations to patient	 1. Wife
2. Husband
3. Daughter
4. Son
5.	 Sister
6. Brother
7. Friend
8. Other
DATE PLANNED
Number of weeks after loss
MODE OF CONTACT:
BY.
1. Visit
2. Letter
3. Card
4. Telephone
5. Other
1. Sister
2. Doctor
3. Social Worker
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DATE
1	 I	 ,	 1
I
--- •	 -
I
WEEK N MBER
„ApprAMMOVAIIIVAMI
AillEMIEWIMINIMAI
GOALS
SYMPTOMS: -
1.	 PAIN
2.	 OTHER
1
ANXIETY: - A I I ra a I rid ra el M I IngiNel 111511 NOWA I 111 I We
1.	 PATIENT
2.	 FAMILY 1
INSIGHT:- ,	 7-	 7	 .	 '	 /	 ,	 7
.	 PATIENT
I	 i
1
2.	 FAMILY
PREDICTABILITY
PLANNING
.	 •
PRACTICAL
FINANCIAL
WASTED TINE
SPIRITUAL I	 i
,
COMMUNICATION : - , , /	 / / / / / / 1 '
	
7	 , /	 / / / 
1. PATIENT TO FAMILY
I
i
2. BETWEEN PROFESSIONAL •
PROFESSIONALS TO
3. PATIENT AND FAMILY
PROFESSIONAL ANXIETY
ADVISING PROFESSIONALS
.
1 OTHER MAIN SYMPTOM	 I
CONTACT
KEYWORKER (S) L	 i
/ // 	 / // /// //./.DAYS IN:— 1 /// /////
-HOME I
- HOSPITAL
1 -HOSPICE
_.
KARNOFS KY
COMMENTS -plus
(Carer' s Karnof sky if
changing)
10 '7
25
IIIHOSPITAL NUMB ER
HOSP I TAL
WARD
PHONE NO.
DISTRICT NURSES
SOCIAL WORKER
SOCIAL SERVICES / OTHER AGENCIES
CONSULTANTS
OTHER HOSPITAL STAFF
HOSPITAL SOCIAL WORKER
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Team D
NAME
	 SEX M/F
DATE OF BIRTH	 AGE
ADDRESS
	 ACCESS ROUTE
Area	 1. Hammersmith 2. Fulham
	 3. Chiswick	 4. White City	 5. Earls Court
6. Middlesex	 7. Out of Area
PHONE NUMBER E.
Status I. Married 2. Widowed 3. Divorced / Separated	 4. Single	 5. Other
Nationality 1. British 2. Irish 3. Greek	 4. Italian 5. Asian
6. W. Indian 7. African O. Other
la
Religion I. C / E 2. R. Catholic 3. Greek Orthodox
	 4. Jewish 5. Other Religion
6. Atheist 7. Agnostic
LIVING ALONE
OR LIVING WITH 1 2 3 4 >5_ OTHERS	
+5
NEAREST CARER
RFI ATION 1. Wife 2. Husband 3. Daughter 4. Son 5. Sister 6. Brother 7. Friend 8. Other
ADDRESS
	
•
EftW.CIPL	 I. Part / 2. Full-time
3. No Job / 4. Retired
Cnrer's Karnofsky
PHONE NUMBER
KEY RELATIVES OR OTHER FRIENDS
0.P.
ADDRESS
I	 I 41-6-42
32.
I	 I
33 -
S.F
35-
3'
-
3o
LJ
6. Other
31-to
DIAGNOSIS
DATE FIRST DIAGNOSED
rIFTASTASIS
	 1.	 2.
DTHFR  DIAGNOSFS  CAUSING  SYMPTOMS
1.
2.
DISEASE  fiLT.E.P1OSI ACTIVE 1. PRIMARY SITE
2. rETASTASIS
3. OTHER DIAGNOSIS
REFERRED  BY I. GP 2. Radiotherapist 3. Oncologist 4. Surgeon 5. Physician
NtnE
DATE OF REFERRAL
Time diagnosis to referral: 1. 0-1 mth 2. 1-3 mths 3. 3-6 mths 4.6 mins - 1 yew 5. 1-2 yrs
6. 2-3 yrs 7. 3-5 yrs 8. 5+ yrs
DATE FIRST SEEN
REASONS FOR REFERRAL 1.
2.
Other Main Problems at Referral:
Drugs at Refer&
SOCIAL CIRCUMATANCES:
ACCOMODAT ION: 1. Owner ozcupied 2. Private rented 3. Council 4. Hostel 5. Other
ACCESS:	 1. Ground floor	 2. By lift	 3. By stairs
NOTES / OTHER RELEVANT INFORMATION
Prognosis estimate: fromt 	 I tor-ri weeks	 53-Su
299
INTENSITY	 DURATION	 NATURE & COMMENTS
None
Mild	 weeks /
Moderate	 months
Severe
Overwhelming
e.g. Intermittent or Constant
Sharp / Dull / Colic
PAIN 1
PAIN 2
OTHER
PAINS
300
BEREAVEMENT FOLLOW-UP
REASON
1. No relatives EL
24
74
21
34
ag
31.
21
31.-
11
ge
AY_	 1. Nurse
Z Dcctor
3. Social Worker
3,-
is
NOTES / ADDITIONAL INFORMATION HI
FOI IOW-UP 
1. DISCHARGED/P ENDI NO
DATE
Days from referral to discharge f	 I I:-
Reason I. Left area
	 01.
2. Non Resident in Home care area
/ Ward are only
3. Long term Hospice/Nursing
Home care
4. Refused
5. Disease regressed/Tco eerly
6. Inappropriate because....
2. DIED
DATE
Days from referral to teeth I
no_ of death
	
1. Home
2. HosPital
3. HasPics
r I
1°11:
os
I	  ti 11266,
16
7. Other
•
2-11.5
NUMBER OF PEOPLE.
NAMES .
2. Relatives live out of area
3. Not enough contact
4. Refused
5. No need because__
6. Other
Relations to patient
DATE PLANNED
Number of weeks
MODE OF CONTACT
-
I. Wife
2. Husband
3. DeoStiter
4. Son
5. Sister
6. Brother
7. Friend
a. other
1. Visit
2. Letter
3. Card
4. Telephone
5. Other
after loss 	 I_ 1
Dal
301
1	 4-1
3 0 li- 1-3
DATE
5 b "7- V 9 10 1 1
g Pain control
Other Symptom control
Patient anxiety
Family anxiety
Patient insight
Family insight
Predictability
Planning
Practical
Financial
Wasted time
Spiritual
Comm. between patient & family
Comm. between professionals.
Comm. profs to patient & family
Professional anxiety
Advising profs.
2- TOTAL26.
03NTACT WITH TEAM
2%-21 Key team worker
DAYS IN	 Home
Hospital
WEEK
r
1Hospice
OTHER MAIN SYMPTOM
33-
314
35 - Of SKY
3+
COMMENTS
.1"1007.0"..4V-Affr.///.. ArOMar"
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Dg
9-10
1-10-
if -2,9
Team E
Date:
Place:
'Ii
Hospital No.
Patient No.
Name:	 M / F
Address:	 Age:
• Sheet 1
I-
 1 orsi.
-3
I
Initial Assessment
D. of B.
0/c of Pt:
0/c of H/H
Tel
Area: 1. Bickley	 2. Biggin Hill	 3. Bromley 4.0rpington 5. Chislehurst
6. Petts Wood 7. Farnborough 8. St. Paul's Cray 9. St. Mary's Cray
10. Other
Map Ref:
Status	 1. Married 2. Widowed	 3. Divorced/Sep	 4. Single 5. Other
Nationality	 1. British 2. Irish 	 3. Greek	 4. Italian 5. Asian
6. W. Indian 7. African	 8. Other
Religion	 1. C/E	 2. R. Catholic 3. Greek Orthodox 4. Jewish
5. Other Religion	 6. Atheist 7. Agnostic
Living alone 	  or living with 1 2 3 4 5+ Others
•
Nearest Carer:
Relaticn 1. Wife 2. Husband 3. Dawthz er 4. Son 5. Sister 6. Brother
-7 . Friend 8. Other
Address:	 Carer's Work 1. Part/	 2. Full-time
2. No Job k . Retired
Carer's Karnofsky
Tel:
G .P.	 Hospital
23
Address:
	 Consultants:	
H 
Tel:
Diagnosis
Date first diagnosed:
Metastasis:	 1.	 2.
Other diagnoses causing symptoms:
1.
2.
Disease site most active: 1. Primary site 2. Metastasis 3. Other diagnosis
303
Reasons for Referral:	 1. [II q:P -4/
63-54.
55-64
sheet 1B
Referred by: 1. G.P.	 2. Radiotherapist	 3. Oncologist	 4. Surgeon
5. Physician 6. Other
NAME:
Date of referral
Time diagnosis to referral
(1) 0-1 mth	 (2) 1-3 mths	 (3) 3-6 mths	 (4) 6 mths - 1 year
(5) 1-2 year	 (6) 2-3 year	 (7) 3-5 years	 (8) 5+ years
MUM
D.
2. I	 10-So
Present Condition
Appetite Nausea Vomiting Dysphagia Weight
Bowels Mict. Incont. Discharges Bleeding
Sleep Cough Dyspnoea Bedsores Oedema
Weakness Headaches Anxiety Confusion Depression
Pain Sore Mouth Vision Hearing
H.P.C.
P.M.H.
Cigarettes
	 Alcohol
Social circumstances:
Accomodation 
1. Owner occupied 2. Private rented 3. Council 4. Hostel 5. Other
OP
Access 
1. Ground Floor	 2. By Lift 3. By Stairs E:152
Prognosis estimate: 	 weeks from II I ton-1
304
INTENSITY	 DURATION	 NATURE & COMMENTS
None
Mild	 weeks /
Moderate	 months
Severe
Overwhelming
e.g. Intermittent or Constant
Sharp! Dull / Colic
PAIN 1
PAIN 2
OTHER
PAINS
305
Initial Assessment
Sheet 2
Observation
Insight
(a) Patient
(b) Family
Auxiliary services
G.P.	 O.T.
DIN	 SBH Volunteer
PHYSIO	 M.O.W.
S.W.	 H.H.
H.V.	 OTHER
306
SOCIAL RECORD
Admission
Diagnosis
GPANTS - BENEFITS
plied
Existing
	 For 
Supplementary
Benefit
Mobility
Attendance
Invalid Care
NSCRChange of
diagnosis
REPORT AND RECORD
(Each entry mist be signed)
Space for family tree
DATE
,
307
4-1
Elice_ aLsIcalli 1. Home
2. HA Hospital
2b. Other Hospital
3. Hospice
a
2. DIED
DATE
Days from referral to death I
	
II
a,
a-mt
LI,
0 S
FOLLOW-UP 
1. DISCHAROED/PENDINO
DATE
Days from referral to discharo I
	
I	 I	 II;
Reason 1. Left area	 OS
2. Non	 Resident / Ward
care only
3. Long term Hospice/Nursing
Home care
4. Refused
5. Disease regressed/Too early
6. Inappropriate because....
7. Other
BEREAVEMENT FOLLOW-UP
L_Mil
REASON
1. No relatives
2-XF.3
IT.
 NAMES
NUMBER OF PEOPLE.
2. Relatives live out of area
3. Not enough contact
4. Refused
5. No need because.....
6. Other
Relations to patient 1. Wife
2. Husband
3. Daughter
4. Son
5. Sister
6. Brother
7. Friend
B. Other
DATE PLANNED
Number of weeks after loss
MODE OF CONTACT I. Visit
2. Letter
3. Card
4. Telephone
5. Other
EIY_	 1. Nurse
2. Doctor
3. Social Worker
4. Voluntary Berea-
vement Carer
[	
0 31
S. c.	 E	 ,
ranted. with Patient ACIMOOLTIeceet
Visits ( +OPD)
Day II	 33Phone RhTChemotherapy I
Night NB
Total Flotron
SO
308
3 1 -3
DATE 
WEEK 0 3 44 . 6 4 to 12_
g Pain o3ntrol 
Other Symptom control
Patient anxiety 
Family anxiety 
Patient insight 
Family insight 
Predictability
Planning 
Practical
Financial
Wasted time 
Spiritual
Comm. between patient & family
Comm. between professionals.
Comm. profs to patient & family
Professional anxiety
Advising profs.
TOTAL
CONTACT WITH TEAM
ai-21 Key team worker
DAYS IN	 Home 
Hospital 
Hospice 
OTHER MAIN SYMPTOM
33-
35- KARNOFSKY
COMMENTS
374,-5
44.
309
